SI8110859A8 - Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host - Google Patents

Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host Download PDF

Info

Publication number
SI8110859A8
SI8110859A8 SI8110859A SI8110859A SI8110859A8 SI 8110859 A8 SI8110859 A8 SI 8110859A8 SI 8110859 A SI8110859 A SI 8110859A SI 8110859 A SI8110859 A SI 8110859A SI 8110859 A8 SI8110859 A8 SI 8110859A8
Authority
SI
Slovenia
Prior art keywords
leu
glu
arg
gln
ser
Prior art date
Application number
SI8110859A
Other languages
Slovenian (sl)
Inventor
Walter Charles Fiers
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Priority claimed from YU859/81A external-priority patent/YU45104B/en
Publication of SI8110859A8 publication Critical patent/SI8110859A8/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

POSTUPAK ZA PROIZVODNJU POLIPEPTIDA TIPA HUMANOG FIBROPLASTNOG INTERFERONAPROCEDURE FOR THE MANUFACTURE OF A HUMAN FIBROPLAY INTERFERON TYPE POLYPEPTIDE

Oblast tehnikeTechnical field

Pronalazak je iz oblasti bio-tehnoloških postupaka za sintezu polipeptida. Oznaka prema Medjunarodnoj klasifikaciji patenata je C 07 C 103/52; C 12 N 15/00; C 12 P 21/02; C 07 H 21/04; A 61 K 45/02.The invention is in the field of biotechnological processes for the synthesis of polypeptides. The designation according to the International Patent Classification is C 07 C 103/52; C 12 N 15/00; C 12 P 21/02; C 07 H 21/04; A 61 K 45/02.

Tehnički problemTechnical problem

Sadašnjim pronalaskom rešen je tehnički problem postupka za proizvodnju polipeptida tipa IFN-beta njihovom ekspresijom u transformisanom domačinu, pri čemu je transformacija domačina izvršena prethodno lociranim i izolovanim sekvencama i rekombinantnim molekulima DNK koji kodiraju za ekspresiju HuIFN-beta.The present invention solves a technical problem of a method for producing IFN-beta type polypeptides by their expression in a transformed host, wherein the transformation of the host is effected by previously located and isolated sequences and recombinant DNA molecules encoding for HuIFN-beta expression.

Stanje tehnikeThe state of the art

U ovoj prijavi korističe se nomenklatura interferona objavljena u Natur», 284, p. 2421 (10 joll, 1980). Ova nomenklatura zamenjuje ono koja Je korifidena o naiim raniJim prijavama na osnovu kojih sadafin prijava Ima prioritet. P.pr., IP je sada označen kao IFN a fibroblaetn i' interferon je sada označen IPR—beta.This application uses the interferon nomenclature published in Natur », 284, p. 2421 (10 Joll, 1980). This nomenclature supersedes the one that has been amended on our earlier applications on the basis of which the now-finalized application has priority. P.P., IP is now designated IFN and fibroblaetn and 'interferon is now designated IPR-beta.

Poznato je da posteje dve klase interferona (IFH). Interferoni Klase I sn mali (gliko)-proteini, a talilni n kiselinama, koji čine deli je otpomii’ na infekciju virusima (λ, Issacs and J. Lindennann, •Virus Interference I. Interferon*, Proč» Royal Soc. Ser. B., 147, pp. 258-67 (1957) I W.E. Stevart, II, «Pha Interferon Svste», Springer-Verli (1979)(ovde kasnije The Interferon Syatea·))»Klasa II IFN su labilni i kiselinana. Trenutno, oni su slabo okarakterisan!. Mada su u irvesnom obimu specifični na de lije (The Interferon Sveten, pp. 135-45), IFN nisu specifidni na viruse. I zaista, IFN Stiti deli je protiv širokog spektra virusa.It is known to fast two classes of interferons (IFH). Class I interferons are small (glyco) -proteins, and melt-n-acids, which make up the components, repel 'virus infection (λ, Issacs and J. Lindennann, • Interferon I. Interferon *, Away »Royal Soc. Ser. B ., 147, pp. 258-67 (1957) AND WE Stevart, II, "Pha Interferon Svste", Springer-Verli (1979) (hereafter The Interferon Syatea ·)) "Class II IFNs are labile and acidic. Currently, they are poorly characterized !. Although they are specific for de leves (The Interferon Sveten, pp. 135-45), IFNs are not virus specific. Indeed, IFN Stiti shares it against a wide variety of viruses.

Ljudski interferon (HuIFN·) je klasifikoran u tri grupe, alfa, beta i gam. HuIFN-beta ill fibroblastni interferon se proizvodi posle odgovarajude Indukcije u diploidnia fibroblastni® delijana. Takodje se proizvodi u ainomim količinam, zajedno sa glavno® količino® HuIFN-alfa, u limfoblastoidni» delijana. IFN-beta napravljen iz ovih deli ja je ekstenzivno prečiSden i okarakterisan (E. Knight, Jr., •Interferon t Purification And Znitial Characterization Pro® Bunan Diploid Celi··, Proč. Kati. Aoad. Sol. OSA, 73, pp. 52023 (1976).Human interferon (HuIFN ·) is classified into three groups, alpha, beta, and gamma. HuIFN-beta or fibroblast interferon is produced after appropriate Induction into diploidnia fibroblast® delian. It is also produced in anomalous amounts, together with the major® amount of HuIFN-alpha, into the lymphoblastoid »delian. IFN-beta made from these parts is extensively cross-linked and characterized (E. Knight, Jr., • Interferon t Purification And Znitial Characterization Pro® Bunan Diploid Whole ··, Contd. Kati. Aoad. Sol. OSA, 73, pp. 52023 (1976).

To je gliko-protein aoleknlske težine oko 20,000 (M. M^ranovskaStevart, et al., Contributions Of Carbohjdrate Moieties To The Physi And Biologioal Properties of Humane Leukocyte, Lys^phoblastoid And Fibroblast Interferons, Abet. Ann. Maeting Anar. Soc. Mlcroblol., p. 246 (1978). Takodje je heterogen u pogledu veličine verovatno zbog ugljenhidratnih vrsta.It is a glycol protein of aolecnl weight of about 20,000 (M. M ^ ranovskaStevart, et al., Contributions of Carbohydrate Moieties To The Physi And Biologioal Properties of Humane Leukocyte, Lys ^ phoblastoid And Fibroblast Interferons, Abet. Ann. Maeting Anar. Soc. Mlcroblol., P. 246 (1978) It is also heterogeneous in size probably because of its carbohydrate species.

Aainokiselinski sastav autentičnog ljudskog fibroblastnog interl roaa je takodje objavljen (E. Knight, Jr., et al., Huaan Fibroblast Interferon: Anino Acid Analysis And Anino-Terainal Anino Acid Seguence, Science, 207, pp. 525-26 (1980)). X abjašnjavanje aztinckiselinske sekvence autentiSnog ljudskog fibroblastnog proteina je n napredovanju.The amino acid composition of authentic human fibroblast interl roaa has also been published (E. Knight, Jr., et al., Huaan Fibroblast Interferon: Anino Acid Analysis And Anino-Terainal Anino Acid Seguence, Science, 207, pp. 525-26 (1980)) . X explaining the amino acid sequence of an authentic human fibroblast protein is n progression.

Do sada, obkavljena je aminokiaelinska sekvenca NHj teminusa autentiSno« zrelog proteina sa prvih 13 aninokiselinskih ostataka: Met-Ser-TyrAan-Leu~Leu-Gly-Phe-Leu-Gln-Arg-Ser-Ser... (E. Knight, Jr., et al., gore).Until now, the amino acid sequence of the NHj teminus has been authenticated to an authentically mature protein with the first 13 amino acid residues: Met-Ser-TyrAan-Leu ~ Leu-Gly-Phe-Leu-Gln-Arg-Ser-Ser ... (E. Knight. Jr., et al., Above).

Dva distinktna gena, jedan lociran na hranozoan 2, drugi na hronozossu 5, objavljeno je da kodiraju za IFH-beta (D.L. S late and F.H. Ruddle, Fibroblast Interferon In Man Is Coded Tvo Loči On Separate Chromosones, Celi, 16, pp. 171-80 (1979))· Medjutin, druga proučevanja ukazuj u da je gen za IPH-beta lociran na hronosonu 9 (A. Medger, et al. Involvenent Of A Gene On Chronosone 9 Zn Hunan Fibroblast Interferon Productioa”, Mature, 280, pp. 493-95 (1979).Two distinct genes, one located on Foodsan 2 and the other on Chronososus 5, have been reported to code for IFH-beta (DL S late and FH Ruddle, Fibroblast Interferon In Man Is Coded Tvo Loci On Separate Chromosones, Celi, 16, pp. 171 -80 (1979)) · Medjutin, other studies indicate that the IPH-beta gene is located on chronosone 9 (A. Medger, et al. Involvenent Of A Gene On Chronosone 9 Zn Hunan Fibroblast Interferon Productioa ”, Mature, 280. pp. 493-95 (1979).

Mada je autentični HuIFN-beta glikozlllran, uklanjanje ugljeahidrž ne vrste (F. J. Bridgen, et al., Hunan Lynphoblastoid Interferon*,Although an authentic HuIFN-beta glycosyllran, the removal of a carbohydrate species (F. J. Bridgen, et al., Hunan Lynphoblastoid Interferon *,

J. Biol. Chen., 252, pp. 6585-87 (1977)) lli sinteza IFH-beta u prisustvu inhibitora Sija je svrha da iakljuSe glikoziliranje (H. E. Stevart, II, et al., *8ffect of Glyoosylatiee Inhibitors On The Prodne ti o And Pruperties of Hean Leukcyte Interferon, Vlrology, 97, pp.J. Biol. Chen., 252, pp. 6585-87 (1977)) or the synthesis of IFH-beta in the presence of a Sia inhibitor is intended to induce glycosylation (HE Stevart, II, et al., * 8ffect of Glyoosylatiee Inhibitors On The Prodne ti on And Pruperties of Hean Leukcyte Interferon, Vlrology. 97, pp.

473-76 (1979) ; J. Fujisava, et al·, Honglyoosylated Mouse L Celi Interferon Produced By The Action of Tunicaarfcin, J. Biol. Chezu, 253 pp. 8677-79 (1978); E. A. Havell, et al·, *Altered Molecular Bpsoies Of Hunan Interferon Produced in the Prosence of inhibitors of Glycosvlation J. Biol. Chem., 252, pp. 4425-27 (1977); The Interferon Systsn, p. 181) daje sanji oblik IFH-beta koji jofi uvek zadrfava najvedi dao 111 celokupni deo od svoje 37H aktivnosti.473-76 (1979); J. Fujisava, et al ·, Honglyoosylated Mouse L Whole Interferon Produced By Tunicaarfcin Action, J. Biol. Chezu, 253 pp. 8677-79 (1978); E. A. Havell, et al ·, * Altered Molecular Bpsoies Of Hunan Interferon Produced in the Proslence of Glycosvlation Inhibitors J. Biol. Chem., 252, pp. 4425-27 (1977); The Interferon Systsn, p. 181) gives a sleeker form of IFH-beta, which joffes always keep the most 111 of its 37H activity.

HuIFH-beta, kao 1 smogi ljudski proteini, note takodje biti poli* raorfan. Zbog toga, čelija odredjenih pojedinaea mogu proizvoditl IFN-beta vrste koje sn unutar opSt1je IFM-beta klase koje sn fiziološki slične ali sn strukturno neznatno različlte od prototipa klase čiji sn deo. Zbog toga, dok je proteinska struktura IFN-beta uglavnom dobro definisana, odredjeni pojedino! mogu prolzvodlti IFN-beta koji su neznatne varijaclje opšteg tipa.HuIFH-beta, as 1 smog human protein, should also be poly * raorphic. Therefore, the cells of certain individuals may produce IFN-beta species that are within a general IFM-beta class that are physiologically similar but structurally insignificantly different from the prototype class of which sn is a part. Therefore, while the protein structure of IFN-beta is generally well defined, some individually! can produce IFN-beta, which are minor variants of the general type.

IFN-beta ae obično ne de tek tu j e n normalnim ill zdravim čelijama (The Interferon Svstea, pp. 55-57). umesto toga, protein se proizvodi kao posledica izlaganja čelije ITN induceatn. IFN indueenti sn obično virusi ali takodje mogu biti antivirusnog karaktera kao ito su prirodn« 111 slntetske RNA sa dvostrukom niti, intračelijski mikrobi, mikrobni proizvodi i razna hemijska sredstva, činjeni su brojni pokušaj! da se iskorlste ovi nevlrusai indueenti da se ljudkse čelije učine rezlstentnia na virusno ingekciju (S. Baron and F. Bianzani (eds.), Teras Reports on Blolocrr And Medicine, 35 (Teras Reports), pp. 528-40 (1977))· Ovi pokuiaji niso bili vrlo uspešni, umesto toga, sada je poieljno koriščenje egsogenog BuIFN-beta.IFN-beta is not normally found in normal or healthy cells (The Interferon Svstea, pp. 55-57). instead, the protein is produced as a consequence of exposure to the ITN induceatn cell. IFN induce sn agents are usually viruses but can also be of antiviral character, such as naturally occurring double stranded RNA slats, intracellular microbes, microbial products and various chemical agents, numerous attempts have been made! to exploit these neurus and inducers to make human cells resistant to viral injection (S. Baron and F. Bianzani (eds.), Teras Reports on Blolocrr And Medicine, 35 (Teras Reports), pp. 528-40 (1977)) · These attempts were not very successful; instead, the use of exogenous BuIFN-beta is now preferred.

Terapija interferenca protiv virusa 1 tumora ill karcinoma vršena je u raznim doznim intervalima i sa rasnim načinima davanja (The Intor feron System, pp. 305-321). Na primer, interferon je efikasno davan oralno, inokulaoljom — intravenozno», intranuskularnom, intranazalno» intradermalnom i potkoinom — i u obliko kapi sa (Ao, masti 1 sprejova Obično se daje 1 do 3 pata dnevno o dozama 10 do 10 jedinica. Obira terapije savlsi od paoljenta 1 stanja koje se tretira. Na primer, virusne infekcije se obično tretiraju sa 1 lli 2 doze dnevno tokom nekoliko dana do dve nedelje a tnaori 1 karcinomi se obično tretiraju sa jednom 111 više doza dnevno tokom nekoliko meseci iii godina. Najefikasalju terapiju sa odredjenog paoljenta mora naravno odrediti lekar, koji če razmotrlti takve dobro poznate faktore kao što su tok bolesti, prethodna terapija i pacijentova reakcija na interferon sa izbor načina davanja i doznog intervala.Therapy for interference against tumor 1 virus or cancer was performed at various dose intervals and with racial routes of administration (The Intor feron System, pp. 305-321). For example, interferon is effectively administered orally, with an inoculum - intravenously, intranusally, intranasally, "intradermally, and subcutaneously - and in the form of drops with (Ao, fat 1 sprays. It is usually given 1 to 3 pats a day for doses of 10 to 10 units. For example, viral infections are usually treated with 1 or 2 doses a day for a few days to two weeks and tnaori 1 cancers are usually treated with one 111 multiple doses a day for several months or years. the particular patient should, of course, be determined by a physician, who will consider such well-known factors as the course of the disease, previous therapy and the patient's response to interferon with the choice of route of administration and dose interval.

Kao antivirusno sredstvo BalTO js korilden ss slededes respiratorne infekcije (Teras Reports, pp. 486-96)»herpes simpleks karatitis (Teras Reports, pp. 497-500» R. Sundnacher, Erogenous Interferon in Eye Diseases, International Vlrologv IV« The Bagae, Abstract nr. W2/ll, p. 99 (1978))» akatnl hesnragičnl konjaaktivitis (Teras Reports, pp. 501-10)» adenovirasni keratokonjunktivitis (A. Sooano, et el., ISM Meao I-A8131 (Oktober, 1979))» varičela soeter (Teras Reports, pp. 511-15)» elteoegalovirusne infekcije (Teras Reports, pp. 523-27)» i hepatitis B (Teras Reports, pp. 516-23). Vidi takodje The interferon Sveten, pp. 307-19. Msdjutln, koriidenje ITO kao antlvirasnog sredstva zahteva vede količine ITO nego Sto en doseda bile prietspačne.As an antiviral agent BalTO is corilden with following respiratory infections (Teras Reports, pp. 486-96) "herpes simplex caratitis (Teras Reports, pp. 497-500" R. Sundnacher, Erogenous Interferon in Eye Diseases, International Vlrolog IV "The Bagae , Abstract nr. W2 / ll, p. 99 (1978)) »Acute Hesnragic Conjunctivitis (Teras Reports, pp. 501-10)» Adenoviral Keratoconjunctivitis (A. Sooano, et al., ISM Meao I-A8131 (October, 1979 )) "Varicella soeter (Teras Reports, pp. 511-15)" elteoegalovirus infections (Teras Reports, pp. 523-27) "and hepatitis B (Teras Reports, pp. 516-23). See also The interferon Holy, pp. 307-19. However, using ITO as an antidote requires more ITO than has been anticipated so far.

ITO iaa druge efekte pored evog entivlruenog dejstva· Be primer, on antagoniznje efekat faktora stisnlisanja kolonija, inhibira rast kana deli ja koje fomiraju hemopoletska kolonija i <neta nerealna diferenci jeclja prekursora granalocita 1 makrofaga (TeraB Reports. op. 343-49). On takodje inhibira erltroidna diferencijacija aa DMSO-tretirania delijama Prisad leukemije (Teras Reports, pp. 420-28) · Snačajno je da neke deli jeke linije noga biti značajno oeetljivlje na BalTO-beta neg* na BaZTO-alfa a ovca pogleda (S. Einhom sad H. Strander, Is Interferon Tissa«-8peclfio? - Bffect of Banan Leukocyte And Pibrcblaet Interferona On The Groath of ppaphoblastoid And Oeteoeareona Celi Lines*, J. Cen, Virol., 35, pp. 573-77 (1977)» T· Kosata, et al·, Coaparlson Of The Suppresslon Of celi And Virus Groath In Trsna formed Banan Celiš By Leukoepte And Pibrcblaet Interferon, J. Gen. Virol.,ITO Has Other Effects Apart from Its Entivlruded Effect · Be an example, it antagonizes the effect of colony squeezing factors, inhibits the growth of henna fragments forming hemopoietic colonies, and has no unrealistic differentiation of the macrophage granalocyte precursor marrow (TeraB Reports. Op. 343-49). It also inhibits erltroid differentiation of aa by DMSO-treatment with delays. Leukemia Attack (Teras Reports, pp. 420-28) · It is significant that some parts of the echo line of the leg are significantly more sensitive to BalZo-beta neg * to BaZTO-alpha and the sheep gaze (S. Einhom sad H. Strander, Is Interferon Tissa «-8peclfio? - Bffect of Banan Leukocyte And Pibrcblaet Interferon On The Groath of ppaphoblastoid And Oeteoeareon Whole Lines *, J. Cen, Virol., 35, pp. 573-77 (1977)» T · Kosata, et al ·, Coaparlson Of The Suppresslon Of Whole And Virus Groath In Trsna Formed Banana Celish By Leukoepte And Pibrcblaet Interferon, J. Gen. Virol.,

43, pp. 435-39 (1979)).43, pp. 435-39 (1979).

ITO stoSe takodje igrati aloga a regulacij i ismnoloSke reakcije.ITO will also play a role in regulation and technological reaction.

Re prieer, zavosno od doze 1 vremena prinene a odnosa na antigen.Re prieer, depending on the dose of 1 time of yield and the antigen ratio.

ΙΓΝ nože biti i imunopotennirajuči i imunosupresivan in vivo i in vitro (Texas Reports, pp. 357-69). Dalje, zapadeno je da specifično senzltivir&ni limfociti proizvode ITO posle kontakta sa antitelom. Takav antigenom indukov&ni ΤΓΝ rože zato biti regultator imunološke reakcije, utičuči i na cirknlaeiju nivoa antigena i na ekspresijo čelijskog imuniteta (Texas Resorts, po. 370-74). Takodje je poznato da IPN pojačava aktivnost limfocita ubica 1 delijama-posredovana citotoksičnosti zavlzne od antitela (R.R. Herberman, et al., Augmentatlon By Interferon of Human Matural And Antibody-Dependant CellMediated Cytotoxicity, Mature, 277, op. 221-23 (1979); P. Beverly and D. Knight, *Kllling Comes Maturally, Hattre, 278, pp. 119-20 (1979); Texa» Reporta, pp. 375-80; J. R. Hiddlestone, et al., Inducti And Kinetios Of Matural Killer Celiš in Humana Folloving Interferon Therapy, Nature, 282, pp. 417-19 (1979); S. Einhorn, et al., Interferon And Spontaneous Cytotoxicity In Man. II. Studie« In Patients Recelving Ezogenous Leukocyte Interferon, Acta Med» Soand., 204, pp. 477-83 (1978)). Oba mogu biti direktno iii indirektno sključeni u imunološkem napadu na Čelije tumora.ΙΓΝ Knives are both immunopotential and immunosuppressive in vivo and in vitro (Texas Reports, pp. 357-69). Furthermore, it is noted that specifically sensitizing lymphocytes produce ITO after contact with the antibody. Such antigen-inducing antigens therefore serve as a regulator of the immune response, affecting both the circulation of antigen levels and the expression of cellular immunity (Texas Resorts, pp. 370-74). IPN is also known to enhance murine lymphocyte activity by deletion-mediated antibody-dependent cytotoxicity (RR Herberman, et al., Augmentatlon By Human Matural Interferon And Antibody-Dependant CellMediated Cytotoxicity, Mature, 277, op. 221-23 (1979) ; P. Beverly and D. Knight, * Kllling Comes Maturally, Hattre, 278, pp. 119-20 (1979); Texa »Reporta, pp. 375-80; JR Hiddlestone, et al., Inducti And Kinetios Of Matural Killer Celiš and Humana Folloving Interferon Therapy, Nature, 282, pp. 417-19 (1979); S. Einhorn, et al., Interferon And Spontaneous Cytotoxicity In Man II Studies "In Patients Recelving Esogenous Leukocyte Interferon, Acta Med" Soand ., 204, pp. 477-83 (1978). Both can be directly or indirectly contracted in an immune attack against Tumor Cells.

Zbog toga, pored njogovog koriščenja kao antivirusnog sredstva, HuZPM ima potencijalnu primenu u antltumomoj 1 antikancerogenoj terapiji (The Interferon System, g». 319-21 1 394-99). Poznato je da IPM utiče na rast mnogih klasa tumora u mnogim Slvotinjama (The Interferon System, pp. 292-304). Interferonl, kao 1 mnoga druga antitumorna sredstva izgleda ju najefikasniji kada se primene protiv malih tumora. Antitumoml efekti šivotinjskog IPM zavisnl su od doze i vreaena ali au demonetrirani u konoentraoijama ispod toksičnih nivoa. Prana torne, vršena su brojna istraživanja 1 kllničkl testovi 1 nastavljaju da se vrše u oblasti antitumornih i antlkaneerogenih osobina HuIFN. Ova uključuju tretiranja nekoliko malignih bolesti kao što ja oeteoaarkom, akutna milelidna leukemija, multipli mielomi 1 Hodikinsova bolestTherefore, in addition to its use as an antiviral agent, HuZPM has a potential application in antithumoma 1 anticancer therapy (The Interferon System, g ». 319-21 1 394-99). IPM is known to influence the growth of many classes of tumors in many Slavic countries (The Interferon System, pp. 292-304). Interferonl, like many other antitumor agents, seems to be most effective when used against small tumors. The antitumoml effects of animal IPM were dose- and baggy but demon- strated in conoentraea below toxic levels. Prana thorne, numerous investigations have been performed 1 clnical tests 1 continue to be performed in the field of antitumor and anticancer properties of HuIFN. These include treating several malignancies such as I oeteoaarcoma, acute myelid leukemia, multiple myeloma 1 Hodikins disease

- 7 Taras Reports, pp. 429-35). Dalje, pokazano je nedavno da HuIPN-beta izaziva lokalna regresij« tumora kada se obrizga a potkoSne teaorne fivorove kod melanoma 1 pacljenata napadnntih ea ifednino««» dojke (T. Nemo to, et al., Human Interferona And Intralesional Therapp Of Melanoma And Breast Carčinoma. Amer. Assoc. Por Cancer Research, Abs. nr. 993, p. 246 (1979)). Mada su rezultati ovih klničklh tastova ohrabrujudi, antltumorne i antikancerogene primane ΧΡΝ-beta sa bile jako oteiane nedostatkom adekvatnog izvora prečiidenog ZPH-beta.- 7 Taras Reports, pp. 429-35). Furthermore, HuIPN-beta has recently been shown to induce local tumor regression when truncated and subcutaneous tea fivors in melanoma 1 of the invading ea ifednino breast (T. Nemo to, et al., Human Interferon And Intralesional Therapp Of Melanoma And Breast Carcinoma. American Assoc. Por Cancer Research, Abs 993, p. 246 (1979). Although the results of these clinky tastes were encouraging, antitumor and anticancer prim-beta recipients were severely swollen by the lack of an adequate source of purified ZPH-beta.

Značajno je de neke deli jeke linije koje ee opira antideli jakim efektima IFN-alfa ostaju osetljive za ΠΉ-beta. Ovaj difereneijalni efekat sugerira da se IFN-beta mole uspeBno koristiti protiv lzvesnih klasa otpornih deli ja tumora koje ae javljajo pod selektivnim pritiskom kod pacljenata tretiranih sa visokim dozama ZPN-alfa (T. Kuva ta, et al«, gore; A. A. Creasv, et al., The Bole of G^-Gj Arreet In The Inhibition Of Tumor Celi Grovth By Interferon, Abstracts, Conferenee On Regulator? Punctions Of Interferona. M.I. Acad. Sci., nr. 17 (October 23-26,Significantly, some parts of the echo lines that resist the antibodies with strong IFN-alpha effects remain sensitive to ljive-beta. This diferential effect suggests that IFN-beta may be used successfully against certain classes of resistant tumor portions that occur under selective pressure in patients treated with high doses of ZPN-alpha (T. Kuva ta, et al, supra; AA Creasv, et al., The Bole of G ^ -Gj Arreet In The Inhibition Of Tumor Whole Grovth By Interferon, Abstracts, Conferenee On Regulator? Punctions Of Interferon. MI Acad. Sci., No. 17 (October 23-26,

1979)).1979).

Na biokemijskem nivou IPN lndukuju formiranje najmanje 3 proteina, protein kinaze (B. Lebleu, et-1., Interferon, Double-Stranded RNA And Protein Phosphorylation, Proč. Mati. Acad. Sd. USA, 73, pp. 3107-11 (1976); A. G. Hovanesslan and I. il. Nerr, The (2*-5*) Ollgoadenplate (ppp Α2'-5Α2'-5·Α) Saynthetase And Protein Kinase(s) Prom InterferonTreated Celiš, Bur. J. Blochem., 93, pp. 515-26 (1979)), (2’-5')oligo{ polpmeraae (A. G. Hovanesslan, et al., Spnthesla Of Lev-Moleeular Neight Inhibitor Of Protein Spntheels Nlth Bnzyme Prom InterferonTreated Celiš, Nature, 268, pp. 537-39 (1977); A. G. Hovanesslan and I.M. serr, Bur. J. Blochem., stroga) 1 fosfodiesherase (A. Schmidt, et al·, An Interferon-Induced Phosphodiesterase Degrading (2'-5')oligolsoadenvlate And The C-C-A Terminu» Of tRNA, Proc.Natl.Acad.Sci.At the biochemical level, IPNs induce the formation of at least 3 proteins, protein kinases (B. Lebleu, et-1., Interferon, Double-Stranded RNA And Protein Phosphorylation, Proceedings of the Mother. Acad. Sd. USA, 73, pp. 3107-11 ( 1976); AG Hovanesslan and I. il Nerr, The (2 * -5 *) Ollgoadenplate (ppp Α2'-5Α2'-5 · Α) Saynthetase And Protein Kinase (s) Prom InterferonTreated Celish, Bur. J. Blochem. , 93, pp. 515-26 (1979)), (2'-5 ') oligo {polpmeraae (AG Hovanesslan, et al., Spnthesla Of Lev-Moleeular Neight Inhibitor Of Protein Spntheels Nlth Bnzyme Prom InterferonTreated Celish, Nature, 268 , pp. 537-39 (1977); AG Hovanesslan and IM serr, Bur. J. Blochem., strict) 1 phosphodiherase (A. Schmidt, et al ·, An Interferon-Induced Phosphodiesterase Degrading (2'-5 ') oligolsoadenvlate And The CCA Term »Of tRNA, Proc.Natl.Acad.Sci.

- 3 OSA, 76, pp. 4788-92 (1979,).- 3 OSA, 76, pp. 4788-92 (1979).

I IFN-beta i iFN-alfa izgleda da akti vira ju slična anziiaatske puteve (C. Baglioni/ aInterferon-Induoed Lnzjmatic Activities And Their .Role In The Antiviral State4/ Celi, 17, pp, 255-64 (1979) i oba mogu deliti zajedničko aktivno unutrašnja icosto zato što oba raapoznaju dalij ski receptor kodiran ca krcEiosoir.o?i 21 (M. Viranovzska-Stevart,I IFN-beta and IFN-alpha seems to sources cited by similar anziiaatske Roads (C. Baglioni / Interferon-a Induoed Lnzjmatic Activities And Their .Role And The State Antiviral 4 / Cell, 17, pp 255-64 (1979) and both may share a common active inner cleft because they both recognize the distal receptor encoded by krcEiosoir.o? i 21 (M. Viranovzska-Stevart,

The Rele Of Human Chromosoiie 21 in Senzitivity To Interferona”/ «J. Gen. Virol., 37, pp. 629-34 (1977)). Izgled jednog iii više od ovih enzima u delijama tre tirani® aa ΙΓ77 treba da omoguči dal ju karakterizacija proteina ea aktivuo^du slienora ea ΙΓΝ.The Releases of Human Chromosoiie 21 in Sensitivity to Interferon ”/“ J. Gen. Virol., 37, pp. 629-34 (1977). The appearance of one or more of these enzymes in the tertiary ® aa ΙΓ77 deletions should be facilitated by further characterization of the protein ea by the activator of slienora ea ΙΓΝ.

Dana* ae HuIFN-beta proizvodi ljudskim delijakim linijama kultivisanim u kulturi tkiva· To ja skupi postupak niskog prinosa. Jedan veliki producent pravi aas» oko 40-50 x 10 jedinica S ir ovog IFN-beta na godinu (V.G. Edy, et al., Human Interferons Large Scale ProductionDana * ae HuIFN-beta Produces Human Partial Lines Cultured in Tissue Culture · This is a costly low yield procedure. One large producer makes aas »about 40-50 x 10 units S ir of this IFN-beta per year (V.G. Edy, et al., Human Interferons Large Scale Production

In Embrio Fibroblast Culturas, u Huanan Interferon (W. R. Stinebring and R. J· Chapple, eds.}, Plenum Publishing Corp., pp. 55-60 (1978))·In Embrio Fibroblast Culturas, in Juan Interferon (W. R. Stinebring and R. J · Chapple, eds.}, Plenum Publishing Corp., pp. 55-60 (1978)) ·

Posle prečiščavanja adaorpcijom na staklenim zrnima kontrolisanih pora, noše se izolovati IFH-beta specifična aktivnost o<3 oko 10 jedinica/mg u 50% prinosu iz ekstrakata sirovih deli ja (A. Billiau, et al.,After purification by adsorption on glass beads of controlled pores, IFH-beta specific activity of <3 about 10 units / mg in 50% yield from the extracts of the crude parts was isolated (A. Billiau, et al.

Human Fibroblast Interferon For Clinical Trialst Production, PartialHuman Fibroblast Interferon For Clinical Trialst Production, Partial

Purufucation And Characterization, Antimlcrobial Aoents And Chemother« py, pp. 49-55 (1979)). Dalje prečiščavanje na specifična aktivnost o od oko 10 jediniea/mg postiše se ciak-helatnom afinitivnom hromatografijom u oko 100% prinosu (A. Billiaa, et al., Production, Purifica* tlon And Properties Of Human Fibroblast Interferona, Abstracts, Conference Oa Re<yulatoryFcnctlons of Interferons, N.T, Acad. Sci., nr. 2 (October 23-25, 1979))· Zato Sto je specifična aktivnost HuITN—beta tako visoka, količina IFN-beta potrebna za kooercijalne primene je niška. Ha primer, 100 g čistog IFH-beta obezbedide izmedju 3 i 30 ailiona dosa.Purufucation And Characterization, Antimlcrobial Aoents And Chemother «py, pp. 49-55 (1979). Further purification to a specific activity of about 10 units / mg was achieved by cyan-chelate affinity chromatography in about 100% yield (A. Billiaa, et al., Production, Purifica * soil And Properties Of Human Fibroblast Interferon, Abstracts, Conference Oa Re <yulatoryFcnctlons of Interferons, NT, Acad. Sci., nr. 2 (October 23-25, 1979)) · Because the specific HuITN-beta activity is so high, the amount of IFN-beta required for cooercial applications is low. For example, 100 g of pure IFH-beta provide between 3 and 30 illion doses.

~ 9 Sedavni napredak n molekularnoj biologiji oaogučio je uvodjenje DMA koja kodira za specifične nebakterijake eukariotske proteine u bakterijske delije. Uglavnom, sa DNA koja se razlikuje od one napravljene hemijekom sintezo», konstrukcija takvih rekombinantnih DNA molekula obuhvata faze proizvodnje proizvodnje DNA kopije sa jednom niti (cDNA) šablona prečiščene meelndžer RNA (fiRNA) za željeni protein/ konverzija cDNA u DNA sa dvostruko® niti/ vezivanje DNA za odgovara j ude mesto n odgovara j udom nosaču za kloniranje tako da se formira rekombinantni DNA molekul 1 onda se transformiBe odgovarajuči domačin sa tim rekombinantni» DNA molekule«. Takva transformacija može omoguciti domačinu da proizvodi protein. Dobiveno je nekoliko ne-bakterijskih gena i proteina u E. poli koriščenjem rekembinantne DNA tehnologije. Ovi uključuju, na primer, IFN-alfa (S. Naga ta, et al. £yathesie in E. coli Of A Polypeptide vlth Human Leukoejte Interferon Activity, Dature, 284, pp. 316-20 (1980))· Dalje, rekombinantna DNA tehnologija koriščena je sa proizvodnju plazmida za koji se kaže da sadrži sekvenca gena koja kodira za IFH-beta (T. Taniguchi, et al., Constructioa And Identification Of A Bacterial Plasmid Containing The Human F ib rob last Interferon Gene Seguence, Proč. Japan Acad. Ser. 55, pp. 464-59 (1979)).~ 9 Recent advances in molecular biology have facilitated the introduction of DMA, which codes for specific non-bacterial eukaryotic proteins into bacterial cells. Basically, with DNA different from that made by chemistry synthesis, "the construction of such recombinant DNA molecules involves the steps of producing a single strand (cDNA) DNA copy template production of the purified RNA (fiRNA) template for the desired protein / cDNA conversion to double-stranded DNA / binding the DNA to the corresponding n place where n corresponds to the two cloning carrier so that recombinant DNA molecule 1 is formed then the corresponding host is transformed with that recombinant "DNA molecule". Such transformation may enable the host to produce protein. Several non-bacterial genes and proteins have been obtained in E. poly using recombinant DNA technology. These include, for example, IFN-alpha (S. Naga ta, et al. £ yathesie in E. coli Of A Polypeptide vlth Human Leukoejte Interferon Activity, Dature, 284, pp. 316-20 (1980)) · Further, recombinant DNA technology has been used to produce plasmids that are said to contain a gene sequence encoding IFH-beta (T. Taniguchi, et al., Constructioa And Identification Of A Bacterial Plasmid Containing The Human F ib Slave Last Interferon Gene Seguence, Proc. Japan Acad. Ser. 55, pp. 464-59 (1979).

Medjutim, u ni jednom od prethodnih redova nije bila opisana stvarna sekvenca gena sa IEN-beta niti je ta sekvenca upored jena sa početnon aninokieelinskcm sekvencom lli sa aminokledinskim sastavern autentičnog IFN-alfa. Banijl redovi bili su uraereni samo na IFN-alfa, koji je distinktna kemijska, biološka i imunoločka Klasa I interferona od IFH-beta (cf. gore). Poslednji rad je na bazi samo hibridazadonih podat&ka. Samo ovi podaci ne omogučuju da se odredi da 11 izabrani klon sadrži kompletna ill stvarnu sekveacu gena koja kodira za ZFNbeta ill da de sekven-g kloniranog gena biti sposobna da izrazi iFK-beta u bakterijama. Hibridizacija samo dokazuje da jeHowever, in neither of the preceding rows was the actual sequence of the genes with IEN-beta described, nor was the sequence compared to the initial aninokieelin sequence or to the amino-acid composition of authentic IFN-alpha. Banijl lines were targeted only at IFN-alpha, which is a distinct chemical, biological and immunological IFN-beta class I interferon (cf. above). Recent work is based on hybridazadone data only. These data alone do not make it possible to determine that the 11 selected clone contains a complete or actual gene sequence encoding for ZFNbeta or that the sequenced-g of the cloned gene is capable of expressing iFK-beta in bacteria. Hybridization only proves that

- it u odredjeno· DNA insertu sekvenca u lzvesno· oblam honolega »a 1 kooplementama ea mRNA komponento· poli (A) RNA kako da indukuje interferonsku aktivnost kada se ubaci u oocite. štaviše, obim nakcje homolo je zavisten od lzabraaih oslova hibridizacije za postupak testiranja. Zbog toga, hibridizacija saao u oRiiA komponenta poli (A) RNA ne demonstrira da je izabrana DNA sekvenca sekvenca koja kodira za HuIFN-beta ill polipeptid koji iapoljava ilaunološku ill biološku aktivnost BulFN-beta lli da de takva sekvenca biti korisna u proizvodnji takvih polipeptida a odgovarajadia dooačiniaa.- it into a specific DNA insertion sequence in a conscious honolomegase with 1 co-complement of the ea mRNA component · poly (A) RNA how to induce interferon activity when inserted into oocytes. moreover, the extent of the nac homol is dependent on the selected hybridization axes for the test procedure. Therefore, hybridization of the saao to oRiiA component of poly (A) RNA does not demonstrate that the DNA sequence selected is a sequence encoding a HuIFN-beta or polypeptide that enhances the ilunological or biological activity of BulFN-beta or that such sequence will be useful in the production of such polypeptides a corresponding to doo dooiniaa.

Na seainaru n Cirihu 25 februara, 1950 Taniguchi Je naveo da je odredio nukleotidna sekvenca se jedan od njegovih hibridizujadlh klenova. Takodje je naveo da sa prvih 13 aminokiselina sa koje kodira ta sekvenca bile identične ee onima koje je odredio Knight, et al., gore za autentienu HuIFN-beta. Taniguchi nije opisao punu nukleotidnu sekvenca sa svoj klon niti je uporedio aiainokiselinski sastav sa sastavo antentlSaog HuIFH-beta. Taniguiehi je odonda objavlo punu nukleotidnu sekvenca sa svoj hibridizujudi klon (T. Taniguiehi et al.« Cene« 10« pp. 11-15 (1950))· Sekvenca se razlikueje za jedan nukleotid od one koja je opisana i saštideaa u Britanskoj patentnoj prijavi 8011306, koja je podneta 3 aprila, 1980, a to je prijava na bazi koje sadafinji prijava stiče prioritet, Audaokiseliaska sekvenca koju je naveo Taniguiehi je identična sa enom koja je opisana i zaštidena u prethodnoj prijavi. Taniguiehi takodje nije objavio ekspresiju u odgovarajudem domačinu polipeptida koji ispoljavaju imunološka iii bio fiku aktivnost HeIFN-beta u vreme poenotenja Britanske patentne prijave 89.18701, podnete 6 jona, 1980, prijav» na osnovu koje ova prijava zahteva prioritet. Baš ova ekspresija u doaačinu polipeptide koji ispoljavaju imunološku iii biolcŠku aktivnost UuIFN-beta 1 posl pci, polipeptid!, geni i njihovi rekombinantni DHA molekuli, karakterlšu ovaj pronalazak.At the Seainar n Zurich on February 25, 1950, Taniguchi stated that a nucleotide sequence was determined to be one of its hybridizable maples. He also stated that the first 13 amino acids from which the sequence encodes were identical to those determined by Knight, et al., Above for authentic HuIFN-beta. Taniguchi did not describe the full nucleotide sequence with its clone, nor did it compare the amino acid composition with the composition of the antentiSaog HuIFH-beta. Taniguiehi has since published a full nucleotide sequence with its hybridizing clone (T. Taniguiehi et al. "Prices" 10 "pp. 11-15 (1950)). The sequence differs by one nucleotide from that described and stored in the British patent application. 8011306, filed April 3, 1980, which is an application on the basis of which the present application is prioritizing, the Audaokiseliase sequence cited by Taniguiehi is identical to the one described and protected in the previous application. Taniguiehi also did not announce expression in the appropriate host of polypeptides that exhibit immune or biophysical activity of HeIFN-beta at the time of unification of British Patent Application 89.18701, filed 6 ion, 1980, on the basis of which this application claims priority. It is this expression of the polypeptides that exhibit the immune or biological activity of UuIFN-beta 1 agents, polypeptides, genes, and their recombinant DHA molecules, that characterize the present invention.

- 11 Uiti ee ovaj pronalazak odnosi kao što je očevidna sugestija Istrašivačkog Opisa Ho. 18309, pp. 361-62 (1979) da se napravi čista iii suštinski Sista mRNA. IFN-alfa pre pokušaj?» da se klonira IFN gen iii da se proizvedu fJLbroblastni polipeptidi slični interferonu u bakterijskim domačinima.- 11 Ui ee this invention will relate to such as the obvious suggestion of Research Description Ho. 18309, p. 361-62 (1979) to produce pure or substantially Sista mRNA. IFN-alpha before attempting? »To clone the IFN gene iii to produce interferon-like fJLbroblast polypeptides in bacterial hosts.

Konačno, treba da ae shvati da izbor ONA sekvence iii konstrukcija DNA molekula koji hibridisuje u ηΐΐ’Α iz peli?« DNA, pri čr.nu ta ®SNA proizvodi auIPlii aktivnost u oocitima, rije zodovoljavajuči da se demonstrira da DNA sekvenca hibridnog inserta rekembinantnog DMA molekula odgovara HuIFN. Umesto toga, u otsustvu upo r-s d jen ja aminokiselinske sekvence koja ae kodira pomodu odrodjone DMA sekvence 1 aminokiselinske sekvence autentičnog proteina, samo proizvodnja polipeptida koji ispoljava imunološku iii biološka aktivnost HnIFN moše stvarno demonstrirati da izabrana DNA sekvenca lli konstruirani tekosnbinantni DSA molekul odgovara HuIFN. Značajni je, samo posle takve nuIFN aktivnosti pokazano je da se DSA sekvenca, rekombinantni DNA molekul iii njima srodne sekvence mogu korisno upotrebiti prema ovom ovom pronalasku sa izbor drugih sekvenci koje odgovaraju HulFM lli sa proizvodnju rekombinantnih DNA molekula koji mogu izrašavati proizvode koji imaju imunološku lli biološku aktivnost HuIFN-beta.Finally, he needs to understand that the choice of the ONA sequence or the construction of a DNA molecule that hybridizes to ηΐΐ'Α from a pell? DNA, in black, that ®SNA produces auIPlii activity in the oocytes, sufficiently demonstrating that the DNA sequence of the hybrid insert is recombinant The DMA molecule corresponds to HuIFN. Instead, in the absence of an amino acid sequence that encodes a native DMA sequence 1 amino acid sequence of an authentic protein, only the production of a polypeptide that exhibits HnIFN immune or biological activity can truly demonstrate that the selected DNA sequence or DS construct is a DNA molecule. Significantly, only after such nuIFN activity has it been demonstrated that the DSA sequence, recombinant DNA molecule, or related sequences thereof, can be used useful in the present invention with the selection of other sequences corresponding to HulFM or the production of recombinant DNA molecules capable of expressing products having an immune or biological activity of HuIFN-beta.

Iz prethodnog de zato hiti jasno da se problem proizvodnje HuX?N-beta koriščenjem tehnologije rekombinantne DNA mnogo razlikuje od makojeg od gore opisanih postupaka. Ovde mora da se nad j e odredjene DNA sekvenca neposnete strukturo — koja kodira za ekspresijo HuIFN-bet u odgovarajučem domačinu — I da se odvoji iz vrlo kompleksne smeše DBA sekvenci u cilju da se koristi za proizvodnju HuIFN-beta. Dalje, ovaj problem lokacije 1 odvajanja je otežan predvidi vem ekstremno nlekem koncentracije» šel jene DNA sekvence u kompleksno j smeši i nedoststakom eflkasnlh sredstava za brzu analizu mnogih DNA sekvenci smeše radi izbora i odvajanja željene sekvence.It is therefore clear from the foregoing that the problem of HuX? N-beta production by using recombinant DNA technology is much different from any of the methods described above. Here, the specific DNA sequence must be restrained by a structure - encoding for HuIFN-beta expression in the appropriate host - and separated from a very complex mixture of DBA sequences in order to be used to produce HuIFN-beta. Furthermore, this problem of separation site 1 makes it difficult to predict the extremely extreme concentration of the desired DNA sequence in a complex mixture and the lack of effective means for rapid analysis of many DNA sequences of the mixture to select and separate the desired sequence.

Opis rešenja tehničkog problemaDescription of solution to a technical problem

Sadašnji pronalazak rešava probleme u vezi sa obezbedenjem, u saglasnosti sa pronalaskom, postupka za proizvodnju polipeptida koji poki zuju biološfcu iii imunološku aktivnost HuIFN-beta· Postupak iz sadašnji pronalaska je naznačen time št® se uzgaja domačin, koji je transformisi ea DNA sekvencama iii rekombinantnim DNA molekulima koji diriguju proi: vodnju polipeptida koji pokazuju imunološku iii biološku aktivnost H ul J -beta, i što se polipeptid ubira iz uzgojene kulture.The present invention solves the problems of providing, in accordance with the invention, a method for the production of polypeptides that exhibit biological or immunological activity of HuIFN-beta · The method of the present invention is characterized by the fact that a host is grown, which is transformed by DNA sequences or recombinant DNA molecules that conduct the proi: guided polypeptides that exhibit the immunological or biological activity of H ul J-beta, and that the polypeptide is harvested from the cultured culture.

Na osnovu ovog pronalaska moguce je dobiti polipeptide koji ispol, vaju imunološku iii biološku aktivnost HuIFN-beta za koriščenje u anti· virusnim i antitumomim iii antikancerogenim sredstvima i postupcima. Ovaj pronalazak omogučije proizvodnju ovih polipeptida u količinama i postupcima koji do sada nisu bili pristupačni.Based on the present invention, it is possible to obtain polypeptides exhibiting immunological or biological activity of HuIFN-beta for use in anti-viral and antitumor or anticancer agents and methods. The present invention makes it possible to produce these polypeptides in amounts and processes that have not been available so far.

Kao što ce biti jasno iz opisa koji sledi, postupak u kome se u o govarajučem domačinu zbiva replikacija navedenih DNA sekvenci i rekomb nantnih DNA molekula, omogučava u velikim količinama proizvodnju gena koji kodiraju za navedene polipeptide. Molekulska struktura i osobine polipeptida mogu se lako odrediti. Polipeptidi i geni su korisni, iii što su proizvedeni u domačinu, iii posle odgovarajuče derivatizacije i modifikacije., u preparatima i postupcima za detekciju i poboljšanje pr izvodnje ovih proizvoda, a i za koriščenje u anti virusnim, anti turno mi iii antikancerogenim sredstvima i postupcima.As will be apparent from the description that follows, the process of replicating said DNA sequences and recombinant DNA molecules in the talking host enables the production of genes encoding for said polypeptides in large quantities. The molecular structure and properties of polypeptides can be easily determined. Polypeptides and genes are useful, either produced locally, or after appropriate derivatization and modification, in preparations and methods for detecting and improving the performance of these products, and for use in anti-viral, anti-cancer, or anticancer agents and methods.

Ovaj postupak se zato jasno razlikuje od postupaka iz ranije nau koji su pomenuti gore, po torne sto ovaj postupak, nasuprot postupcima ranije nauke, uključuje pravljenje i izbor DNA sekvenci i rekombinantn DHA molekula koji sadrže odgovarajuče DNA sekvence koje kodiraju za ηε manje jedan polipeptid koji ispoljava imunološku iii biološku aktivnos HuIFN-beta.This method is therefore clearly different from the methods previously mentioned above, in that, as opposed to the methods of the prior art, it involves the production and selection of DNA sequences and recombinant DHA molecules containing the corresponding DNA sequences encoding for ηε at least one polypeptide that exhibits immune or biological activity of HuIFN-beta.

-15 Biče jasno iz prethodnog da je suštinski deo ovog pronalaska postupak za obezbedenje DNA sekvence koja se karakteriše time što kodira za polipeptid koji ispoljava imunološku iii biološku aktivnost HuIFN-beta, a bita se iz grupe koja sadrži DNA inserte G—pHFIF-1, G—pHFTF-3,G—pHFIF—6 G-pHFEF-7, G-pPla-HEEF-67-12, G-pPla-HFIF-67-12deltal9, GpPla-HiIF-67-8, G-pPla-HFIF-67-12delta279T, G-pPla-HFEF-67-12deita218Ml, G-pPla-HilF-6712deltaMl, G-pPla-HKF-67-12deltal9BX-2, DNA sekvence koje hidrolizuju u ma koji od prethodnih DNA inserataa, BNA sekvence, dobijene iz ma kojeg izvora, koje uključuju prirodne, sintetske iii polusintetske izvore, koje su srodne na osnovu mutacije, uključujuči jednostruku iii višestruke, zamene baza, izostavljanja, umetanja i inverzije sa ma kojim od prethodnih DNA sekvenci i inserata, i DNA sekvence koje obuhvataju sekvence iii kodone koji prilikom ekspresije kodiraju za polipeptid koji ispoljava sliČnu imunološku iii biološku aktivnost sa polipeptidom koji je kodiran posle ekspresije kodona ma kojom od prethodnih DNA sekvenci. Sekvence dobijene prema metodu iz sadašnjeg pronalaska se dalje koriste za proizvodnju HuIFN-beta i polipeptida sličnih HuIFN-beta u domačinima.-15 It will be clear from the foregoing that an essential part of the present invention is a method of providing a DNA sequence characterized by encoding for a polypeptide exhibiting immunological or biological activity of HuIFN-beta and selected from the group consisting of G-pHFIF-1 DNA inserts. G-pHFTF-3, G-pHFIF-6 G-pHFEF-7, G-pPla-HEEF-67-12, G-pPla-HFIF-67-12deltal9, GpPla-HiIF-67-8, G-pPla-HFIF -67-12delta279T, G-pPla-HFEF-67-12deita218Ml, G-pPla-HilF-6712deltaMl, G-pPla-HKF-67-12deltal9BX-2, DNA sequences that hydrolyze in any of the preceding DNA inserts, BNA sequences, obtained from any source, including natural, synthetic or semi-synthetic sources, related by mutation, including single or multiple, base substitutions, omissions, insertions and inversions with any of the preceding DNA sequences and inserts, and DNA sequences comprising sequences or codons that, when expressed, encode for a polypeptide exhibiting similar immune or biological activity with p an olpeptide encoded after codon expression by any of the preceding DNA sequences. The sequences obtained according to the method of the present invention are further used for the production of HuIFN-beta and HuIFN-beta-like polypeptides in the hosts.

Slika 1 je shematski prikaz jedne realizacije postupka iz ovog pronalaska za pravljenje smeše rekombinantnih DNA molekula, od kbjih se neke karakterišu umetnutim DNA sekvencama koje kodiraju za polipepti iz ovog pornalaska.Figure 1 is a schematic representation of one embodiment of the method of the present invention for making a mixture of recombinant DNA molecules, some of which are characterized by inserted DNA sequences encoding for polypeptides of this porn.

Slika 2 je shematski prikaz početnog postupka .za testiranje klona iz ovog pronalaska.2 is a schematic illustration of an initial process for testing a clone of the present invention.

Slika 3 je shematski prikaz jedne realizacije postupka za testirar klona koriščenjem DNA sekvenci napravljenih prema pronalasku.3 is a schematic representation of one embodiment of a method for a clone tester using DNA sequences made according to the invention.

Slika 4 prikazuje kompletnu nukleotidnu sekvencu nitiFigure 4 shows the complete nucleotide sequence of the strands

--.— .14Lt za kodiranje BuZFN-bata DBA. Sekvenca je označena brojevina od početk umetka kao 1 u netranslatiranoj oblasti umetka. Nukleotidi 65-127 pre stavljajn signalnu sekvenca a nukleotidi 128-625 pretstavljaju zreo flbroblastni interferon. Aainokiselinske sekvence slgnalnog polipeptida date su iznad njihovih odgovarajučih nukleotidnih sekvenci; aninokiseline slgnalnog polipeptida označene su brojevina od -21 do -la aminokiselina szelog interferona označene su brojevina od 1 do 166. Pregled podataka restrlkeione 1 fragmentne analize RuIFN-beta DNA prisutne u kulturi koja je deponovana u vesi sa patentnem prijave Velike Britanije 80.11306, podnete 3 aprila, 1980, pokazao je da su dva nukleotida promenjean na Slici 4 u poredjenju sa Slikam 4 te Britanske prijave. Ove premene su u netranslatiranoj sekvenci koja prethodni predlolenoj signalno j sekvenci BuIFN-beta ORA. Ove promene ne utiču na sekvenca BuIFN-beta DNA iii na aminokiselinsku sekvencu njenog translatacionog proizvoda 1 takodje ae meajaju koriščenje sekvenca kao hibridisaoione sonde sa ispitivanje klona za BuIFN-beta srodne DNA inserte.--.— .14Lt for encoding a BuZFN-bat DBA. The sequence is indicated by the number from the beginning of the insert as 1 in the untranslated region of the insert. Nucleotides 65-127 predate the signal sequence and nucleotides 128-625 represent mature flbroblast interferon. The amino acid sequences of the slgnal polypeptide are given above their respective nucleotide sequences; slg polypeptide anino acids labeled from -21 to -1 amino acids of the whole interferon numbered from 1 to 166. Review of restriction data 1 fragment analysis of RuIFN-beta DNA present in the culture deposited with UK patent application 80.11306, filed 3 April 1980, showed that two nucleotides were altered in Fig. 4 compared to Fig. 4 of that British application. These changes are in the untranslated sequence that precedes the predetermined signal sequence of the BuIFN-beta ORA. These changes do not affect the BuIFN-beta DNA sequence iii or the amino acid sequence of its translatable product 1, nor do they alter the use of the sequences as hybridization probes with clone testing for BuIFN-beta related DNA inserts.

Slik« 5 prikazuje orljentaciju i restrlkeione mape nekoliko pla: mida prema pronalasku.FIG. 5 shows the orientation and restriction maps of several plaques of the invention.

Slika 6 js ftporedjenje sminoklselinskog sestava ljudskog fibroblastaog interferona kao Sto je odredjen prema ovom pronalasku i onog koji js odredjen is auteatičnog fibroblastaog Interferona.Figure 6 is a comparison of the amino acid composition of the human fibroblast interferon as determined according to the present invention and the one that is also determined from the automatic fibroblast interferon.

Slike 7 prikazuje restrlkelonu mspu BumM>eta gena iz ovog pro laska i strategije sekveneiranja koja se koristi u sekvendranju pBFZF3, pBFIFi 1 pHTCF7.Figure 7 shows the restrackelone mspu of the BumM> eta gene from this sequence and the sequencing strategy used in sequencing pBFZF3, pBFIFi 1 pHTCF7.

Slika 8 je shematski prikaz konstrukcije rekombinantnog DNA molekula pPLa-HFIF-67-1 iz ovog pronaiaska.Figure 8 is a schematic illustration of the construction of recombinant pPLa-HFIF-67-1 DNA molecule from this invention.

Slika 9 js shematski prikaz konstrukcije rekombinantnog DNA molekula pPLa-BFIF-67-12 i pPLa-HFIF-67- 12*19 is ovog pronaiaska.Figure 9 is a schematic illustration of the construction of recombinant DNA molecules pPLa-BFIF-67-12 and pPLa-HFIF-67-12 * 19 from this finding.

* 15* 15

Slika 10 Ja sheaatskl prikaz koaztrakeija rekesfcinaatnog nm m» lakala ρΤηΑ-Ώ&ΗΡ-$7~9 is ovog pronalaska.Fig. 10 I sheaatskl view of the coaztrakei of the recesfinaat nm m »lacquer ρΤηΑ-Ώ & ΗΡ- $ 7 ~ 9 from this invention.

Slika 11 ja OhanatZki prikaz orljaataelje i pareijalna roatrifceion« mapa pPLa-HFXF-<7-l2 iz ovog pronalaska.Fig. 11 shows an Ohanatal view of the skeleton and a paired roatrifceion map of the pPLa-HFXF- <7-l2 of the present invention.

Slika 12 ja sheaatski prikaz orijentaelja i pareijalna matrik·» eioae napa gp£a*BFX^d?~12dl9 lz ovog pronalaska.Figure 12 shows a schematic view of the oriental and pareial matrix · »eioae hood gp £ a * BFX ^ d? ~ 12dl9 lz of the present invention.

Slika 13 ja aheaatski prikaz erijentaeije 1 pareijalna reatrdkelen<Fig. 13 i aheaatic view of erytheae 1 pareial reatrdkelen <

imasemn saChi gmotam ηαα&ΛΒη.imasemn saChi gmotam ηαα & ΛΒη.

eilja da aa ovde opisani proaalasak boljo razom« zate oa dajo aladadl dataljaa opla.He wants a better description of the process described here for you to give aladadl date opla.

Sofcleotld—» Mzomacna jadlaloa nm iii ΗΛ koja oo zastoji od Borfzrao vrata (pestom), fosfata i aaotna batarooiklidaa baza» Baza jz rožena sa Bedama vrata prske glikozidao «gljealka (1' agljanik pentozo) 1 ta »oahlaaolja baza 1 Bedam sova oo aeklzozid· Sasa korak* tarile aoklootld· Satiri BMk baza za adaaia (k), gazela (·β·), eitosia (*C·) i tista {»·). Satiri baza n 1, S, C l araeil <·9*|.Sofcleotld— "Tangible sailboat nm iii" that stalled by Borfzrao door (pestomo), phosphate and aaot batarooiklidaa base »A base born with Bedama door spray glycosidao« gleak (1 'aglyan pentozo) 1 ta »oahlaamol base a · Sasa step * tarile aoklootld · Satiri BMk base for adaaia (k), gazelle (· β ·), eitosia (* C ·) and those {»·). Satire base n 1, S, C l araeil <· 9 * |.

mm Sekvpaea—Llaosml rod aoklootida spoje&ib jedan sa drogi foafodiastarakia vezana iznadja 3* i 5* sgljantka zaaodaib pentoza«mm Sekvpaea — A llaosml genus of alochloid compound & ib one with drug foafodiastarakia bound upper 3 * and 5 * sgla zaaodaib pentose «

Kodoo** nm sakvoaaa tri aaklaotida (triplet) koja kodira preko s a SBlnokiseliaa, tranzlaelzai ztsrtal signal 171 translaeloai temi*** aaeleal zigaal« Sa priasr« adklootldal triplati TTk, TT6, CK» CK, CTk 1 CTS kodirajo za aaiaekieelina lozaota (*Xzuw), TbS, Tik i TA 1 to za translaeloai zzastavai signali a IM ja traazlaeizai polazni signal.Kodoo ** nm saquaaaa three aaclaotides (triplet) encoding via with SBlnokiseliaa, translaelzai ztsrtal signal 171 translaeloai temi *** aaeleal zigaal «With priasr« adklootldal triplets TTk, TT6, CK »CK, CTk 1 CTS encode for aaozaekieelina Xzu w ), TbS, Tik, and TA 1 to translaeloai the delayed signals and IM i traazlaeizai the starting signal.

«» —“ « trM«l«d.}· «& a pravilni mn sa ofiitszanja« Ba priaar, nm zekvanea GCTOOTTeTkke nora «· usrasiti α tri rana sa očitavanje iii tri faze, pri čenu evaka daje rasličite aninokieelinsku eekvenaut«» - «« trM «l« d.} · «& A proper mn from ofiitszanja« Ba priaar, nm zekvanea GCTOOTTeTkke nora «· to heal α three wounds with readings or three phases, whereby evaks give different aninokieelin eq.

GCT GOT TOT AAG—Ala-Glv-Cve-LvaGCT GOT TOT AAG — Ala-Glv-Cve-Lva

G CTg gTT GTK AG—Leu-Val—ValG CTg gTT GTK AG — Leu-Val — Val

GC TOG TTG TAA G—Trp-Leu- (STOP)GC TOG TTG TAA G — Trp-Leu- (STOP)

Polipeptid—Linearni red aninokiaellna spojenih jedna za drugu peptidnin vezana isnedju alfa-anino 1 karbekai grupa sosednih aminokiselina·Polypeptide — The linear order of aninociaellin-coupled peptidines linked to each other by alpha-anino 1 carbekai groups of adjacent amino acids ·

Genonr- Celokupna DMA delijo lli virusa. Vključuje Iznedju ostalo* strukturne gene koji kodiraju sa polipeptide aupetance,kao 1 sa operator, prenoter 1 vezivno mesto ribeson* 1 interekoiome sekvenc», uključujudl takve sekvence kao Sto au Shine-Delgamo sekvence.Genonr- All DMAs are shared by viruses. It includes, inter alia, * structural genes encoding aupetance polypeptide, such as 1 with the operator, prenoter 1 binding site of ribeson * 1 interecoome sequences, including such sequences as the Sto au Shine-Delgamo sequences.

Strukturni gen—DBA sekvenca koja kodira kros Šablon lli nesindSe BKA (aBBA) sekvencu aninokiaellna koja je karakteristične sa specifični polipeptid·Structural gene — a DBA cross-coding sequence A template or a non-indigenous BKA (aBBA) sequence of an aninokiaellar characteristic of a specific polypeptide ·

Transkripcija—Postanek proizvodnje ufiHA is struktuznog gena.Transcription — The start of ufiHA production from a structural gene.

TZgugaglja—Postopek sa proizvodnju polipeptida is nBHA.TGugaglja — The process of producing polypeptides and nBHA.

Ekspresija—Postupak kojen je podvrgnut strukturni gen sa proizvodnju polipeptida· To je koafeinacija transkripcije 1 translacije·Expression — A process that undergoes a structural gene to produce a polypeptide · It is a transcription 1 transcription caffeine ·

Plasnid— Sehraeosenna sekvence DBA sa dvostrukon niti koja obuhvata netaktnuti replikoa* tako da se plasnid replicira u daliji donadina· Kade se plasnid stavi unutar nonodelijakog organi sna, karakteristike tog organizma se noga menjati lli traaafomisati kao rezultat DBA plasnida. Ba priner, plasnid koji nosi gen sa otpornest na tetraciklin (Tat11) transfomiSe dalija koja jo bila prethodno oaetljiva na tetraciklin u deliju koja je rezistentna na njega.Plasnid - Sehraeosenic double-stranded DBA sequences that include intact replicas * so that the plasmid replicates in the distant donor · When the plasmid is placed within a non-partial organ of sleep, the characteristics of that organism are changed or transformed as a result of the DBA plasmid. Ba priner, a plasmid carrying a tetracycline-resistant gene (Tat 11 ), is a transfomile of dahlia previously sensitive to tetracycline in a resistant cell.

Čelija traasfandsana pleznidon sove se tranafomant.The cell of the traasfandsana pleznidon owl is a tranafomant.

Pag 111 bekterlofeo—Bakterijski virus od kojih mnogi sadrže DBA sokvenoe kepsulizane u proteinski anoteč ill prevlaku (*kapsidw).Pag 111 Bekterlofeo — A bacterial virus many of which contain DBAs encapsulated in protein anotech or coating (* capsid w ).

Bonač sa kloniran je— Plasnid, oba faga 111 druga ZIBA sekvencaThe cloner is cloned— Plasnid, both phages 111 the second ZIBA sequence

- 17 koja može da se replicira u daliji domačina, a karakteriše se man jim brojem mesta za raspoznacranje endonukleaza na kojim ase takve DNA sekvence mogu iseči na odred j en način bez gubi jen ja suš— tinske biološke funkcije DNA, n.pr., replikadje, proizvodnje proteina prevlake iii g-bljenja promotorskih iii mesta za vezivanje , i koji sadrži marker podestan za koriščenje u identifikaciji transformi sanih čelija, n.pr., otpornost na tetraciklin iii otpornost na ampicilln. Nosač za kloniranje se često sove vektor.- 17, which can be replicated in the host further and is characterized by a small number of endonuclease recognition sites at which such DNA sequences can be excised in a particular manner without loss of the essential biological function of the DNA, e.g. replicates, the production of a coating or g-binding protein of promoter or binding sites, and comprising a marker suitable for use in the identification of transformed cell salts, e.g., tetracycline resistance or resistance to ampicillin. The cloning carrier is often an owl vector.

Kloniranje— Postupak za dobivanje popualeije organizama lli DNA sekvenci izvedenih iz jednog takvog organizma lli sekvence aseksualno» reprodukcijo».Cloning - A process for obtaining popu- alia of organisms or DNA sequences derived from one such organism or sequences asexually "reproducing".

Rekonblnantnl DNA molekul ill Hibridna DNA— Molekul koji sadrži segmente DNA iz različitih genoma koji su bili spojeni kraj-za-kraj van živih čelija 1 imaju kapacitet da inficiraju neke čelije domačina 1 mogu se održavati u njima.Reconblnnt DNA molecule ill Hybrid DNA— A molecule containing DNA segments from different genomes that have been spliced end-to-end outside living cells 1 have the capacity to infect some host cells 1 can be maintained in them.

Sekvenca za kontrole ekspresije— Sekvenca nukleotida koja kontroliše 1 reguliše ekspresijo strukturnih gena kada su oni operativno povezani u tim genima. Oni uključuju lac sistem, glavne operaterske i promotorske reglone faga lambda, region za kontrolu fd proteina prevlake 1 druge sekvenee za koje se zna da koatrolišu ekspresijo gena prokarlotsklh iii eukarotskih čelija i njihovih virusa.Expression Control Sequence— The nucleotide sequence that controls 1 regulates the expression of structural genes when they are operatively linked in those genes. These include the lac system, the major operator and promoter regions of phage lambda, the fd protein control region 1 of the other sequence that is known to co-control the expression of prokaryotic or eukaryotic cell genes and their viruses.

Na Slici 1, mi smo prikazali shematski prikaz jedne realizacije postopka za pravljenje smeše rekombinantnih DNA molekula, od kojih neki uključuju umetnute DNA sekvence koje karakterišu ovaj pronalazakIn Figure 1, we have shown a schematic representation of one embodiment of a process for making a mixture of recombinant DNA molecules, some of which include the inserted DNA sequences that characterize the present invention

PRAVLJENJE POLI (A) RNA KOJA SADRŽI mRNA FIBROBIASTNOG INTERFERONA (IFN-beta BRNA)MAKING POLY (A) RNA CONTAINING FIBROBIA INTERFERON mRNA (IFN-beta BRNA)

RNA koriščena u ovom pronalasku ekstrahovana je iz humanih VOS čelija, diploidne fibroblastne čelijske linije koja se može propagirati u »enoslojnim kulturama na 37°c. IFN-beta ae proizvodiThe RNA used in the present invention was extracted from human VOS cells, a diploid fibroblast cell line that could propagate in single-layer cultures at 37 ° c. IFN-beta ae products

- 18 ta ovi» deli jasa poale indukcije a« poli(I,C) ta prisuatvu oiklohekaiialda.- 18 these "parts of the poala induction a" poly (I, C) of this oichlohekaiiald.

Sa tipično RNA isolovanje, svaka od 20 boca aa diploidno»With typical RNA isolation, each of 20 bottles aa diploid »

VGS delljaraa α konfluenters sloju prisira se preko nodl aa 100 jedinica/nl IFN-beta i kulture au indukovane 1 časa sa 100 ^ug/»l poli(I,C) 1 50 /Ug/al) ciklohekalinida, inkubirane au aa ciklohekallsidott (50 /Ug/»1) toke» 4 Sasa, obrane au grebanjem u fosfatr puferovani elani rastvor 1 centrifugirane su. čelije ae raakinu teko» 15 »in. na 0°C da ae odvoje netaknuta jesgra koja sadrže MIA i da se isoluje citoplasaična RNA auependovanjea u hipotoničnoi puferu (10 »M Tris-HCl (pl 7.4), 10 »M NaCl i 1.5 »M MgClj) i dodavanje» NP40 do 1%. Jesgra ae odvoje granulacijo» u Sorvall SS-34 rotoru tako» 5 »in sta 3000 rp». Dodaju ae natrijun-dodecilsulfat (SDS) 1 EDTA u aupernatant do lt, odnosno 10 »M, i aaeSa ae ekstrahuje 5 puta aa 2 x sapr. 1:1 redestiliaanog fenola i hloroforB-isoBBilalkohola (25:1), pti čeara ae vodene fase koje aadrla RNA odvajaju centrifugiranje» u Sorvall SS-34 rotoru na 8000 rp» toke» 10 »inuta posle svake ekstrakcije. RNA ae ataloži is vodene faae dodavanje» 1/10 sapr. 2 M natrljuv-acetata (pH 5.1} 1 2.5 sapr. etanola. Obično ae dobiva 60 do 90 /Ug ukupne citopla? tične RNA po boči.The VGS delljaraa α confluenters layer was primed over nodl aa 100 units / nl IFN-beta and culture au induced for 1 hour with 100 ^ ug / l poly (I, C) 1 50 / Ug / al) cyclohecalinide, incubated au aa cyclohekallsidott ( 50 / Ug / »1) points» 4 Sasas, defenses, and scratches in phosphate buffered saline 1 were centrifuged. cells ae raakinu fluid »15» and. at 0 ° C to separate the intact nuclei containing MIA and isolate cytoplasmic RNA auxiliaries in hypotonic buffer (10 »M Tris-HCl (pl 7.4), 10» M NaCl and 1.5 »M MgClj) and add» NP40 to 1 %. They separate the granulation »in the Sorvall SS-34 rotor both» 5 «and 3000 rp». They add ae sodium dodecyl sulfate (SDS) 1 EDTA in the aupernatant to lt, or 10 µM, and aaeSa ae extracted 5 times aa 2 x sapr. 1: 1 redistillated phenol and chloroforB-isoBBalalcohol (25: 1), five cups and aqueous phases separated by RNA separating centrifugation »in a Sorvall SS-34 rotor at 8000 rp» points »10» inut after each extraction. RNA ae attaches from aqueous faae addition »1/10 sapr. 2 M sodium acetate (pH 5.1} 1 2.5 ethanol. Usually 60 to 90 / ug total cytoplasmic RNA per bottle is obtained.

Takodje au koriSdeni drugi postupci sa ekstrakcije citoplaan. tične RNA. Na priatar, delijo ae totalno raakinu poale hoeogenisac je u 0.2 N Tria-HCl (pH 9.0), 50 »H NaCl, 20 »M EDTA i 0.5«Other cytoplaan extraction methods have also been used. tical RNAs. To the primate, the total raacin fraction was precipitated in 0.2 N Tria-HCl (pH 9.0), 50 "H NaCl, 20" M EDTA and 0.5 "

SDS 1 ekatrahuju ae aa fenol-hloroforno» kao gore (F. H. Reynolda et al·, Interferon Activity Produced By Translation Of Human Interferon Heaaenger EMA In Cell-Free Riboseaal Syate»a And Zn lanom» Ooocytea, Proč. Na tl, Acad. Acad, Sci.PSA, 72, pp. 4881-87 (1975)) 111 ae isprane delije suapenduju n 400 /Ul 0.1SDS 1 is extracted ae aa phenol-chlorophore »as above (FH Reynolda et al ·, Interferon Activity Produced By Translation Of Human Interferon Heaaenger EMA In Cell-Free Riboseaal Syate» And And Flax »Ooocytea, Proceed To tl, Acad. Acad , Sci.PSA, 72, pp. 4881-87 (1975)) 111 and the washed portions co-opted n 400 / Ul 0.1

-15M NaCl, 0.01 Μ Trls-BCl (pH 7.5) 1 0.001 Μ EDTA (*ΝΤΕ pufer) i 2.5 ml 4 Μ guanidinijum-izotiocijanata 1 1 M beta-merkaptoetanola u 20 mM natrljum-aeetata (pH 5.0) se dodaju a onda se čelije homogenlsuju. Lisat se rasloji na 1.3-ml 5.7 M CsCl sloja u Beckman SW-60 Ti nitroceluloznoj epruveti, rotira se pri 39000 rpn tako da se granulu j e RNA i odvoji se od DNA, proteina 1 lipida i SNA se ekstrahuje jednom sa fenol-hloroformom (J. Morser, et al., Charaoterisation Of Interferon Messenger SNA Fram Human Lymphobl*stoid Celiš, J. gen, Vlrol., 44, pp. 231-34 (1979)).-15M NaCl, 0.01 Μ Trls-BCl (pH 7.5) 1 0.001 Μ EDTA (* ΝΤΕ buffer) and 2.5 ml 4 Μ guanidinium isothiocyanate 1 1 M beta-mercaptoethanol in 20 mM sodium acetate (pH 5.0) are added and then the cells homogenize. The lysate was layered on a 1.3-ml 5.7 M CsCl layer in a Beckman SW-60 Ti nitrocellulose tube, rotated at 39,000 rpn so that the granule was RNA and separated from DNA, protein 1 lipid, and SNA was extracted once with phenol-chloroform ( J. Morser, et al., Charaoterisation Of Interferon Messenger SNA Fram Human Lymphobl * stoid Celish, J. Gen, Vlrol., 44, pp. 231-34 (1979).

Ukupna SNA se testira na prisustvo IFN-beta mRNA ubrizgavanjem u citoplazma Eancpas laevis oocita i odredjivanjem IFN-beta aktivnos koja se u njima indukuje (Rejnold, «tal., gore). Test se vrši rastvaranjem SNA u vodi i ubacivanjem oko 50 ^ul u svaki oocit. Oociti se inkubiraju preko noči na eobnoj temperaturi u Barth podloz (J. Gurdon, J. Bmbrvol. Bsper. Morphol., 20, pp. 401-14 (1968)), homogenlsuju se u delu podloge, otpacl se odvoje centrifugiranjem i odredi se IFN-beta aktivnost supernatanta. Detekcija IFN-beta aktivnosti bila je smanjlvanjem cltopatakog efekta (N. B. Stevart and S. E. Sulkia, Interferon Production in Hampsters Experimentally Infected Nith Babica Virus, Proč, Soc. Bsp. Biol. Med., 123, pp. 550-53 (1955))· Karatni virus bio je virus vesikularnog stoaatitisa (Indian soj) a čelije su bile ljudske diploidne flbroblastne čelije trlsomne sa hrcnosoa 21 tako da se dobiva viža IFN-beta osetl jivost. IFN-beta aktivnost izražava se u odnosu na IFN referentni standard 59/19.Total SNA is tested for the presence of IFN-beta mRNA by injection into the cytoplasm of Eancpas laevis oocytes and determination of the IFN-beta activity that is induced therein (Reynold, supra, above). The assay is performed by dissolving the SNA in water and injecting about 50 µl into each oocyte. The oocytes were incubated overnight at eobic temperature in Barth substrates (J. Gurdon, J. Bmbrvol. Bsper. Morphol., 20, pp. 401-14 (1968)), homogenized in part of the substrate, separated by centrifugation and determined. IFN-beta activity of the supernatant. Detection of IFN-beta activity was by reducing the cltopathic effect (NB Stevart and SE Sulkia, Interferon Production in Hampsters Experimentally Infected Nith Midwife Virus, Away, Soc. Bsp. Biol. Med., 123, pp. 550-53 (1955)) · Carat virus was a vesicular stoaatitis virus (Indian strain) and the cells were human diploid flbroblast cells trlsomna with cartilage 21, thus obtaining higher IFN-beta sensitivity. IFN-beta activity is expressed relative to IFN reference standard 59/19.

Poli (A) SNA koja sadrži IFN-beta aSSA izoiuje s« iz citoplasmat δηβ SNA adsorpcijom ollgo(dT)- celuloze (tip 7; P-L Biochemieals) u 0.4 M NaCl, 19 mM Tris-HCl (pH 7.8), 10 mK EDTa 1 0.2« 8DS tokom 10 minuta aa sobnoj temperaturi. Agregaclja SNA se minimlraPoly (A) IFN-beta aSSA-containing SNA isoylated with cytoplasmic δηβ SNA by adsorption of ollgo (dT) - cellulose (type 7; PL Biochemieals) into 0.4 M NaCl, 19 mM Tris-HCl (pH 7.8), 10 mK EDTa 1 0.2 «8DS for 10 minutes at room temperature. SNA aggregation is minimized

----- 20 segrevanjem SNA tokom 2 »in na 70°C pre adsorpcije. Poale ispiranja celuloze za gore spomenuti» pufero», frakcija poli(A) RNA se eluira sa 10 »M Tris-HCI (pH 7.8), 1 »M EDTA i 0.2« SDS. Ona obično obuli vata 4-Sr ukupne ΓΝΑ, kne 5tc jc morene cptičkora gustinen na 269 m----- 20 by heating the SNA for 2 "and at 70 ° C before adsorption. Cellulose leaching slides for the aforementioned "buffer", the poly (A) RNA fraction was eluted with 10 "M Tris-HCl (pH 7.8), 1" M EDTA and 0.2 "SDS. It usually raises 4-Sr watts of total ΓΝΑ, kne 5tc and more marine crickets at 269 m

Dalje prečiščevanja sa obogačivanja poli (A) PHA u IFN-beta »SNA vrši se pomoču forstaatld-saharoznih gradlenata (T. Pavson, et a.' The sla« of Rous Sarooma Virus aRNAz Activs Zn Cell-Free Trans lati< Nature, 268, pp. 416-20 (1977). Ovi gradienti daju »nogo više razlaganje od denattrisanih saharoznlh gradienata. Obično se oko 80 /Ug poli (A) RNA rastvori u 50% formaaidu, 100 zM LICI, 5 mM EDTA 0.2% SDS i 10 dH Tris-HCI (pH 7.4), zagreva na 37°C tokom 2 minuta tako da ae sprečl agregacija i šarfira se na 5-20% saharoznom gradientu u Beckman SW-60 Ti pollalomerne epruvete. Posle centrifug ranja na 20°C tokom 4.5 časa na 60000 rpm u Beckman SW-60 Ti rotoru sa ukupno» ^e-marklranom eukarlotskom SNA koja slufl kao marker veličine, pri čemu se gradient frakdonlše 1 odredi se optička gustina gradienta. Sve RHA frakcije ze staloie dva puta za 0.5 M NaCI i 2.5 sapr. etanola, i testira se na mRNA aktivnost kao što je opisano gore. Ovi postupci za prečiščevanje dovoda do oko 40-strukog povečanja u ZFN-beta mRNA sadriaju poli (A) RNA.Further purification from the enrichment of poly (A) PHA in IFN-beta "SNA is performed using forstaatld-sucrose gradients (T. Pavson, et a. 'The sla' of Rous Sarooma Virus aRNAz Activs Zn Cell-Free Trans lati <Nature, 268 , pp. 416-20 (1977) These gradients give slightly higher decomposition than denaturated sucrose gradients, typically about 80 / ug poly (A) RNA is dissolved in 50% formaide, 100 zM LICI, 5 mM EDTA 0.2% SDS and 10 dH Tris-HCl (pH 7.4), warmed to 37 ° C for 2 minutes so as to prevent aggregation and to be screwed on a 5-20% sucrose gradient in Beckman SW-60 Ti pollalomer tubes. 4.5 hours at 60000 rpm in a Beckman SW-60 Ti rotor with a total »e-labeled eukarlot SNA that serves as a size marker, determining the optical gradient density by gradient 1. All RHA fractions were quenched twice by 0.5 M NaCI and 2.5% ethanol, and tested for mRNA activity as described above. about a 40-fold increase in ZFN-beta mRNA contains poly (A) RNA.

Alternativno ee ollgo(dT)-edsorbovana mRNA (60 ^ug) frakcioniS elektroforesom na 4% pollakrilaaldnom golu u 7 Mkarbamidu, 0.1% SD 50 mM Tris-borata (pH 8.3) i 1 sW EDTA, pri čemu se mRNA rastvori u ovom puferu i zagreva 1 min na 55°C pre primene na gal. Posle elektroforeze isoku ze odel jel širine 2 m sa gela 1 RNA se eluira sa svakog homogenisovanog dela gela, dalje se oslobodnl nečistoča adsorpcijom na oligo(dT)-celulozi 1 testira ae na ZFN-beta mRNA kao ranije.Alternatively, ee ollgo (dT) -sorbated mRNA (60 ^ ug) fractionated by electrophoresis on a 4% pollacryaldal nude in 7 Mcarbamide, 0.1% SD 50 mM Tris-borate (pH 8.3) and 1 sW EDTA, whereby mRNA was dissolved in this buffer and heated for 1 min at 55 ° C before being applied to gal. After electrophoresis iso ze a 2 m wide section of gel 1 RNA was eluted from each homogenized portion of the gel, further cleared by impurity by adsorption on oligo (dT) cellulose 1 tested ae on ZFN-beta mRNA as before.

U ovom momentu treba da ae shvati da čak i poli (A) EMA prolsvc * 2.1: “ dobiven is formami d-eaharoznih gradienata niti is frakoionisanja na poliakrilamidnom gelu ne sadrži vrlo veliki broj različitih mRNA. I sure v sa mRNA koja je specifična sa IPN-beta, druge mRNA sa nepoželjni kontaminantl (Slika 1). Na nesreča, ove kontaainaatne RNA ponašaj u se slično u odnosu na HuIFN-beta mRNA u ostataku postupka kloniranja is ovog pronalaska. Zbog toga de njihovo prisustvo u poli (A) RNA dovesti do obavesnog pravljenja velikog broja neželjenih bakterijskih klenova koji sadrže gene koji mogu kodirati sa polipeptida koji se razlikuj u od IFN-beta. Ova kontaminaciji atvara kompleksne probleme u testiranju u isolovanju žaljenih IPN-beta hibridnih klona, ϋ »lučaju IPN-beta, problea testiranja se dalje uvedeva nedostatke« sadovoljavajude prečiščanog usorka HuIPN-beta mRNA ill ONA iii njenog dela sa dejstvo kao sonda sa testiranje ra identifikaciju žaljenih klenova. Zbog toga, postupak testiranja sa IFN-beta klone troši mnogo vremena 1 težak Je. Dalje, sbog vrlo melog procenta IFN-beta klona, sa koje se očekuje da če sami izraziti IPN-beta u biološki ill umunološkl aktivnem obliku, izolovanje aktivnog klona je igla u plaztu sena n postupku testiranja.At this point, it should be understood that even poly (A) EMA prolsvc * 2.1: “obtained both from d-echarous gradient forms and from fractionation on polyacrylamide gel does not contain a very large number of different mRNAs. I sure v with mRNA that is specific with IPN-beta, other mRNAs with undesirable contaminant (Figure 1). Unfortunately, these containeate RNAs behave similarly to HuIFN-beta mRNA in the rest of the cloning process of the present invention. Therefore, their presence in poly (A) RNA will lead to the obligatory generation of a large number of unwanted bacterial maples containing genes that can encode from a polypeptide different from IFN-beta. This contamination poses complex testing problems in isolating deplorable IPN-beta hybrid clones, "secreting IPN-beta, probing probes further introduces the disadvantages" of a solely purified HuIPN-beta mRNA ill ONA sample, or part thereof acting as a probe for identification testing. mourned maples. Therefore, the IFN-beta clone test procedure consumes a lot of time 1 heavy Je. Further, because of the very small percentage of IFN-beta clones that are expected to express IPN-beta themselves in biologically or immunologically active form, isolation of the active clone is a needle in a haystack n test procedure.

Podesno, mi možemo koristiti rekombinantnu DNA tehnologije za obe«bedjIvanje prečiščenog uzorka HuIFN-beta mRNA lli cDNA lli njenog dela. Prečiščena mRNA ill cDRA može se tada koristiti za brso testiranje vrlo velikog broja bakterijskih kloneva pa se tako značajno povešava verovataoča izolovan ja klona koji izražava IPN-beta u aktivnem obliku.Conveniently, we can use recombinant DNA technology to harbor a purified sample of HuIFN-beta mRNA or cDNA or a portion thereof. The purified mRNA or cDRA mRNA can then be used to rapidly test a very large number of bacterial clones, thus significantly increasing the likelihood of an isolated clone expressing IPN-beta in active form.

SINTEZA OPNA SA DVOSTROKR« NITI KOJA SADEŽI IFN-beta pPNASYNTHESIS OF DOUBLE TWO-FRAME THREAD CONTAINING IFN-beta pPNA

Poli (A) SNA obogadena sa IPN-beta mRNA koristi se kao šablon sa pravljenje komplementarne DNA (cPSA), suštinski kao što je opisano u S. D·vos, et al·, Canstruotion And Charaetarisation ofPoly (A) SNA enriched in IPN-beta mRNA is used as template with complementary DNA (cPSA) production, essentially as described in S. D · vos, et al ·, Canstruotion And Charaetarisation of

-22 λ Plasaid Contalalng A Nearly Full-Siza DNA Copy Of Saoteriophage MS2 KNA*.J. Mol. Biol., 128, pp. 595-619 (1979) s« konstrukcija plazaida koji sadrži D2?A koniju bakteriofaga MS2 WA.-22 λ Plasaid Contalalng A Nearly Full-Siza DNA Copy Of Saoteriophage MS2 KNA * .J. Mol. Biol., 128, pp. 595-619 (1979) s «construction of a plasmid containing the D2? A horse of bacteriophage MS2 WA.

cDKA sa jednoetrukcva niti napravi se iz poli (A) RNA pomoču polimeraze DSA zavisne od RNA (25 jedinica) iz virusa ptičjeg mieloblastozisa (*AMV“) i to njegova reversne trasnakriptaze (poklon od Dr. J. Beard-a, Life Science·, Gulfport, Florida), inicirane aa (dT)J0 primerom (6 ^ug, Mila·) koji ja hlbridizovan na poli (A) repu SNA, u 50 ^ul 50 mM Tris-HCl (pH 8.3), 10 oM MgClj, 30 OM betaarkaptoatanola, 4 aM Ha^PjO?, 2.5 /Ug//Ul inaktiviranog albumina volovskog seruna, dTTP, dATP, dCTP i dGTP, svaki pri 0.5 MM i alfa^^P-dATP (20 /UCi, Amarsham) · Posle 30 minuta na 41°C, reakcija se zavrži dodavanjem EDTA do 10 nM, reakciona sasža se ekstrahuje sa jednakom zapr. fenolthlorooformtisoemilalkabola (25<24tl) i vodena faza se raslojl na Sephada:: G50 koloni i eluira se u TE puferu (10 nM Tris-NCl (ph 7.5) 1 raft EDTA). Prazne frakcije koje ispoljavaju radioaktivnost se stalože dodavanjem 10 ^ug Tt, transfer RNA, kalijua-acetata (pB 5.1) do 0.2 M 1 2.5 zapr.single-strand cDKA is made of poly (A) RNA using DSA-dependent RNA polymerase (25 units) from avian myeloblastosis virus (* AMV) and its reverse transcriptase (gift from Dr. J. Beard, Life Science · , Gulfport, Florida), initiated by aa (dT) J0 primer (6 ^ ug, Mila ·) which was hybridized to the poly (A) tail of SNA, in 50 ^ ul 50 mM Tris-HCl (pH 8.3), 10 oM MgClj. 30 OM Betaarcaptoatanol, 4 aM Ha ^ PjO ?, 2.5 / Ug // Ul inactivated bovine serum albumin, dTTP, dATP, dCTP and dGTP, each at 0.5 MM and alpha ^^ P-dATP (20 / UCi, Amarsham) · After For 30 minutes at 41 [deg.] C., the reaction was quenched by the addition of EDTA to 10 nM, the reaction was extracted with an equal volume of. phenolthlorooformtisoemylalkabolol (25 <24tl) and the aqueous phase was separated on a Sephada :: G50 column and eluted in TE buffer (10 nM Tris-NCl (ph 7.5) 1 raft EDTA). Empty fractions exhibiting radioactivity were precipitated by the addition of 10 µg Tt, transfer of RNA, potassium acetate (pB 5.1) to 0.2 M 1 2.5 closed.

etanola.ethanol.

cDNA populacija sintatizeva.ua gora ja ustvari kompleksna soaSa cDNA koja potiSu iz razliSitih mRNA koja su bile prisutne u cboga« denoj poli(A) mRNA (Slika 1). Dalje, zbog prevreasne tarminacije AMF reversne transkrlptaze, mnoge cDNA su nekoupletne kopije razliSitih mRNA u poli(A) RNA (nije prikazano na Šilci 1).The cDNA population synthesized above actually represents complex cDNAs originating from different mRNAs that were present in different poly (A) mRNAs (Figure 1). Furthermore, due to premature labeling of AMF reverse transcriptlase, many cDNAs are incomplete copies of different mRNAs in poly (A) RNA (not shown in Spill 1).

Pre nego fito se učini da cDNA ima dvostruku nit, odvoji se iz njenog agregata sa koapiementarnim šah ionom «NA taloženjem sa etanolom i inkubacijcm u TE puferu (10 ad: Tris-HCl (pfi 7.5), 1 mK EDTA) sa ribonukleascm (10 jedinica, Sankyo Co·, Ltd) i pankreasnom ribcnukleazom A (10 /ng, Sigma) do 20 ^ul tokom 30 minuta naBefore the phyto is said to have a double strand, the cDNA is separated from its aggregate with a co-complementary chess ion «NA by precipitation with ethanol and incubation in TE buffer (10 ad: Tris-HCl (pfi 7.5), 1 mK EDTA) with ribonucleases (10 unit, Sankyo Co ·, Ltd) and pancreatic ribcnuclease A (10 / ng, Sigma) up to 20 ^ ul for 30 minutes at

-2337°C (ribonuklease su slobodne od specifičnih endo- i egzo-deoksiribonukleaza sa jedno- niti). Odvajanje» šablonske niti poraodu ribonuklecze um3to ea alkalijama Izbegava se aoguda mutacija cDNA pomodu deaminacije katalizovane alkalijama.-2337 ° C (ribonuclease are free of specific endo- and exo-deoxyribonucleases with one). Separation of the template strand by ribonuclase um3to ea by alkali Avoid cDNA mutation by alkali-catalyzed deamination is avoided.

cDNA nit se mole «Siniti da bude sa dvostrukom niti pOmodu DNA polimeraze X (A. Efstratiadis, «t al., Enzynatic In Vitro Synthe Of Globin Genes”, Celi, 7, pp. 273-86 (1976)). 10 ^ul ribonuklease/ cDNA smeše is gornjeg dela razblaži se na 20 ml sa MgClj do 10 nM, dodaju se DTT do 10 mM, kalijua-fosfat (pB 6.9) do 100 nM, dATP, dCTP, dTTp i dSTP svaki do 0.3 mM, alfa-32P-dATP (2- ^uCi, Amersha») i DMA polimeraza I (49 jedinica, Biolabs). Posle 6 časova na 15°C doda se 2DTA do 10 uN 1 SDS do 9.1% i cDKA sa dvostraka» niti izoluje se ekstrakcijo« (fenoljhloroformiizeamllalkohol), Kromatografij om (Sephadez G50) i taloŠenjem praznih frakcija kao gore.The cDNA strand is prayed to be "sintered to be double stranded by DNA polymerase X (A. Efstratiadis," t al., Enzynatic In Vitro Synthe Of Globin Genes, Celi, 7, pp. 273-86 (1976)). The 10 µl ribonuclease / cDNA mixture from the above was diluted to 20 ml with MgClj up to 10 nM, DTT up to 10 mM, potassium phosphate (pB 6.9) up to 100 nM, dATP, dCTP, dTTp and dSTP each up to 0.3 mM were added , alpha- 32 P-dATP (2- ^ uCi, Amersha ») and DMA polymerase I (49 units, Biolabs). After 6 hours at 15 ° C, 2DTA up to 10 uN 1 SDS was added up to 9.1% and cDKA from two-strand "filament extraction" (phenol-chloroformiizeamyl alcohol), chromatography (Sephadez G50) and precipitation of the blank fractions as above.

Da se otvori kolo sa jednom niti koje zaostaja na strukturi cDNA sa dvostrukom niti, stalolena cDNA se rastvori u 109 ^ul 0.2 M HaCl, 59 natrijum-acetata (pB 4.5), 19 mM cink-acetat* i 2 ^ugTo open a single-strand latch on the double-stranded cDNA structure, the stalolen cDNA was dissolved in 109 ^ ul 0.2 M HaCl, 59 sodium acetate (pB 4.5), 19 mM zinc acetate * and 2 ^ ug

DiiA kravljeg timusa danaturisane zagrevanjem i reaguje sa Sl nukleazoa (5 jedinica, Sigma) tokom 30 minuta na 37°C. Dodavanje» EDTA do 10 zaM, eks trakci jom aa femolthloroform:ixoaailalkoholoja i taoženjeai vodene faze dodavanje» 10 ^ug S. coli transfer SNA kao nosača, 0.2 M natrijum-acetata (pH 5.1) i 2.5 sapr. etanola tako da se dobiva smeša cDNA sa dvostrukom niti i slepim krajem. Ova smeša je heterogena i kao posledica heterogenosti poli (A) SNA koja se koristi kao šablon za njeno pravljenje (Slika 1) i zbog prevremsne terminad; CONA transkripata poactiu SiiV reversne transfcriptaze (nije prikazano na Slici 1) ·DiiA of cow thymus denatured by heating and reacted with Sl nuclease (5 units, Sigma) for 30 minutes at 37 ° C. Addition of EDTA up to 10 µM, ex bands of aa femolthloroform: oxoyl alcohol and precipitation and aqueous phase addition of 10 µg S. coli transfer of SNA as carrier, 0.2 M sodium acetate (pH 5.1) and 2.5 sapr. ethanol so that a cDNA mixture with a double strand and a blank end is obtained. This mixture is heterogeneous both as a consequence of the heterogeneity of the poly (A) SNA used as a template to make it (Figure 1) and due to premature termination; CONA transcripts of Poactiu SiiV reverse transcriptase (not shown in Figure 1) ·

Da se oslabi efekat poslednje heterogenosti, sDNA sa dvostrukom niti se sortira elektroforezora ca 4% poliakrllaadLdnoat gelu u 50 »M — 24 —To attenuate the effect of the latter heterogeneity, double-stranded sDNA is sorted by electrophoresis ca 4% polyacrylateLdnoat gel in 50 »M - 24 -

Tris-borataog pufera (pH 6.3) i 1 «H FDTA, pri čemu 5*- Paarkiranl restrikeioai fragmenti (0X174 (?T)-DNA) služe kao narkari veličine. Bira ju se DNA trake odgovarajuče veličine (n.pr., klase i». vna-SSO bp,- 6*0-700 bp i 550-650 bp).Tris-borate buffer (pH 6.3) and 1 «H FDTA, where 5 * - Paarkiranl restrikeioai fragments (0X174 (? T) -DNA) serve as size junkers. It is selected by DNA bands of appropriate size (eg, class i ». Vna-SSO bp, - 6 * 0-700 bp and 550-650 bp).

Sabo Sto je oDNA sa dvostrukom niti napravljena elektroforezo» poli (A) RNA na poliakrllamidnon gelu ispoljava la primlaentnu traku na oko 850 bp, enatra ae da ova traka pretstavija punu dužinu DNA. Trake se eluira ju mrvi jenjea gela u 0.5 M anonijuK-aeetatu i 0.1%As double-stranded single-stranded DNA was electrophoresed, the poly (A) RNA on the polyacrylamide gel exhibits a primal band at about 850 bp, ena that this band represents the full length of the DNA. The bands were eluted with crumbled gel in 0.5 M anonium K-acetate and 0.1%

SDS 1 a» San j en preko noči. Pošto se otpaoi uklone centrifugiranje», DNA ee adsorbuje oa hidroksiapatitni prah, Sar žir a se na Sephadez G50 kolonu u 5 afl natrijum-fosfatu, (pH 7.5), ispere ee obilno sa puferon, eluira se sa 0.45 K natri ju»-fosfata (pH 7.5) i trenutno se os lobodi soli efekte» sejanja Sephadex G50 matriksa.SDS 1 a »Sleep j one overnight. As the waste is removed by centrifugation, DNA is adsorbed on the hydroxyapatite powder, and is digested on a Sephadez G50 column in 5 µl sodium phosphate (pH 7.5), washed extensively with buffer, eluting with 0.45 K sodium phosphate. (pH 7.5) and the immediate effect of the salt is the effects of seeding the Sephadex G50 matrix.

Frakcije koje sadrže eluiranu DNA, kao Sto se regietruje 32P-radioaktivnoSču, se stalože dodavanje» 10 ^ug E. coli transfer BNA, natrij ua-ace ta ta do 0.2 H i 2.5 sapr. etanola.Fractions containing eluted DNA, such as 32 P-radioactively regirated, were added the addition of 10 [mu] g E. coli transfer BNA, sodium acetate to 0.2 H and 2.5 sapr. ethanol.

Efikasnoet cDNA preparata, opisanog gore, demonstrirana je tipični» ekeperinenton u koje» je oko 2 ^ug poli (A) RNA posle foramamid-sabaroznog gradienta dalo oko 16 ng cDNA sa dvostruko» niti koja iaa interval veličine 900 do 900 bp.The efficacy of the cDNA preparation described above was demonstrated by typical "ekeperitinone" in which about 2 µg of poly (A) RNA yielded about 16 ng of double-stranded cDNA after a foramamide-sucrose gradient, which has an interval of 900 to 900 bp.

Ponovo nora da se shvati da je cDNA sa dvostruko» niti snela velikog broja cDNA, od kojih su samo nekoliko ITN-beta cDNA (Slika 1) dka sa dvostrdsom nitiAgain, it is crazy to realize that a double strand cDNA has produced a large number of cDNAs, of which only a few are ITN-beta cDNAs (Figure 1) with a double strand strand

Mogu se koritstiti rasne kombinacije dooačin/nosač sa kloniranje u kloniranju cDNA sa dvostruko» niti preaa ovo» pronalasku«Can use racial combinations dooin / carrier with cloning in cDNA cloning with double "nor transfer this" invention "

Na primer, korisni nosači sa kloniranje mogu se sastojati od segmsnata hromosoanih, nehroaozoasnih i sin te takih DNA sekvenci, kao Sto su rasni posneti derivati SV40 i poznati bakterijski plazmi di, n.pr., plazaidi iz K. coli koji uključuju col El, pCRl, « 25 pBR322, ρΜΒ3 i njihovo derivate, plazcd.de raznih dommcina, n.pr.,For example, useful cloning carriers may consist of segregated chromosoans, non-chroasoas and syn, and such DNA sequences, such as racially imaged SV40 derivatives and known bacterial plasma di, e.g., K. coli plasaids that include col El. pCRl, «25 pBR322, ρΜΒ3 and their derivatives, plascd.de of various domains, e.g.

RP4, DNA faga, «.pr., brojne derivate faga lambda, »»pr., Hl-i 989 1 druge fage DNA, a.pr., HI 3 χ Fliatoanteoua DNA iage sa jednoia niti i vektore izvedene lx kombinacija pla2.nj.da J. DNA fage kao Što su plazmidi koji en modifikovani za koriščenje DNA faga ill drugih sekvenci za kontrola ekspresije lli plazzd.de kvaaca kac što je 2 plazmid iii njegovi derivati. Korini domačini raogu uključivati bakterijske domačine kao što su E. coli HB 101, E. crCl Χ1776,RP4, DNA phage, ". Eg., Numerous phage lambda derivatives," "e.g., hl-i 989 1 other DNA phages, e.g., HI 3 χ Fliatoanteoua DNA iage with equations and vectors derived lx combination of pla2. J. DNA phages such as plasmids that have been modified to use DNA phages or other sequences to control expression or plasmid DNA of a yeast such as 2 plasmids or derivatives thereof. Corina hosts may include bacterial hosts such as E. coli HB 101, E. crCl Χ1776,

E. eolj Χ2232, E. coli MSCI i aojeve Pseudomonas, 3ect.Ilua subtilis, Bacillus stcarotheraophllga i druge bacile, kvasne i druge gljlvioe, llvotinjske lli biljne domačine kao št* su Čelije životinja (uključujučl čoveka) iii biljaka u kulturi iii drugim domačlalaa. Naravno, nisu sve kombinacije domačln/vekfcor podjedamko efikasne. Odredjeni izbor kombinacije domačin/noeeč za kloniraj« mogu izvršiti stručnjacl posle dužnog razmatranja prikasa&žh principa bez otstupanja od obima ovog premalaska.E. eolj Χ2232, E. coli MSCI and Pseudomonas aoea, 3ect.Ilua subtilis, Bacillus stcarotheraophllga and other bacilli, yeast and other gljlvioe, lvivorous lli or native plants such as * Cells of animals (including human) or other plants in culture iii . Of course, not all home / vefcor combinations are equally effective. Certain choices of the clone / host clone combination may be made by an expert after due consideration of the principles and principles without departing from the scope of this underwriting.

Dalje, unutar svakog specifičnog nosača za kloniranje, mogu se izabrati razna mesta za umeten je DNA sa dvostrukum niti. Ova mesta se obično konstruišu pomoču restrikdone endonuklease koja ih seča.Further, within each specific cloning carrier, different sites for double stranded DNA insertion can be selected. These sites are usually constructed with the help of restricdone endonuklease that cuts them.

Na primer, u p3R322 Peti mesto se locira u genu sa beta-laktamazu, izmedju nukleotidnih tripleta koji kodiraju za aainofciseline 181 i 182 tog proteina. Ovo mesto je kor is tio na početku S. Nagata at al., gore, u sintezi polipeptida koji ispoljavaju insrološku ill biološku aktivnost IFH-alfa. Jedno od dva rvesta raspccaavanja Hladil endonuklease je izmedju tripleta koji kodirajm za aminekiseline 101 1 102 a jedno od nekoliko Tag mesta je na trioletu koji kodira za aminokiselina *ft* <5 beta-laktamaze u pMt323. Na sličan način, Ecom mesto i PvuII mesto u ovom plazmidu leže van makojeg regiona za kodiranje, BooKl mesto je locirano izmadjm gena koji kodira ju za otpornost na tetraciklin, odnosno ampicilin. Ovo mesto koristili sn T. Taniguichi et al., gore, υ njihovo j cekombinantnoj s in te te ko j shemi. Ova »seta sn stručnjaei dobro ehvatili. Naravno, treba da sa shvati da nosač za kloniranje koji je koristan n ovca pronalaska a« nora da ima mesto raspotnavanja endonukleaze za ometanje izabranog SKR fragmenta. Umesto toga, nosač se može spojiti za fraguene alternativnim postupcima·For example, in p3R322, the Fifth locus is located in the beta-lactamase gene, between nucleotide triplets encoding for aainophyseles 181 and 182 of that protein. This site was used at the beginning of S. Nagata et al., Supra, in the synthesis of polypeptides exhibiting the in vitro or biological activity of IFH-alpha. One of the two spreads of Hladil endonuclease is between the triplets I code for amino acids 101 1 102 and one of several Tag sites is on the triolet that codes for amino acids * ft * <5 beta-lactamase in pMt323. Similarly, the Ecom site and the PvuII site in this plasmid lie outside the coding region, the BooK1 site is located between the gene encoding it for resistance to tetracycline or ampicillin. This site was used by sn T. Taniguichi et al., Supra, υ their ccombinant scheme and scheme. This set of experts have been well received. Of course, it should be appreciated that a cloning carrier useful for a sheep of the invention must have an endonuclease junction site for interfering with the selected SKR fragment. Instead, the carrier can be coupled for fraguene by alternative procedures ·

Vektor lli nosač za kloniranje i odredjeno mesto izabrano n njena «a spajanje izabranog DMA fragmenta radi obrazcvanjo rekombinantnog DNK molekula o&redjuje ae na osuovu raznih fak tor a, n.pr., brojen mesta koja su prljemčiva za odredjeni restrikcioni enzis, veličinom proteina koji treba da se izrazi, prijemčivoiču 8 sl jenog proteina ra proteolitičku degradacija pomoču enzima čelija domačina, kontarinaci jom iii vezi van jem proteina koji treba da se izrazi pcmoča proteina čelija domačina koji se teško odvajaJu ra vreme prečiščevanja, ekspresionim karakteristikama, kao Sto su lokacija polaznih 1 zauslavnih kodona u vezi sa vektorom sekvenci, i drugim faktorima koje shvata ju stručnjaei. Izbor vektora i mesta ometanja za odredJeni gen odredjen je balansom ovih faktora, i nisu svi izbori podjednako eflknsni sa dati slučaj.A vector or cloning carrier and a specific site selected from its junction of the selected DMA fragment to form recombinant DNA molecules are arranged on the axis of various factors, e.g., numbered sites that are adherent to a particular restriction enzyme, by the size of the protein required 8 Proteolytic degradation by host enzyme enzymes, contrains, or extracellular protein expressions that are difficult to separate during purification time, by expression characteristics, such as the location of starting points 1 key codons related to the sequence vector, and other factors understood by those skilled in the art. The choice of vectors and sites of interference for a given gene is determined by the balance of these factors, and not all choices are equally effective with the given case.

Inko je u nauči poznato nekoliko poetupaka za umetanje strane DNA u nosač s» kloniranje lli vektor radi obrazovanja rekambinantaog DMA molekula, poSeljan postupak sa početno kloniranje prema ovom pronalasku jeste digerovanje plazmida (odredjeno p88322) sa restrikeienim enzimom koji je specifičen sa mesto koje je izabrano sa unetanje (odredjeno Peti) i dodavanje dA repov» na 3' krajev« pomoču terminalne transferaze. Ma sličan način, eDMA sa dvostrukom niti se isduži dodavanjem dT repova na 3' Jerajeve tako da se omogučl spajanje sa repni plasmid· Repni plasmid i cDMA ee tada kale takoInko has learned several techniques for inserting foreign DNA into a carrier with a cloning or vector to form a recombinant DMA molecule, a preferred method of initial cloning according to the invention is plasmid digestion (determined p88322) with a restriction enzyme that is specific to the site selected with insertion (designated Fifth) and adding dA tails "at 3 'ends" to the terminal transferase. In a similar way, double strand eDMA is elongated by adding dT tails to 3 ′ jeres so as to allow fusion with the tail plasmid · The tail plasmid and cDMA ee then kale

- 2? :da s« umetne cDTIA u odgovarajuče nos to nlasnaida i da no cirkularizuje hibridna R!’A, pri 2 onu ’:anplonsntarni karakter repova oraogučuje njihov v kohesiju (Slika 1) . Robiveiii rekciitinantni DNA molekul sada nor»! uaetnuti gen na irabranon P::tl rontrikcionoit rsesfcu (Slika 1). Ovaj postupak da-dT repnog vezivanja za umetanje opisan je u R. A. Jackson et al., Diooheiaical Methcda Por Inserting Hew Gene ti c Information Into DNA Of Sinian Virus 40: Circular SV40 DNA Molecules Containing Laada Phage Genes And The Galactose Operon Of Hscherichia coli, Pre c. TTatl. Acad, Sci. USA, 69, pp. 2904-909 (1972) i R. Devos Qt al., gore. On dovodi do oko 3 puta vi5e rekombinantni h DKA plaziaida kao dG-dC repno vezivanje.- 2? : to s «insert cDTIA into the proper nose of the nlasnaid and circularise the hybrid R! 'A at 2 on': the anplonsntary character of the tails enriches them in cohesion (Figure 1). Robiveiii recititant DNA molecule now crazy »! uaetnut gene at irabranon P :: tl rontrikcionoit rsesfcu (Figure 1). This procedure of da-dT tail binding for insertion is described in RA Jackson et al., Diooheiaical Methcda Por Inserting Hew Gene ti c Information Into DNA Of Sinian Virus 40: Circular SV40 DNA Molecules Containing Laada Phage Genes And The Galactose Operon Of Hscherichia coli. Before c. TTatl. Acad, Sci. USA, 69, pp. 2904-909 (1972) and R. Devos Qt al., Supra. It results in about 3 times more recombinant h DKA plasiaids than dG-dC tail binding.

Naravne, drugi poznati postupci za urnotanje DNA sekvenci u nosače za kloniranje radi formiranja rekombinantnih DNA molekula eu jednako korisni n ovo» pronalasku. Ovi uključuju, na primer, dG-dC repno vezivanje, direktnu ligaciju, sintetska vezivna sredstva, egzonukleazne i poliaerazne reakcije popravljanja vezivanje koje prati ligaclja, iii izdušivanje DNA niti sa DNA polioerazom i odgovarajudim šablono» sa jedno» niti posle ligacije.Natural, other known methods for inserting DNA sequences into cloning carriers to form recombinant DNA molecules are equally useful in the present invention. These include, for example, dG-dC tail binding, direct ligation, synthetic binders, exonuclease and polyerase repair responses that accompany ligacs, or elongation of DNA strands with DNA polyerase and a corresponding template with one strand after ligation.

Treba naravno da je jasno da nukleotidne sekvence lli cDNA fragmenti uisetnuti na izabranom iseetu nosača za kloniranje mogu uključivati nukleotide koji nisu deo stvar nog struktumog gena za željeni polipeptid iii mogu uk1jučivati samo fragment iii komplete strukturni gen za željeni protein. Jelino što je potrebno jeste, da bez obzira koja je DiiA sekvenca uiaetnuta, transformiaani domačin proizvodi polipeptid koji ima biološku iii imunološku aktivnost HuIFN-beta iii da je sama DNA sekvenc? korlsna kao hibridizaciona sonda za hiranje klona keji sadrže DNA sekvence korisne u proizvodaj polipeptida koji imaju imunološku iii biološku aktivnost HuIFN-beta.It should be understood, of course, that the nucleotide sequences or cDNA fragments inserted on the selected clone carrier iseet may include nucleotides that are not part of the actual structural gene for the desired polypeptide iii, or may include only the fragment or complete structural gene for the desired protein. All that is needed is that no matter which DiiA sequence is involved, the transformed host produces a polypeptide that has the biological or immunological activity of HuIFN-beta or is itself a DNA sequence? Cornell as a hybridization probe for harboring clone cells contains DNA sequences useful in the production of polypeptides having immunological or biological activity of HuIFN-beta.

Nosač za kloniranje iii vektor koji sadrži strani gen koristi s xa trans fomisan je čkruaeina tako da s*> σ'?χ:5ι da dccaačin izrazi polipeptide koji ispoljavaju imunologu ill kioločku aktivnost HuIFN-beta sa koje hibridni gen kodira. Izbor odgovarajučeg doasadina je takodje kontrollsan večin bmjem faktom —ima tih u nauči.The cloning carrier iii vector containing the foreign gene used with xa trans is formed by a ckruaein such that s *> σ '? Χ: 5ι that dccaacin expresses polypeptides that exhibit immunologic or kiologic activity of HuIFN-beta from which the hybrid gene encodes. Choosing the right doasadin is also controlled by most of the fact - those in science.

Ovi uključuju, na primer, kompatibilnost sa izabraaln vektoram, toksičnost proteina kodiranih sa hibridnim plazmidom, lakoču izolovanja željenog proteina, ekspresione karakteristike, bio-bezbednost i cenu. aalans ovih faktora mora da ee procesi ea razumevanjem da ne moraju evi domačini biti oodjodnako efikasni 2a ekspresi ju odred jenog rekombinantno^ DNA rolekula.These include, for example, compatibility with the choice vector, toxicity of proteins encoded with the hybrid plasmid, ease of isolation of the desired protein, expression characteristics, biosecurity and cost. the balance of these factors must ee processes with the understanding that these hosts do not have to be equally effective 2a expressing a particular recombinant DNA strand.

U sadafcjoj sintezi, poštljan početan nesač za kloniranje je bakterijski plazmid pBR322 a poželjno po&etno iieeto restrlkeione endonukleaze u njemu je Peti mesto (Slika 1}. Plazmid je mali (wlekulska teiina približno 2.6 megadaltocaj plazmid koji nosi gene za rezistentnost prema antibiotiku arr* elitna (ληρ, i tetraeiklina (Tet). Plazmid je potpuno okazmkterloan (F. Bolivar et al·, Vonstruetien And Characterization ef ’7av Cloning Vehiclea II· A Multi-Purpose Cloning Sistem, Gane, pp. <5-113 (1977)/ J. G. Sutoliffe, p3R322 Aestriction Map Derived Tron The DNA Segueacet Aoourate SNA Size M&rkers Up To 4361 Nucleotd.de Pairs Long,In the present synthesis, a fair initial cloning carrier is the bacterial plasmid pBR322 and the preferred initiation of restriction endonuclease is Fifth (Fig. 1}. Plasmid is small (about 2.6 megadaltocay plasmid carrying antibiotic resistance * antibiotic resistance genes). ληρ, and tetraeicline (Tet). The plasmid is fully oecmterloan (F. Bolivar et al ·, Vnutrietien And Characterization ef '7av Cloning Vehicle II · A Multi-Purpose Cloning System, Ghana, pp. <5-113 (1977) / J.G. Sutoliffe, p3R322 Aestriction Map Derived Tron The DNA Segueacet Aoourate SNA Size M & rkers Up To 4361 Nucleotd.de Pairs Long,

Nucleic Acida Assearoh, 5, pp. 2721-28 (19713/ J. G. Sutoliffe, Coraplete Hueleotide Seguence of The Escherichia coli Plašnid p3R322,Nucleic Acida Assearoh, 5, pp. 2721-28 (19713 / J. G. Sutoliffe, Coraplete Hueleotide Seguence of The Escherichia coli Plaid p3R322,

Col4 Sprlo» iUrbor »raMtln, 41, I, pp. 77-90 (197«)).Col4 Sprlo »iUrbor» raMtln, 41, I, pp. 77-90 (197 «)).

Ometanje BKA inserta u ovo mesto obezbedjuje veliki broj bakterijskih kloneva od kojih svaki sadrži jedan od DNA gena iii njihovih fragmenata prisutnih u eDNA proizvodu koji je napravljen ranije. Ponovo, samo vrlo nekoliko od ovih klona smdržače gen sa IPN-beta iii njegove fragmente (Slika 1) a ni jedan od njih ne mora da omoguči ekspresije polipeptida koji ispoljavaju immmoloKku ill biololku aktivnost IPN-beta. Poželjan početan domačim prema ovom pronalasku —Obstruction of the BKA insert into this site is provided by a large number of bacterial clones, each containing one of the DNA genes or fragments thereof present in the eDNA product made earlier. Again, only a few of these clones contain the gene with IPN-beta or its fragments (Figure 1), and none of them may allow expression of polypeptides that exhibit immunological or biological activity of IPN-beta. Preferred home based on the present invention -

j· E. coli HB 101.j · E. coli HB 101.

1. Pravljenje Pstl-raskinutog, dA-lzduženog pBR3221. Making Pst1-cleaved, dA-elongated pBR322

Plazmid pBR322 se digeruje koaapletno na 37°C sa Pati endonukleazora (Nev England Biolabs) u 10 «M Tris-HCl (pH 7.6), 7 nW MgCl2r 7 dK 2-merkaptoetanola. SraeSa se ekstrahuje sa 1 zapr fenola i 10 zapr etra i staloši se sa 2.5 zapr. etanola» 0.2 H natri juan-aoetatnog rastvora.Plasmid pBR322 was digested co-aptly at 37 ° C with Pati endonucleosors (Nev England Biolabs) in 10 «M Tris-HCl (pH 7.6), 7 nW MgCl 2 r 7 dK 2-mercaptoethanol. The sraeSa was extracted with 1 vapor of phenol and 10 vapor of ether and settled with 2.5 vapor. of ethanol »0.2 H of a sodium yuan-aoetate solution.

Dodavanje hcsnopolimernih dA repova (Slika 1) terminalno*» deoksinukleotidil transferazom (TdT) (preSiSdena prema L. Chang and F. J.Addition of hcsnopolymeric dA tails (Fig. 1) terminal * »deoxynucleotidyl transferase (TdT) (preSiSden according to L. Chang and F. J.

Bollum, Deoxynucleotlde-Polyxaerizing Eazynes Of Calf Thymus Gland”,Bollum, Deoxynucleotlde-Polyxaerizing Eazynes Of Calf Thymus Gland ”,

J. Biol, Chem., 246, pp. 905-16 (1971) vrfii se u reakcionoj zapremini od 50 ^ul koja sadrli 0.14 M kalijum-kakodilata, 30 mMJ. Biol, Chem., 246, pp. 905-16 (1971) contained in a reaction volume of 50 µl containing 0.14 M potassium cacodylate, 30 mM

Tris-HCl (pH 6.8), 1 aM CoSOj, 0.2 ^ug/^ul albumina volovskog sertsaa 32 inaktivlrsnog zagrevanjem, 0.8 sM DTT, 0.2 aM dATP i neBto alfa- PdATP. Inkubacija je na 37°C tokom 5 minuta pre nego Sto se doda EDTA do 10 aM i SDS do 0.11 pa se smela ekstrahuje ss fenolom i hromatografiBe na Spehadez 650 u TE puferu. Prazne frakcije koje sadrle linearizovan i izdulen pBR322 se dalje prečište adsorpcijorn u 10 aM Tris-HCl (pB 7.8), lmM EDTA i 0.4 M NaCl na oligo(dT)celulozi. Posla ekstenzivnog iapiranja, Beljene frakcije se eluiraju sa 10 aN TTiS-BCl (pH 7.8) i 1 oH EDTA.Tris-HCl (pH 6.8), 1 [mu] M CoSO, 0.2 [mu] g / [mu] l of albumin of oxen sertsaa 32 inactivated by heating, 0.8 sM DTT, 0.2 [mu] M dATP and non-alpha-PdATP. Incubation is at 37 ° C for 5 minutes before EDTA is added to 10 aM and SDS to 0.11 and the bold is extracted with phenol and chromatographed on Spehadez 650 in TE buffer. Blank fractions containing linearized and elongated pBR322 were further purified by adsorption in 10 aM Tris-HCl (pB 7.8), 1 mM EDTA and 0.4 M NaCl on oligo (dT) cellulose. After extensive iaping, the bleached fractions were eluted with 10 aN TTiS-BCl (pH 7.8) and 1 oH EDTA.

2. Pravljenje dt-lzdužene dna2. Making dt-elongated bottom

DNA sa dvostrukom uiti izdužena je ss dTKP ostacims na sličan način kao Bto js opisano gore sa dA repno vezivanje pBR322, izuzev Bto su dTTP i neBto ^Η-dTTP zamenili dATP i alfa-^^P-ATP · PrečlBdar vanje nn oligo(dT) celulozi je naravno izostavljeno. Eno i ranije, dT-izdužena DNA je smela različitih vrsta, od kojih su samo nekoliko u vezi sa HuIFN-beta (Slika 1).Double stranded DNA was elongated with dTKP residues in a similar manner to the Bto js described above with dA tail binding pBR322, except that dTTP and neBto ^ Η-dTTP were replaced by dATP and alpha - ^^ P-ATP · Crosslinking nn oligo (dT ) cellulose is of course omitted. Earlier, dT-elongated DNA was bold of different species, only a few of which were related to HuIFN-beta (Figure 1).

- 303. Pravljenje Ca -tretirane g« coli BB101- 303. Making Ca-treated g «coli BB101

Ca+^-tretirana E. coli HB101 napravljena je postupkom koji su dali E. M. Lederberg and S. M. Cohen, Transformation Of Salmonella Tvphinurlum By piasmid Deoxyribonuolalo Aoid*, J. Bacteriol., 119, pp. 1072-4 (1974) inokulacljoa B. coli HB101 (poklon od H. Boyer) u 5 sl U3 podloge (10 delova baktotriptona, 5 delova ekstrakta kvasca i 5 delova NaCl na litar) i kulture su rasle preko noči na 37°C. Sveie kulture se rasblale 1/100 u 20 al LB podloge 1 kultiviBu se do gustine od oko 2 x 10® bakterija na ni, brzo se jako ohlade na ledu i granuluju na 6000 rpm toka» 5 ainuta u Sorvall S834 rotoru na 4°C. čelije, driane na 0-4°C, se isperu sa 20 ml 100 nM CaCl^. Posle 20 minuta na ledu, delijo se rogra-uluju 1 resuspeaduju u 2 ml 100 aM CaCl? 1 odrlavuju na 0°C tokom 15 ainuta Alikvoti (200 /Ul), dopunjeni sa glicerolom do 11«, aogu se stokifati nekoliko meseci na -80°C bos gubi Jen j a aktivnosti (D. A. Morrison, Transformatlon Zn Bscheriohia coli» Cryogenic Preservation Of Cosapetent Celiš, J. Bacteriol». 132, pp. 349-51 (1977))·Ca + ^ - treated E. coli HB101 was made by the procedure provided by E. M. Lederberg and S. M. Cohen, Transformation of Salmonella Tvphinurlum By piasmid Deoxyribonuolalo Aoid *, J. Bacteriol., 119, pp. 1072-4 (1974) inoculated B. coli HB101 (gift from H. Boyer) in 5 sl U3 media (10 parts of bactotryptone, 5 parts of yeast extract and 5 parts of NaCl per liter) and the cultures were grown overnight at 37 ° C. Candle cultures decayed 1/100 in 20 al LB substrates 1 cultured to a density of about 2 x 10® bacteria per inch, cooled rapidly on ice and granulated at 6000 rpm flow »5 ainut in a Sorvall S834 rotor at 4 ° C . the cells, triturated at 0-4 ° C, were washed with 20 ml of 100 nM CaCl2. After 20 minutes on ice, divisible rogra-ulu 1 resuspended in 2 ml 100 aM CaCl? 1 bleed at 0 ° C for 15 aliquots Aliquots (200 / Ul), supplemented with glycerol up to 11 ", and stokify for a few months at -80 ° C, losing activity (DA Morrison, Transformatlon Zn Bscheriohia coli» Cryogenic Preservation Of Cosapetent Celiš, J. Bacteriol. 132, pp. 349-51 (1977)) ·

4. Kaljenje dA-lsdalenog PBR322 1 dt-lsdulenog DMA molekula dA- i dT-repovi vektora i kemplementaraog DMA umetka omoguduju kaljenje tako da se formira podetao Beljeni hibridni piasmid lli rekombinantni OMA molekul· S« ovu svrhu, dA-repno vezan Pstlraskinut pBR322 vektor 1 smela sortiranih dt-repno vezanih cDKA rastvori se u TSE puferu (10 mM Trle-HCl (pH 7.6), 1 xS< EDTA,4. Quenching of the dA-lengthened PBR322 1 dt-lengthened DMA molecule The dA- and dT-tails of the vector and the complementary DMA insert allow for quenching to form a knock-off Bleached hybrid piasmid or a recombinant OMA molecule · S «for this purpose, the vector 1 of the bold sorted dt-tail-bound cDKA was dissolved in TSE buffer (10 mM Trle-HCl (pH 7.6), 1 xS <EDTA,

100 s« MsCl) do 1.5 plasmida i do molamog odnosa plasmida prema OMA umetku 1.5 do 2.0. Posle segrevanja na 65°C tokom 10 min·, smela se laguno hladi do sobne temperature tokom 4 Sasa.100 s «MsCl) to 1.5 plasmids and to the molar ratio of plasmids to OMA insert 1.5 to 2.0. After warming to 65 ° C for 10 min ·, the bold lagoon cooled to room temperature for 4 hours.

Proisvod je naravno velika smela rasnih rekombinantnih DMA molekula i neito nomada sn kloniranje bes umetnutih ORA sekvenci. Medjutim, svaki rekombinantni DMA molekul sadrll cDHA segment aaThe product, of course, is the great boldness of racially recombinant DMA molecules and the inanimate nomad sn cloning of anger-inserted ORA sequences. However, each recombinant DMA molecule contains a cDHA segment aa

-31P«tl mestu. Svaki takav cDNA segment moše cbuhvatati gen iii njegov fragment. Samo vrlo nekoliko od cDHA fragmenata kodiraju sa HuIFN-beta lli njegov deo (Slika 1). Velika večina kodira sa jedan od drugih proteina lli njihovih delova Sije au »SNA deo poli (A) RNA koriščene u postupku is ovog pronalaska (Slika 1). Treba takodje da je jaano da nijedan od klonova is gornjeg skupa ne mora da omogoči ekspresijo polipeptida koji ispoljavaju imunološku ill biološko aktivnost IFN-beta.-31P «tl place. Each such cDNA segment can capture a gene or fragment thereof. Only very few of the cDHA fragments encode with HuIFN-beta or a portion thereof (Figure 1). The vast majority encodes with one of the other proteins or their portions of the Sia and SNA portion of the poly (A) RNA used in the process and of the present invention (Figure 1). It should also be appreciated that none of the clones in the above cluster need to be able to express polypeptides that exhibit immune or biological IFN-beta activity.

5. Tranafekcjja K. goli HB101 aa kaljenim hibridni» plazmid ima5. Tranafekcja K. bare HB101 aa tempered hybrid »plasmid has

P3 besbedni pogoni koriščeni su kada je potrebno za postupak tranafekoije i sve kasnije faze u kojima se rokuje sa dobivenim transformlsanim bakterijama. Alikvoti (90 ^ul lli manje) gornje smeše ohlade se na 0°C 1 doda se 1 N CaCl? do 0.1 M. Alikvoti (100 /Ul lli manje) ovog rastvora dodaju se na 200 ^ul Ca++-tretirane E. coli BB101 na ledu 1 posle stajanja na 0°C tokom 30 min., čelije se podvrgava ju toplotno» šoku tokom 5 minuta na 37°C i ponovo se hlade na 0°c. teko» 15 minuta. Posle dodavanja 2 ml LB-podloge, čelije se inkubiraju na 37°C u mučkano» vodeno» kupatilu tokom 30 do minuta 1 bakteriaka suspensija se nanese na 1.2% agame plode, koje sadrše LB podlogu dopunjenu sa 10 /Ug/ml tetraclklina.P3 safe drives have been used when necessary for the transfekoic procedure and all subsequent stages in which the resulting transformed bacteria are treated. Aliquots (90 [mu] l or less) of the above mixture were cooled to 0 [deg.] C. 1 N CaCl was added? to 0.1 M. Aliquots (100 / ul or less) of this solution were added to 200 µl of Ca ++ - treated E. coli BB101 on ice 1 after standing at 0 ° C for 30 min., the cells were subjected to heat shock for 5 min. minutes at 37 ° C and cooled again to 0 ° c. for 15 minutes. After the addition of 2 ml of LB medium, the cells were incubated at 37 ° C in a shaking "water" bath for 30 to 1 minute. The bacterial suspension was applied to 1.2% agamous fruits containing LB medium supplemented with 10 / ug / ml tetracycline.

Pošto plazmid pB&322 uključuje gen sa rezistentnost na tetraciklin, E. coli domačini koji su transformisani sa plasmidoa imaju taj gen netaknut pa če rasti u kulturama koje sadrše antibiotik us laki jučivan je onih bakterija koje nisu tako transforstisane. sbog toga, rast u kulturi koja sadrši tetraciklin omogučuje izbor domačina transformisanih sa rekasfcinantnim DHA molekulo» lli sa reciklisovanim vektoro».Since plasmid pB & 322 includes a tetracycline resistance gene, E. coli hosts that have been transformed from plasmids have this gene intact and will grow in light-weight antibiotic cultures of those bacteria that are not so transformed. Therefore, growth in a tetracycline-containing culture allows the selection of hosts transformed with a recashing DHA molecule or a recycled vector.

Posle 24 časa na 37°C, pojedinačno kolonije se sakupe i suspenduju u 100 ^ul LB podloge (dopunjena kao gore) u rupicama mikrotitarskih ploSlca (Dyaateeh). Posle inkubacije na 37°C preko noči, 11 /Ul dlmetilsulfokslda meia se u svakoj rupici i plitioe se zatvore adhesivnora trakom. Pločice se stokiraJu na -20°C i napravi se stok od 17,000 pojedina&nih kolonija transforraisane S. coli HB101. Ovaj stok je izveden i 270 fmolova (128 ng) dT-repno vezanig cDBA inserata, koji su opet sintetizovani izAfter 24 hours at 37 [deg.] C., the colonies were individually collected and suspended in 100 [mu] l LB medium (supplemented as above) in the wells of microtiter plates (Dyaateeh). After incubation at 37 ° C overnight, 11 / Ul dlmethylsulfoxide was mixed in each hole and the plates were sealed with adhesive tape. The plates were stacked at -20 [deg.] C. and a stock of 17,000 individual colonies of transformed S. coli HB101 was made. This stock was also derived from 270 fmol (128 ng) of dT-tail-bound cDBA inserts, which were again synthesized from

4.4 ^ug gradientno preSiičene poli (λ) RNA.Oko 98% klenova iz ovog stoka bilo je osetljivo na karbenicilin (stabilniji derivat aatpicillna). Zbog toga je oko 98% stoke sadrialo plazmid koji ima insert u Pstl-mestu gena sa beta-laktamazu pBR322 i eano oko 2% sadrialo je reeiklisovan vektor bes inserta.4.4 ^ u gradiently cross-linked poly (λ) RNA. About 98% of the clen from this stock were sensitive to carbenicillin (a more stable aatpicillin derivative). Therefore, about 98% of the cattle contained a plasmid having an insert in the Pst1 site of the beta-lactamase gene pBR322, and about 2% contained a re-labeled anger insert vector.

Ovih 17,000 klenove sadrže mnežtvo rekombinantnih DKA molekula koji pretstavljaju kompletne ill parcijalne kopije smefie mBNA u poli(A) RKA preparatu is čelija koje proizvode HuIFN-beta (Slika 2). Glavni deo ovih sadržače samo jedan rekombinantni DNA molekul.These 17,000 maples contain a variety of recombinant DKA molecules that represent complete or partial copies of smefie mBNA in a poly (A) RKA preparation and from cells producing HuIFN-beta (Figure 2). The major part of these contains only one recombinant DNA molecule.

Samo vrlo nekoliko od ovih rekombinantnih DNA molekula biče u vesi sa BuZFB-beta. Prema torne, kloni se moraju testirati da se odvoje NuZPN-beta-srodni kloni od drugih.Only very few of these recombinant DNA molecules will bind with BuZFB-beta. According to Torn, clones must be tested to separate NuZPN-beta-related clones from others.

TESTIRANJE HA KLOR KOJI SADRŽI HuIFK-beta CPHATESTING HA CHLORINE CONTAINING HuIFK-beta CPHA

Postoji nekoliko prilata sa testiranje bakterijskih kloneva koji sadrže HuZFN-betaeDHA. Ovi ukljuSuju, na primer, RNA selekelona hibridizacijo (Alsrine, at al·, dole), diferencijalnu hibridizacija (T. P. St· John and R. V. Davis, Isolation Of Galactose-Inducible DKA Seguences Prom Saceharcmyees Cerevisiae By Dlferential Plague Filter Hybridisation*, Celi, 18, pp. 443-452 (1979)); hibridizacijo sa sintetekem sondom (B. Soyes et al·, Detection And Partial Seguenee Aaalpsls Of Gastrin mRKA By Osing An Oligodeoxynucleotide Probe, Proč, Bati» Acad. Sd· PSA, 76, pp. 1770-74 (1979)) iii testiranje na kolone koji proizvode željen! protein lmunolofiki (L. Villa-Komaroff, et al·, “A Bacterial Člene Synthetozong ProinsullnT, Proč. Na tl, Aoad. Sol, PSA. 75, pp. 3727-31 (1978) ill biološki (A.C.T. Chang, et al., Phenotjpic Erpresslon In E. coli Of A DNA Seguence Coding For Mouse Dihydrofolate Reductase, Nature, 275, pp. 617-24 (1978)). Mi smo izabrali RNA selekcionu hibridizaci ju kao najpodesniju i kao najobedavajudiji postupak za primarno testiranje.There are several approaches to testing bacterial clones containing HuZFN-betaeDHA. These include, for example, RNA selecelone hybridization (Alsrine, at al ·, below), differential hybridization (TP St · John and RV Davis, Isolation of Galactose-Inducible DKA Seguences Prom Saceharcmyees Cerevisiae By Dlferential Plague Filter Hybridization *, Whole, 18 , pp. 443-452 (1979)); hybridization with a synthetic probe (B. Soyes et al., Detection And Partial Seguenee Aaalpsls Of Gastrin mRNA By Osing An Oligodeoxynucleotide Probe, Away, Bati Acad. Sd · PSA, 76, pp. 1770-74 (1979)) columns that produce the desired! protein lmunolophics (L. Villa-Komaroff, et al ·, “A Bacterial Articles Synthetozong ProinsullnT, Proc. on tl, Aoad. Sol, PSA. 75, pp. 3727-31 (1978) ill biological (ACT Chang, et al. , Phenotjpic Erpresslon In E. coli Of A DNA Seguence Coding For Mouse Dihydrofolate Reductase, Nature, 275, pp. 617-24 (1978) We have chosen RNA selection hybridization as the most appropriate and most promising procedure for primary testing.

A. Test RNA selekcioae hibridizacijeA. RNA selection assay for hybridization

1· Opla početnog testa1 · Opla initial test

Ma Slici 2, rekombinantni DNA molekuli izolovani su iz pojedinačnih kultura oko 46 kloneva oeetl jivih na karbenicilin i rezistentnih na tetraciklin iz gornjeg stoka klonova (dve smeše od 2 klona prikazane su na 81id 2) (Faza A) · Rekombinantni DNA molekuli se razklan i hibridizuju u ukupnu RNA koja sadri! HuIFN-beta mRNA napravljc kao ranije (Faza B) · Svi hibridi rekombinantni DNA molekul-ukupna RNA ae odvoje od nehibridlzovane ukupne RNA (Faza C). Hibridizovana ukupna rna se izoluje iz hibrida i prečisti (Faza D)· Regenerisana RNA se testira na HuIFN-beta mRNA aktivnost kao gore (Faza S) · Ako, samo ako, smeža rekombinantnih DNA molekula zadrži rekombinantni DMA molekul koji ima umetnutu nukleotidnu sekvencu koja a»že da hibridizuje u HuIFN-beta uRNA u ukupnoj RNA, pod striktnim hibrldizacionim ušlovima, tada de mRNA oelobodjena iz tog hibrida izazvati obrezovanje HuIFN-beta u ooeitlma, zato Bto mRNA oelobodjena iz makojeg drugog hibrida rekombinantni DNA molekul-ukupna RNA nede biti srodna sa IFN-beta. Ako je grupa od 46 klonova dala pozitivna reakciju, kloni zu regruplzanl u podgrupe - 6 podgrupa (4 podgrupe od po 8 i podgrupe po 7) 1 svaka podgrupa testirana je kao ranije. Ovaj postup se ponavlja dok se ne identifikuje jedan klon koji reaguje na ovaj tecIn Fig. 2, recombinant DNA molecules were isolated from single cultures of about 46 carbenicillin-sensitive and tetracycline-resistant clone-resistant clones (two mixtures of 2 clones are shown in 81id 2) (Phase A) · Recombinant DNA molecules were digested and hybridize to the total RNA it contains! HuIFN-beta mRNA made as before (Phase B) · All hybrids recombinant DNA molecule-total RNA are separated from non-hybridized total RNA (Phase C). Hybridized total rna is isolated from the hybrid and purified (Phase D) · Regenerated RNA is tested for HuIFN-beta mRNA activity as above (Phase S) · If, only if, a recombinant DMA molecule retains a recombinant DMA molecule having a nucleotide sequence inserted that a »to hybridize to HuIFN-beta uRNA in total RNA, under strict hybridization conditions, then de mRNA released from that hybrid will induce HuIFN-beta cropping into ooeitlma, so Bto mRNA released from any other hybrid is recombinant DNA molecule-total RNA molecule-total RNA related to IFN-beta. If a clone of 46 clones gave a positive reaction, clone z regruplzanl into subgroups - 6 subgroups (4 subgroups of 8 and 7 subgroups) 1 each subgroup was tested as before. This procedure is repeated until one clone is identified that responds to this course

NOma sigurnosti da rekaabinantnl SNA molekuli i bakterijske kulture koje su sa njima trans f orni sone, koje su tako identifikovane.There is no certainty that the recaabinant SNA molecules and bacterial cultures that are trans f orated with them are thus identified.

- 34 e a dr Se korapletnu sekvenca ΧΡΝ-beta cDNA lli Sak da DNA sekvenca stvarno kodira za IFN-beta lli da de omogudlti da klon izrazi polipeptide koji ispoljavaju imunološka ill biološka aktivnost IFN-beta. Medjutim, rekonbiaantnl DNA molekuli de lzvesno sadržati ekstenzivne nukleotidne sekvence koje su komplementarne sa sekvenco» za kodiranje IFN-beta »SNA. Zbog toga se rekombinantni DNA molekul mole a najmanja ruku koristiti kao izvor sonde za brzo testiranje drugih rakomfcrlnantnih DNA molekula i kloneva koji su transformlsani sa njima tako da ae identif ika ju dalji setovi klenova koji mogu sadržati autantidnu lli korapletnu nukleotidna sekvenca za kodiranje IFN-beta. ovi kloni se mogu tada analizirati na mogudu ekspresije polipeptida koji ispoljavaju biološka lli imunološka aktivnost IFN-beta. I nukleotidna sekvenca umetnutog DNA fragmenta ovih hibridnih plazmida 1 njegov aminokiselinski translacioni proizvod mogu ee odrediti i korelisati, ako je rnogude, sa aminokiselinski» sestavom i podetnom sekvenco» koja je objavljena za autentidni IFN-beta (gore).- 34 e a dr The ap-beta cDNA or lll sequence is encoded that the DNA sequence actually encodes for IFN-beta or ll enable the clone to express polypeptides that exhibit immune or biological activity of IFN-beta. However, reconnaissance DNA molecules will certainly contain extensive nucleotide sequences that are complementary to the IFN-beta encoding sequence for SNA. Therefore, the recombinant DNA molecule should at least be used as a probe source for rapid testing of other recombinant DNA molecules and clones that have been transformed with them to identify further sets of maples that may contain an authentic or caraplet nucleotide sequence for IFN-beta encoding . these clones can then be analyzed for expression of polypeptides that exhibit the biological or immune activity of IFN-beta. And the nucleotide sequence of the inserted DNA fragment of these hybrid plasmids 1 its amino acid translational product can be determined and correlated, if any, with the amino acid "composition and pod sequence" published for the authentic IFN-beta (above).

2. Sprovodjenje podetnog testa2. Conducting a business test

Faza A - Pravljenje smeše rekombinantnih DNA molekulaPhase A - Making a mixture of recombinant DNA molecules

Replikacije mikrotitarske plode koja sadrži 96 klonova iz gornjeg stoka klonova vršen« su na LB-agarnim pločama, od kojlh jedna sadrži 10 /Ug/ml tetraciklina a druga je dopunjena sa 100 /Ug/ml karbeniellina. Na ovaj način se sakupe dva seta od oko 45-46 klona koji su rezlstentni na tetraciklin 1 osetljivl na karbeaicilln, i kul ti viša se posebno preko nodi na 37°C u 100 ml LB podloge, koja sadrži 10 /Ug/ml tetraciklina. Ove kultu» se sakupe, rotira ju se u Sorvall OS-3 rotoru pri 8000 rpm tokom 10 minuta, isperu se dva puta sa TBS puferom (50 mM Tris-HCl (pH 8), 5 »M EDTA, 5 »M BaCl) i resuspenduju se u 40 ml TBS na litar početae zapremine kulture.Replicates of a microtiter fetus containing 96 clones from the top clone stock were performed on LB agar plates, one containing 10 / ug / ml tetracycline and the other supplemented with 100 / Ug / ml carbeniellin. In this way, two sets of about 45-46 carbeaicillin-sensitive tetracycline-1 clones were collected and cooled separately at 37 ° C in 100 ml LB medium containing 10 / µg / ml tetracycline. These cultures were harvested, rotated in a Sorvall OS-3 rotor at 8000 rpm for 10 minutes, washed twice with TBS buffer (50 mM Tris-HCl (pH 8), 5 "M EDTA, 5" M BaCl) and resuspended in 40 ml of TBS per liter of starting culture volume.

**

Čalij« se raškimi sa lisesirrTritna K-100 (M. Saka, «t al·, •Plasnid Cleaiag Vehicles Derlved Fran Plasnida Col Sl, T, MK And RK2’ a Betbods Zn Eazvnoloov, 60« Reoonbiaaat OSA (R. ve, ed. )(1988) (a Btaapl) . 49 al, TES euepeadovealh dalija spoja so sa 29 ni 10* saherose u 50 zM Trie*SCl (pH 9) i llsosina do 1.3 ng/el i pasto so da stojo na sobnoj temperaturi tako» 20 nia. Ovoj suspenzi ji se doda 1 ni 0.5 M EDTA—HaflB (pB 8), 8 ni 0,2* Triton*« X*100, 25 UM KOTA, 50 aM Tris-HCl (pa 8) i raskidanje se savrfil na sobnoj teor peratari tokon 10 niauta. čslijskl otpaei i nejvedi dno hronozenae DBA se odvoje graaulevanjan a Backama 8V27 rotor« aa S4000 epa tokon 45 minuta. Prosidena tedaoot se hladi na leda, spoji se sa 1/3 saprenlas 40* polietilenglikola 6000*2 M vacl i pusti ss da stoji preko nodl aa 0°C. Dobiveni talog se sskapl a Barvali SM rotor« na 5000 rg® tokon 10 minuta aa 4°C 1 raotvori ao u TRS pufaru. Rastvor, sa 0.2 sapr 19 ng/nl etldljunhramida (Barva) 1 CsCl do 1 g/nl, ao oaatrifugira u Boeknaaa MO Ti-rotoru na 48000 rpm tokon aajaaajo 48 Časova, pri dana j« obldao jodna polialomeraa epruveta dovoljna sa lizat iz 1*2 litra podata« zapremlne kulturo. DBA trake so noga vizualisovati u eprmti pod OV«osvetljavaajom· Trska najvifie gustine odgovara plasnidu oblika X OBA, droga traka odgovara obliku ττ χ oblika XXX plasmid&ih zma 1 nekih hronosonaih DBA· Prva traka ao sakupi is epruveta, etidljuaforenid se odvoji sa fiest ekstrakcija sa izoaailalkoholcn, 1 vodena £azy se rasblafii sa 3 sapr· vode-dopenjene sa do 6.2 M astrijum-acetata (pB 5.1) pr* talofieaja SBA ssChallium shakes with lisesirrTritna K-100 (M. Saka, «t al ·, • Plasnid Cleaiag Vehicles Derlved Fran Plasnida Col Sl, T, MK And RK2 'a Betbods Zn Eazvnoloov, 60« Reoonbiaaat OSA (R. ve, ed .) (1988) (a Btaapl). 49 al, TES euepeadovealh dalia compound salt with 29 ni 10 * saherose in 50 zM Trie * SCl (pH 9) and llsosin to 1.3 ng / el and paste salt to stand at room temperature "20 nia. To this suspension was added 1 ni 0.5 M EDTA-HaflB (pB 8), 8 ni 0.2 * Triton *" X * 100, 25 UM KOTA, 50 aM Tris-HCl (pa 8) and dissolved perfluorine at room theaters token 10 nuts. chslijskl otpaei and nejvedi bottom chronozenae DBA are separated by a backama 8V27 rotor «aa S4000 epa token for 45 minutes .The prosaic tedaoot is cooled on ice, fused with 1/3 saprenillas 40 * 6000 s. 2 M vacl and allow ss to stand over nodl aa 0 ° C. The resulting precipitate was shaken off with a Colored SM rotor «at 5000 rg® token for 10 minutes aa 4 ° C 1 dissolved ao in TRS buffer. The solution, with 0.2 sap 19 ng / nl etldljunhramida (Color) 1 Cs Cl up to 1 g / nl, ao oaatrifuged in a Boeknaaa MO Ti-rotor at 48000 rpm until aajaaajo 48 hours, at day j ob had iodine poliomeraa tube sufficient with lysate from 1 * 2 liters of data to fill the culture. DBA foot strips visualize in aperture under OV «illumination · Highest density reed corresponds to X OBA plasmid, drug strip corresponds to ττ χ shape of XXX plasmid & zma 1 of some chronosonic DBA · First strip ao to collect from test tubes, ethidophosphoride is separated by fiest extraction isoaailalkoholcn, 1 aqueous £ azy dissolve with 3 sapr · water-doped with up to 6.2 M astrium acetate (pB 5.1) pr * talofieaja SBA ss

2.5 sapr* etanola. SBA ss ponovo rastvori, ekstrahuje so sa fenolen 1 ponovo se stalofii sa eta&olon. Kvalitet DBA se rogistruje elsktrmforeson aa 1* agarosaon gel« u 40 ns Tns*BQfic (pB 67*8), 20 a« aatr acetata, 2 «K ŠOTA, posla doga so vrfii bejsajo sa otidi jmftirnnl (Ion. Ako je DNA suvlfio ssiogo kentsniairaaa sa RNA, onda se predeti daljo oontrifugiraajen as noutralaon saharesaon gradientu: 300 ^ug2.5 sapr * ethanol. The SBA was dissolved again, the salt extracted with phenolene 1 was re-settled with eta & olon. The quality of the DBA is recorded by elsktrmforeson aa 1 * agarosaon gel «in 40 ns Tns * BQfic (pB 67 * 8), 20 a« aatr acetate, 2 «K SOTA, sent dog with vrfii bases with otidi jmftirnnl (Ion. If DNA suvlfio ssiogo kentsniairaaa with RNA, then be further distilled as a nontralaon sucrose gradient: 300 ^ ug

- 36 *- 36 *

DNA o 10 mM Tris-BCl (pa 7.6) i 1 rt EDTA Sarliraju »e aa 36-mlDNA about 10 mM Tris-BCl (pa 7.6) and 1 rt EDTA Sarlated aa 36-ml

5-20» gradienta a 19 rt Trts-HCl (pB 7.6), 1 « EDTA, 1 N NaCI, centrlfuglra s· u polialomema epruvete tokom 16 Sasova aa 24060 rpm a Beekmana SV rotora na 18°C 1 frakcije koja sadrže DNA ^°°260^ se eakt£>e * ataloža sa natri juaacetat-etanolom.5-20 "gradient a 19 rt Trts-HCl (pB 7.6), 1" EDTA, 1 N NaCI, centrlfuglra s · in polioloma tube during 16 Sas aa 24060 rpm a Beekman SV rotor at 18 ° C 1 fractions containing DNA ^ °° 260 ^ se eakt £ > e * atalase with sodium juaacetate-ethanol.

rasa B “ Hibridizacija DNA sa Dkupnam RNArace B “DNA hybridization with Dkupnam RNA

Oko 150 vgfo* tako napravljene, spoji sa sa jednobrazno markiranim 22p-«arketaa DNA i 2 ^ug pSTBV-1 DNA (rekomblnantni plarnid koji sadrži kopija cDNA pano vallSlna satelitnog virusa aakrpsa duvana CSTOT*)-8NA> jr. Van Emnelo, at al., *Constructlo& And Ckaraotarisatiea Of A Plasnid Containing A Neraly Full-Size DNA Copy Of Satellite Tobacco Neerodls Virus RNA, J. Mol« Biol. * (u fitaapi) kao interne kontrole, ppdvrgne ee snieaaja sonikadjon a USE sonikatora 1 staloži se ea natrljaa-acetat-etanoloa.About 150 vgfo * thus made, fused with the uniquely labeled 22 p- «arketa DNA and 2 ^ ug pSTBV-1 DNA (recombinant plarnid containing a copy of the cSTNA pano vallSlna satellite virus aakrpsa tobacco CSTOT *) - 8NA> jr. Van Emnelo, at al., * Constructlo & And Ckaraotarisatiea Of A Plasnid Containing A Neraly Full-Size DNA Copy Of Satellite Tobacco Neerodls Virus RNA, J. Mol «Biol. * (in the fitaapi) as internal controls, ee snieaaja sonikadjon and USE sonicator 1 is deposited ea natrlaa-acetate-ethanol.

Napravi ae čvrst aatrlks dlasobensllokslnetil (DBM)-celulose (cf·, J. C. Alvine, et al·, Mothod Por Dotaction Of Spedflc RKAs Za Agarose 6els 9γ Transfer TO Diazobeazyl Okynetil Paper And Hybridiaing MA Probes, Proo. Natl. Acad. Sd. PSA. 74, pp. 5350· (1977)) prana postupka knji je opisan a J. C. Alaine, et al·, *Deteetlen Of Spedfle RKAs Ir Spedflc Pragnents Of DNA Practionation In (Sela And Trabsfer To Dlasobenzylokxynethyl Paper”, MethodsEnzyaology, 68t Reoombinant DNA (k. Va, ed.) (1980). 8a papirni triks, list Vhatnan 548 paplra se podgednako potopi a rastvor koji sadrži 2*3 ng l*(n*nitcobansilokai)natil piridiaijanblorlda (HPBC/BDH) 1 0.7 ni natrljan-aeetat trihidrata a 28.5 /Ul voda na on , inkubira sa na 6· C do seva i jož 10 nin., 1 pade sa na 130*Make Ae Solid Aatrlks Dlasobensylloxylnethyl (DBM) -Cellulose (cf ·, JC Alvine, et al ·, Mothod Por Dotaction Of Spedflc RKAs For Agarose 6els 9γ Transfer TO Diazobeazyl Okynetil Paper And Hybridiaing MA Probes, Proo. Natl Acad. Sd. 74, pp. 5350 · (1977)) washing the process of the book is described by JC Alaine, et al ·, * Deteetlen Of Spedfle RKAs Ir Spedflc Pragnents Of DNA Practionation In (MethodsEnzyaology, MethodsEnzyaology, 68t Reoombinant DNA (k. Va, ed.) (1980) 8a paper trik, Vhatnan 548 paper is submerged submerged, and a solution containing 2 * 3 ng l * (n * nitcobansilokai) natil pyridiaianblorld (HPBC / BDH) 1 0.7 is not rubbed- acetate trihydrate a 28.5 / Ul water on on, incubate at 6 · C to strain and another 10 nin., 1 drop to 130 *

I35°C tokov 30-40 nin. Posle ispiranja nekoliko pata aa vodom (oko 29 nin.), 3 pata sa acetonom (oko 20 nin) i šali se pa se etoklra· Papir ao iakzbira aa 60eC tokom 36 nin. a 0.4 ni 20» natrljundltlonlt2 «β» 37 * τ sa povremaaln mečkanjem. Papir m ponovo ispere 4 peta aa vodom, jednom aa 34« sirdstaom kiaeliaom tokom 5 min. 1 4 puta aa vodom, prenese ao aa 0.3 ml po on2 ledeno hladno 1.2 M HCl kojoj ja bilo dodano 10 mg/ml svešeg ltaNO2 (neposredno pro koriščenja tokom 30 min. na 0°C), 1 ispere se brso 2 puta sa 80% dimetilsulfoksidom (spektrofotemetrljskl kvalitet. Merek)-20% 25 nM natrljua-fosfata (pH 4.0). Za matrike u prahu suštinski so prati ist postupak koriščenjem mikrogranulamog oelulosnog praha (Nhatman CC31), pri Somu so količino izralavaju ssspraa odgovarajuče toSiao oelulosnog matriksa.I35 ° C currents 30-40 nin. After rinsing a few pats with water (about 29 nin.), 3 pats with acetone (about 20 nin.) And joking and ethochlor · Paper ao extracted aa 60 e C for 36 nin. a 0.4 ni 20 »natlndltlonlt2« β »37 * τ with occasional wrinkling. The paper m is again washed with 4 heels 5a a water, once aa 34 «sirdsta kiaelia for 5 min. 1 4 times aa with water, transfer ao aa 0.3 ml per hen 2 ice cold 1.2 M HCl to which 10 mg / ml of fresh lTANO 2 was added (immediately after use for 30 min at 0 ° C), 1 was washed quickly 2 times with 80% dimethyl sulfoxide (spectrophotometer quality. Measure) -20% 25 nM sodium phosphate (pH 4.0). For powdered matrices, substantially the same procedure is followed by the use of microgranular oelulos powder (Nhatman CC31), at Som with the amount of ssspraa of the corresponding toSiao oelulosic matrix.

a početku smo koristili matrike u prahu «ato Sto jo kapacitet vesivanja bio viši, tako da se mogle da oe koriste relativno manje sapremine sa hibrldisaoiju, ispiranje i eluiranje. Ksenije smo koristili papirni natri)» sa pojedinačne testiranje klona. Koriščen, papira omoguduje efikasne eluiranje sa vodom Sto ee jo pokesalo bolj im sa kasnija testiranje IFV-heta uAMA·and in the beginning we used powdered matrices as long as the weighing capacity was higher, so that relatively smaller sapremins with hybridization, rinsing and elution could be used. Xenia we used paper natri) »with individual clone testing. Used, the paper allows for efficient elution with water.

OSA napravijena gora rastvori so a 25 nM astri jum-fosfata (pB 4.0), aagreva so 1 minut, jako ss hladi 1 dodaju so 4 sapr.The OSA-made mount was dissolved with 25 nM aster of phosphate (pB 4.0), aerated with 1 minute, very cool with 1 added with 4 sapr.

DMSO. Kuplovaajo sa matrike (50 mg, prah) lli papirni disk (prodnik 10 nm) so obično vrši preko vikenda na 4®C sa kontinualnis mešanjem. Zapremina DMA so odrSava da huda priličao mala tako da ss omogoči bliski kontakt sa matriksom pa ss tako pojačava kuplovanjo DHA sa matrike. Posl« kuplovanja, matrike sa siporo 4 puta aa vodom i 4 puta sa 0·4 ll VaOB na 37°C tokom 10 minuta svaki put« ponovo 4 puta sa vodom na sObmoj temperaturi 1 konačno dva puta sa puforom sa hibrldisaoiju (501 focmsnid (dojonisovaa, Baker), an plperesin-N,W*-bIe(2-etaneul£eneka kisalina) (pB 4«4)(”FXP88* Sigma), 1 uM KOTA, 0.5 * KaCl i 0.1% 808) na 4°C. Kfikasnestl kaplovnnja moro so ^^P-radioaktivnošču.DMSO. They were purchased from a matrix (50 mg, powder) or a paper disk (10 nm pebble) was usually bubbled over the weekend at 4 ° C with continuous stirring. The volume of DMA is maintained to be severe enough to allow close contact with the matrix, thereby enhancing DHA buying from the matrix. After coupling, siporo arrays 4 times aa with water and 4 times with 0 · 4 ll VaOB at 37 ° C for 10 minutes each time again 4 times with water at ambient temperature 1 finally twice with buffer with hybridized (501 focmsnid ( dojonisova, Baker), an plperesin-N, W * -bile (2-ethaneulic acid) (pB 4 «4) (” FXP88 * Sigma), 1 μM KOTA, 0.5 * KaCl and 0.1% 808) at 4 ° C. Kfikasnestl dripwood have ^^ P-radioactivity.

^ug «kapne BKA, napravljene ka ranije, 1 50 sg BTBV-SKA^ ug «drops BKA, made towards earlier, 1 50 sg BTBV-SKA

- je rastvori se u 259 y«l (59 ^ul za papirni Matrike ( hlbridisadonog pufera i doda se oa DKa k«plovani matrika. Matrike se zagreva aa 70°C tokom 2mia. i drii se na 37*C preko noči sa blagim mešanje».- dissolve it in 259 y «l (59 ^ ul for paper Matrices (chlbrizadon buffer and add oa DKa k« floated matrix. The matrices are heated aa 70 ° C for 2m. and kept at 37 * C overnight with mild mixing ».

Faza C - Odvajanje hibridizovane totalne RNA-DNA iz nehibridizovane totalne RNAPhase C - Separation of hybridized total RNA-DNA from non-hybridized total RNA

Poale centrifugiranja aatrikaa u prahu, aehibridlzovane RNA ae odvoje 1 aatri|a se ispere 7 puta sa ukupno 2 »1 501 fomaaida, mM PZPSS (pH 6.4), 1 mM EDTA, 0.3 M NaCI i 0.11 SDS, pri Senu sa niši aadriaj ovih filtrata od ispiranja destabllicuje nespecifičnim RHA-DNA veziven jen. Svake Izpiranje je predeno resuzpandovanjam matriksa u pufer«· Sa kaznijl tast, prvo izpiranje sa zakupi sa nahibridizovaaom RKA (•Frakcija 1) a sakupe se 1 ispiranja 2-4 (•Frakcija 2* i ispiranja 5-7 (•Frakcija 2·) · D hibridizacijama na papirnem matrike« koriščen je lati postopek lzusev Sto je «kupna zapremina ogranlčeaa na 1 ml.Powders of aatrix powder centrifugation, aerial hybridized RNAs, and separated 1 aatride were washed 7 times with a total of 2 »1 501 fomaaids, mM PZPSS (pH 6.4), 1 mM EDTA, 0.3 M NaCl and 0.11 SDS, at Sen with lower aadrii of these The leachate filtrate destablicates non-specific RHA-DNA-bound yen. Each Rinse is given to resuspending the matrix into the buffer. ”· With penalty, first rinse with RKA (• Fraction 1) leases, and 1 rinses 2-4 (• Fraction 2 * and Rinses 5-7 (• Fraction 2 ·) are collected. · In hybridizations on a paper matrix, a "lacy process is used, which is" the purchasing volume is limited to 1 ml.

Pasa P * Prečiščevanje Ribrldizevone «kupne RNAPasa P * Purification of Ribrldizevone «Purchase RNA

Hihridisovana ukupna RNA—DNA eluira sa ss matriksa u prahu sa 3 eluiranja od «kopno 900 ^ol 991 formamida, 0.21 SDS na 70°C . tokom 2 min. i jako se ohladi na led«.Okopan postopek hibridizacije i eluiranja sa formsmidem bili su suštinski kao što jo opisano u A. G. Smith (privatno saopštanje). Hibridizovana «kupna RNA-DUA eluira so so papirnog matriksa najpre ispiranjam sa 100 ^ul ledeno hladno vodo 1 pooio toga oa dva eluiranja aa vodom (ukzgpno 300 yal) na 80°C tokom 2 mla.Sa kaanijl tast ova eluiranja 1 100 ^ul izpiranja so sakupe (”Frakclja 4).The hydrated total RNA-DNA eluted from the ss powder matrix with 3 elution from land 900 ^ ol 991 formamide, 0.21 SDS at 70 ° C. for 2 min. and cooled very well on ice. ”The vicious process of hybridization and elution with formsmidem were essential as described in A. G. Smith (private communication). Hybridized "RNA-DUA heap eluted with a paper matrix salt, first by rinsing with 100 [mu] l of ice cold water, 1 by two elution with water (total 300 yal) at 80 [deg.] C. for 2 ml. the rinses are collected (“Fraction 4).

NU jednu polovinu svako od 4 frakcije, doda se tRNA jetra tolsta ili rtbouosna RIA (Frakcija ΙΑ, 2A, Sa i 4a) a na drugu polovinu 0^«$ eukarlotske poli (A) RNA lli rlbosemno RNA (Frakcije IB, 2B, SB, 4B). Frakolje sa prečiste talošenjem dodavanjen 0.5 N saci 1 2.5 sapr. etanola da so uklone trugovi formamida 1 drugih nečistoča.To one half of each of the 4 fractions, add tRNA liver fat or rtbous RIA (Fraction ΙΑ, 2A, Sa and 4a) and to the other half 0 ^ «$ eukarlot poly (A) RNA or rbbosemic RNA (Fractions IB, 2B, SB , 4B). Purification Droplets added 0.5 N saci 1 2.5 sapr. ethanol to remove formamide 1 tubes of other impurities.

- 39 Faza E - Odredjivanje IFN-beta mRNA aktivnosti- 39 Phase E - Determination of IFN-beta mRNA activity

Frakcije ΙΑ, 2A, 3A i 4A se translatiraju u 25 ^ul nukleazom-tretiranog retikulocitnog lizata kuniča (napravljen prema postupku iz R. B. Pelham andThe fractions ΙΑ, 2A, 3A and 4A were translated into 25 µl of nuclease-treated rabbit reticulocyte lysate (made according to the procedure of R. B. Pelham and

R. J. Jackson, An Efficient mRNA-Dependent Translation Systera For ReticulocyteR. J. Jackson, An Efficient mRNA-Dependent Translation Syster For Reticulocyte

Lysates, E ur. J. Bjochem., 7, pp. 247-56 (1976)) postupkom koji su daliLysates, E ur. J. Bjochem., 7, pp. 247-56 (1976)) by the procedure they gave

B. LeBleu, et al., Translation Of Mouse Interferon rnftMA In Xenopus LaevisB. LeBleu, et al., Translation Of Mouse Interferon rnftMA In Xenopus Laevis

Oocytes And In Rabbit Reticulocyte Lystes, Biochem. Biopfays. Res. Commun.,Oocytes And In Rabbit Reticulocyte Lystes, Biochem. Biopfays. Really. Commun.,

82, pp. 665-673 (1978) izuzev što se doda 250 mM spermidin-HCl, 1 mM fruktoza3582, p. 665-673 (1978) except the addition of 250 mM spermidine-HCl, 1 mM fructose35

1,6-difosfata u prisustvu raM S-metionina (0.5 mCi/ml, Amersham). Posle inkubacije, 25 ^il retikulocitnog lizata, iz gornjeg dela, spoji se sa 1 pl 10% deoksibolat-10% Triton Χ100 i 2 ^il antlseruma-PBS (1:9) i zagreva se na 37°C 1 čas. Dodaju se 20 yal Staphylococcus aureus Cevran I (sveže ispran, S. W. Kesslerž, et al., Rapid Isolation Of Antigena From Celiš With A Staphylococcal Protein A-Antibody Adsorbent: Parameters Of The Interactlon Of Antlbody-Antigen Complexes Wlth Protein A, J. Immunology. 115, pp. 1617-1624 (1975)) u 10% 100 mM NaCl, mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.05% NP40 i smeša se održava na 20°C tokom 30 minuta i centrifugira se n fippendorf 5412 centrifugi tokom 2 minuta.1,6-diphosphate in the presence of raM S-methionine (0.5 mCi / ml, Amersham). After incubation, 25 [mu] l of reticulocyte lysate from the above was combined with 1 [mu] l of 10% deoxybolate-10% Triton Χ100 and 2 [mu] l of antiserum-PBS (1: 9) and heated at 37 [deg.] C. for 1 h. Add 20 yal Staphylococcus aureus Cevran I (freshly washed, SW Kesslerz, et al., Rapid Isolation Of Antigen From Celish With A Staphylococcal Protein A-Antibody Adsorbent: Parameters Of The Interactlon Of Antlbody-Antigen Complexes Wlth Protein A, J. Immunology 115, pp. 1617-1624 (1975)) in 10% 100 mM NaCl, mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.05% NP40 and the mixture was maintained at 20 ° C for 30 minutes and centrifuged fippendorf 5412 centrifuges for 2 minutes.

Granula se ispere i centrifugira dva puta sa PBS i finalna granula rastvori se u uzorku pufera i podvrgne se elektroforezi u 13% poliakrilaroidnom gelu keo što je opisano u U.K. Laemmli, et al., Cleavage Of Structural Proteina During The Assemhly Of The Head Of Bacteriophage T4, Nature, 227, pp. 680-85 (1970), i onda se podvrgne autorafiografiji. Uporedji vanje STNV-RNA translatiranih proizvoda u Frakcijama IA i 4A obezbedjuje indikacija eflkasnosti hibridizacije i RNA degradacije u postupku.The granule was washed and centrifuged twice with PBS and the final granule was dissolved in buffer sample and electrophoresed in a 13% polyacryloid gel keo as described in U.K. Laemmli, et al., Cleavage Of Structural Protein During The Assemhly Of The Head Of Bacteriophage T4, Nature, 227, pp. 680-85 (1970), and then submitted to the author's CV. Comparison of STNV-RNA translated products in Fractions IA and 4A provides an indication of the efficiency of hybridization and RNA degradation in the process.

Frakcije IB, 2B, 3B i 4B se rastvore u 2 ^il vode i testireju se u oocitima na sadržaj IFN-beta mRNA kao ito je opisano gore.The fractions IB, 2B, 3B and 4B were dissolved in 2 ^ yl of water and tested in oocytes for IFN-beta mRNA content as described above.

3. Kasnijt test - hibridizacija na nitroceluloznim pločama3. Later test - hybridization on nitrocellulose plates

Neki kasni ji testovi pojedinačnih klona izvršeni su na nitroceluloznim pločama (M. Cochet, et al., Cloning Of An Almost Full-Lengt Chicken Conalbumin DoubleStraaded cDNA”, Nucleic Acids Research, 6, pp. 2435-2452 (1979)). DNA se rastvc o u 2M NaCl i 0.2 M NaOH, zagreva se na 100 C tokom 1 minuta, jako se ohladi, i nanese se kao mrlja na Milllpore filtre koji su siobodni od deterdjenata (veličina pora 0.45 um; prečnik 7 mm). Filtri se peku 2 časa na 80°C, isperu se u 0.3 MSome late J tests of single clones were performed on nitrocellulose plates (M. Cochet, et al., Cloning Of An Almost Full-Lengt Chicken Conalbumin DoubleStraaded cDNA ”, Nucleic Acids Research, 6, pp. 2435-2452 (1979). The DNA was dissolved in 2M NaCl and 0.2 M NaOH, warmed to 100 C for 1 minute, cooled strongly, and applied as a stain to Millerpore filters that were deoderate-free (pore size 0.45 μm; 7 mm diameter). The filters were baked for 2 hours at 80 ° C, washed in 0.3 M

- 40 NaCl, 2 mM EDTA, 0.1% SDS, 10 mM Tris-HCl (pH 7.5) i suše se na sobnoj temperaturi. RNA se hibridizuje 3 časa na 47°C u 30% formamidu, 0.5 NaCl, 0.4% SDS, mM EDTA, 50 mM PIPES (pH 7.5). Hibridizacija se zaustavi razblaživanjem sa 10 ml 0.1 M NaCl i filtri se eperu nekoliko puta u 15 ml 0.3 M NaCl, 0.1% SDS, mM EDTA, 10 mM Tris-HCl (pH 7) mučkanjem na 45°C i nekoliko puta u istom rastvoru bez SDS na 4°C. Eluiranje hibridizovane RNA-DNA vršeno je u 30 ^ul O mM kalij um-hlorida na 100 C tokom 1 minuta.- 40 NaCl, 2 mM EDTA, 0.1% SDS, 10 mM Tris-HCl (pH 7.5) and dried at room temperature. RNA was hybridized for 3 hours at 47 ° C in 30% formamide, 0.5 NaCl, 0.4% SDS, mM EDTA, 50 mM PIPES (pH 7.5). Stop the hybridization by dilution with 10 ml of 0.1 M NaCl and filter the filters several times in 15 ml of 0.3 M NaCl, 0.1% SDS, mM EDTA, 10 mM Tris-HCl (pH 7) by shaking at 45 ° C and several times in the same solution. without SDS at 4 ° C. Elution of the hybridized RNA-DNA was performed in 30 ^ ul O mM potassium um-chloride at 100 C for 1 minute.

4. Rezultati testa RNA Selekcione hibridizacije4. Results of the RNA Selection Hybridization Test

Testirano je 16 grupa od oko 46 klona (Grupe A-P). U šest grupa Frakcija IB sadržala je samo IFN-beta mRNA aktivnost, u osam grupa nije detektovana IFN-beta mRNA i u dve grupe (Grupe C i O) IFN-beta mRNA je zapažena u Frakciji 4B.16 groups of about 46 clones (Groups A-P) were tested. In six groups, Fraction IB contained only IFN-beta mRNA activity, in eight groups no IFN-beta mRNA was detected and in two groups (Groups C and O) IFN-beta mRNA was observed in Fraction 4B.

Testovi grupe C i O navedeni su u sledečem formatu: logaritam IFN-beta jedinica (kalibrisan naspram referentnog standarda 69/19), detektovanih atestu Frakcije IB (ne-hibridizovana) i u testu Frakcije 4B (hibridizovana). Granica detekcije Ula je 0.1Group C and O tests are given in the following format: logarithm of IFN-beta units (calibrated against reference standard 69/19), detected by Fraction IB (non-hybridized) and in Fraction 4B (hybridized) test. The detection limit of Ula is 0.1

Grupa The group Frakcija IB Fraction IB Frakcija 4B Fraction 4B C C 1.0 1.0 0 0 0.5 0.5 0.5 0.5 0 0 0.2 0.2 0 0 0 0 0 0

0.2 0.50.2 0.5

Grupa O je podpodeljena u 6 podgrupa (Podgrupe O„ do O ; četiri od po osam klona 1 o i dve od po sedam klona) i hibridizovana je i testirana kao ranije, izuzev što je koriščeno 400 ml kulture po klonu. Podgrupe su dale sledeče rezultate, prikazane u istom formatu kao gore. Hibridizacija je vršena ne DBM-celuloznom prahu izuzevGroup O was subdivided into 6 subgroups (Subgroups O 'to O; four of eight clones 1 o and two of seven clones each) and hybridized and tested as before, except that 400 ml of culture per clone was used. The subgroups gave the following results, presented in the same format as above. Hybridization was performed with the exception of DBM-cellulose powder except

ako nije drukčije naznačeno. unless otherwise noted. Podgrupa Subgroup Frakcija IB Fraction IB Frakcija 4B Fraction 4B θ. θ. 0 0 1.2 1.2 1 1 0 0 1.5 1.5 0 0 0.5 0.5 0 0 0.5 0.5 0.2 0.2 0.5 0.5 0 0 a 1.2 a 1.2 O2 O 2 0.7 0.7 0 0 °3 ° 3 0.7 0.7 0 0 0.5 0.5 0 0 °4 ° 4 0 0 0 0

Postupak na DBM celuloznom papiru.Procedure on DBM Cellulose Paper.

Podgrupa °5 °6Subgroup ° 5 ° 6

--4-1 Frakcija IB--4-1 Fraction IB

0.50.5

Frakcija 4BFraction 4B

Podgrupa je podpodeljena u svoje po jedinačne klone (označeni kloni θΐ/j - θι/g) * hibridizovana i testirana kao gore, izzuzev ato je korišceno 700 ml kulture po klonu. Hibridizacija je ponovo izvršena na DBM-celuloznom prahu izuzev ako nije drukčlje naznačeno.The subgroup was subdivided into its individual clones (designated clones θΐ / j - θι / g) * hybridized and tested as above, except that 700 ml of culture per clone was used. Hybridization was again performed on DBM-cellulose powder unless otherwise indicated.

KlonClone

Frakcija IBFraction IB

1/11/1

1/i1 / i

1/31/3

1/41/4

1/51/5

1/61/6

1/71/7

1/81/8

Frakci ja 4BFractions I 4B

0.2 0.2 o o 0.7 0.7 0 0 0.7 0.7 θΚκ θΚκ 1.0 1.0 0 0 1.2 1.2 0 0 0.2 0.2 0 „bb 0 „Bb 0.7 0.7 0 0 1.2 1.2 0 0 1.0 1.0 0.2 0.2 1.2 1.2 !.0{?) ! .0 {?) 1.2 1.2 o o 1.2 1.2 0 0 1.2 1.2 0 B 0 B 1.0 1.0 0 0 1.2 1.2 0 0 0.7 0.7 0 0 0.7 0.7 <OČ2* <OCH2 * 1.0 1.0 '0 '0 0.7 0.7 0 0 1.0 1.0 <0.2* £ B» <0.2 * £ B » 0.5 0.5 0 0 0.5 0.5 0 _B 0 _B 1.2 1.2 0 0 <0.2 <0.2 0.9 0.9 0 0 1.7* mr 1.7 * mr ¢0.2 ¢ 0.2 1.2 CT 1.2 CT 0 0 0.7 0.7 0 0 - 1.0 - 1.0

*Postupak na DBM celuloznom papir u.* Process on DBM Cellulose Paper in.

Nitrocelulozne ploče.Nitrocellulose plates.

Zbog toga, klon O . sadrži rekombinantni DNA molekul koji može da hibri1/8 dizuje IPN-beta mRNA iz ukupne RNA koja sadrži IFN-beta mRNA.Therefore, clone O. contains a recombinant DNA molecule capable of hybridizing 1/8 to lift IPN-beta mRNA from total IFN-beta mRNA-containing RNA.

- 42 Nespecifično RNA-DNA vezi vanje je vrlo neverovatno, zato što uporedjivanje- 42 Non-specific RNA-DNA binding is very improbable because of the comparisons

Frrakcija 1A i 4Λ otkriva da suštinski nema nespecifičnog vezivanja STNV DNA u ovim istim eksperimentima. N. pr., kao što je registrovanotranslacijom u retikulo— 35 citnom lizatu kuniča u prisustvu S-metionina, posle gel elektroforeze, kao što je opisano aore. Klon O , označen je £. coli HBl0l(G-pBR322(Pst)/HFIFl 1/8 .....F r of the reaction 1A and 4Λ reveals that suštinski middle nespecifičnog of binding STNV DNA In these same experiments. BC, such as recorded by translocation in the reticulo- 35 citric rabbit lysate in the presence of S-methionine, after gel electrophoresis, as described by aore. Clone O, marked £. coli HBl0l (G-pBR322 (Pst) / HFIFl 1/8 ......

{G-HBlOl-pHFIFl”), njegov rekombinantni DNA molekul G-pBR222(Pst)HFIFl (pHFIFl) i njegov hibridni insert pHFIFl fragment. Ova nomenklatura pokazuje da klon i rekombinantni DNA molekul potiču u Gent (G) i i obuhvata plazmid pBR322 koji sadrži, na Pstl mestu HuIFN-beta cDNA (HFIF), Čiji je odredjeni molekul prvi lociran (’*1M).{G-HBlOl-pHFIF1), its recombinant DNA molecule G-pBR222 (Pst) HFIF1 (pHFIF1), and its hybrid insert pHFIF1 fragment. This nomenclature shows that the clone and recombinant DNA molecule originate in Gent (G) and comprises a plasmid pBR322 containing, at the Pst1 site of HuIFN-beta cDNA (HFIF), whose designated molecule was first located ('* 1 M ).

IDENTIFIKACIJA KLONA KOJI SADRŽE REKOMBINANTNE DNA MOLEKULA UMREŽENOIDENTIFICATION OF CLONES CONTAINING RECOMBINANT DNA MOLECULES

HIBRIDIZOVANE ZA pHFIFl pHFIFl, izolovan gore, koristi se za testiranje stoka klonova, napravljenih ranije, za bakterijske klonove koji sadrže rekombinantne DNA molekule koji imaju srodne DNA insert e, hibridizacijom kolonije (M. Grunstein and D. S.HYBRIDIZED FOR pHFIFl pHFIFl, isolated above, is used to test stock clones, made previously, for bacterial clones containing recombinant DNA molecules having related DNA insert e, by colony hybridization (M. Grunstein and D.S.

Hogness, ”A Method For The Iaolatton Of Cloned DNA's That Contain A Specific Gene, Proč. Natl. Acad. Sci. USA, 72, pp. 3961-3965 (1975)). Ovaj postupak omogu čuje brzu identifikaciju srodnih klona hibridizacijom radioaktivne sonde napravljene iz pHFIFl za DNA raskinutih bakterijskih kolonije fiksiranih u nitroceluloznim filtrimaHogness, ”A Method For The Iaolatton Of Cloned DNA's That Contain A Specific Gene, Cont. Natl. Acad. Sci. USA, 72, pp. 3961-3965 (1975). This procedure enables the rapid identification of related clones by hybridization of a radioactive probe made from pHFIF1 for DNA terminated bacterial colonies fixed in nitrocellulose filters

Stok klona stokiranih na mikrotitarskim plocama, kao što je opisano gore, replicira se na nitroceluloznim pločama slične veličine (prečnik pora 0.45 Schleicher and Schuel iii M illipore), koje su prethodno prokuvane da se ukloni deterdjent, i ploče se stave na LB-agarne ploče koje sadrže tetraciklin (10 ^ug/ml). Bakterijske kolonije se kultivišu preko noči na 37 C. Raskidanje i fiksacija bakterija na nitroceluloznim pločama vrše se uzastopnim ispiranjem u 0.5 M NaOH (dva puta po 7 min.), 1 M Tris-HCl (pH 7.5)(7 min·), 0.5 M Tris-HCl (pH 7.5) i 1.5 M NaCl (7 min.), 2 x SSC (0.15 M NaCl, 0.015 M natrijum-citrat (pH 7.2)(7 min.)). Posle potpunog ispiranja sa etanolom i sušenja na vazduhu, ploče se peku na 80°C tokom 2 časa u vakumu i stokiraju se na sobnoj temperaturi.The stock of clones stacked on microtiter plates, as described above, is replicated on similarly sized nitrocellulose plates (pore diameter 0.45 Schleicher and Schuel iii M illipore) previously boiled to remove detergent and placed on LB agar plates. containing tetracycline (10 µg / ml). Bacterial colonies were cultured overnight at 37 C. Bacteria were dissolved and fixed on nitrocellulose plates by sequential washing in 0.5 M NaOH (twice for 7 min.), 1 M Tris-HCl (pH 7.5) (7 min ·), 0.5 M Tris-HCl (pH 7.5) and 1.5 M NaCl (7 min.), 2 x SSC (0.15 M NaCl, 0.015 M sodium citrate (pH 7.2) (7 min.)). After washing thoroughly with ethanol and air drying, the plates were baked at 80 ° C for 2 hours in vacuo and stocked at room temperature.

Hinf 1 restrikcioni fragment specifičen za pHFIFl fragment (infra) služi kao sonda za hibridizaciju kolonije, kao što je opisano niže. Ovaj fragment (oko 170 parava baza) preči sti se elektrof orezom proizvoda Hinf digerovanja pHFIFl u 6% poliakrilsmidnom gelu. Posle bojenja DNA traka sa etidijumbromidom, specifi - 43 - : ;The hinf 1 restriction fragment specific for the pHFIF1 fragment (infra) serves as a colony hybridization probe, as described below. This fragment (about 170 base pairs) was purified by electrophoresis by cutting the Hinf digester product pHFIF1 in a 6% polyacrylsmid gel. After staining of DNA bands with ethidium bromide, specifi - 43 -:;

Čni fragment se eluira, ponovo se podvrgne elektroforezl i markira se sa 32P pomoču nik translacije” (P.W.J. Rigby et al., Labeling Deoxyribonucleic Actd to High Specific Activity In Vitro By Nick Translation With DNA Polymerase 1”, J. Mol.The fragment is eluted, re-subjected to electrophoresis, and labeled with a 32 P translation aid ”(PWJ Rigby et al., Labeling Deoxyribonucleic Actd for High Specific Activity In Vitro By Nick Translation With DNA Polymerase 1”, J. Mol.

Biol. , 113, pp. 237-251 (1977)) inkubacijom u 50 1 50 mM Tris-HCl (pH 7.4), mM MgClo, 20 mM beta-merkaptoetanola, koji sadrži 2.5 jd i dCTP, dTTP i dGTP pri 400 ^uM, 100 pmolova alfa-ATP (Amersham, 2000 Ci/mmol) l 2.5 jedinice DNApoliraeraze I (Boehringer) na 14°C tokom 45 minuta. Neizreagovani deoksinukleozid trifosfati se odvoje gel filtracijom preko Sephadex G-50 u T£ pufer u. Visoko 32p-markirana DNA se staloži ea 0.1 zapr. 2 M natrijum-acetata (pH 5.1) i 2.5 zapr. o etanola na-20 C.Biol. , 113, pp. 237-251 (1977)) by incubation in 50 1 50 mM Tris-HCl (pH 7.4), mM MgCl o , 20 mM beta-mercaptoethanol, containing 2.5 µd and dCTP, dTTP and dGTP at 400 µM, 100 pmol alpha- ATP (Amersham, 2000 Ci / mmol) l 2.5 units of DNApolymerase I (Boehringer) at 14 ° C for 45 minutes. Unreacted deoxynucleoside triphosphates were separated by gel filtration via Sephadex G-50 in Tg buffer. Highly 32p-labeled DNA is positioned ea 0.1 close. Of 2 M sodium acetate (pH 5.1) and 2.5 mL. o ethanol at-20 C.

Hibridizacija gornje sonde za DNA Impregniranu na filtru vrši se suštinski kao što je opisano u D. Hanaban and M. Meselson (privatno saopŠtenje): Filtri, napravljeni gore se preinkublraju tokom 2 časa na 68°C u 0.1% Ficoll, 0.1% poliviniipirolldonu, 0.1% albuminu volovskog seruma. 0.15 M NaClž 0.03 M Tris-HCl (pH 8), 1 mM EDTA i isperu se sa 0.02% Ficoll, 0.02% polivinilpirolidona, 0.02% albumina volovskog seruma, 0.75 M NaCl, 0.15 M Tris-HCl (pH 8), 5 mM EDTA i 0.5% SDS. Hibridizacija se vrši preko noči na 68°C u rastvoru koji je identičen sa rastvorom za ispiranje koriščenjem P-markirane sonde koja je bila denaturisana na 100°C tokom 5 minuta pre koriščenja. Hibridizovani Hitri se isperu dva puta sa 0.3 M NaCl, 0.06 M Tris-HCl (pH 8), 2 mM EDTA tokom 2 časa na 58°C pre sušenja na vazduhu i autoradiografije·Hybridization of the upper DNA probe Impregnated on the filter is essentially as described in D. Hanaban and M. Meselson (private communication): The filters made above are preincubated for 2 hours at 68 ° C in 0.1% Ficoll, 0.1% polyvinylpyrrolldone. 0.1% bovine serum albumin. 0.15 M NaCl 0.03 M Tris-HCl (pH 8), 1 mM EDTA and washed with 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin, 0.75 M NaCl, 0.15 M Tris-HCl (pH 8), 5 mM EDTA and 0.5% SDS. Hybridization was performed overnight at 68 ° C in a solution identical to the rinse solution using a P-labeled probe that was denatured at 100 ° C for 5 minutes before use. Hybridized Fasts were washed twice with 0.3 M NaCl, 0.06 M Tris-HCl (pH 8), 2 mM EDTA for 2 hours at 58 ° C before air-drying and autoradiography ·

Testira se oko 1350 klona, koji potiču iz klase DNA veličine 800-900. Trinaest kolonija, uključujuči pHFIFl dalo je pozitiven rezultat. Cvik kloni su označeni G-HBlOl-pFIFl do 13 a njhivi rekombinantni DNA molekuli pHFIFl do 13. Jedan od klona. pHFIF2, hibridizovan je u poli(A) mRNA koja sadrži IFN-beta mRNA i testiran je koriščenjem DSM-celuloznog papira (gore). Zato što je ukupbna 1FN-&NA aktivnost detektovana u hibridizovanoj frakciji a neidbridizovana RNA nije sadržala nikakvu deteklujucu aktivnost, jasno je da kloni identifikovani hibridizacijom koloaije na delu pHFIFl fragmenta takodje hibridizuju u IFN-beta mRNA,About 1350 clones are tested, all of which come from the 800-900 DNA class. Thirteen colonies, including pHFIF1, gave a positive result. Zwic clones are labeled G-HBlOl-pFIF1 up to 13 and their recombinant DNA molecules pHFIFl up to 13. One of the clones. pHFIF2, was hybridized to poly (A) mRNA containing IFN-beta mRNA and tested using DSM-cellulose paper (above). Because the total 1FN- & NA activity was detected in the hybridized fraction and the non-hybridized RNA did not contain any detectable activity, it is clear that the clones identified by colloia hybridization on part of the pHFIF1 fragment also hybridize to IFN-beta mRNA.

Naravno da je jasno da se ovaj postupak za testiranje klona koriščenjem HuIFNbeta DNA unsetka pHFIFl iii drugog DNA umetka klona identiflkovanog koriščenjem DNA inserta pHFIFl, kao što je opisano gore, može jdnako dobro koristiti na drugim klenima koji sadrže DNA sekvence koje potiču iz rekombinantne DNA tehnologije,Of course, it is clear that this method for testing a clone using HuIFNbeta DNA insert of pHFIF1 or another DNA clone insert identified using DNA insert pHFIF1, as described above, can be equally well used on other clones containing DNA sequences originating from recombinant DNA technology ,

- 44iz sinteze, iz priročnih izvora iii njihovih kombinacija lli iz klona koji sadrže DNA sekvence srodne sa makojom od gornjih DNA sekvenci na osnovu mutacije, uldjučujuci proste iii višeš t ruke, zamene baza, umetanja, inverzija iii izostavl Janja. Zbog toga, takve DNA sekvence i njihova identifikacija takodje spadaju unutar obima ovog pronaiaska. Takodje tre ha da je jasno da DNA sekvence, koje nisu testirane pomoču gornjih DNA sekvenci, ali ipak zbog rasporeda njihovih nukleotida kodiraju za one poli peptide za koje kodiraju 1 gornje DNA sekvence takodje spadaju unutar obima ovog pronaiaska.- 44 from the synthesis, from convenient sources or combinations thereof or from clones containing DNA sequences related to a mockup of the above DNA sequences based on mutation, including simple or multiple arms, base substitutions, insertions, inversions or omissions. Therefore, such DNA sequences and their identification also fall within the scope of this invention. It is also clear that DNA sequences that have not been tested using the above DNA sequences, but nevertheless due to the arrangement of their nucleotides, encode for the poly peptides for which they encode the 1 upper DNA sequences also fall within the scope of this invention.

KARAKTERIZACIJA IFN-beta SRODNIH REKOMBINANTNIH PLAZMIDACHARACTERIZATION OF IFN-beta RELATED RECOMBINANT Plasmids

Trinaest klena (pHFIFl-13) koji su detektovani hibridi zaci jom kolonije se dalje karakterižu. Konstruisana je fizička mapa umetskn ovih klona i odredjena je orijentacija inserata u raznim klonima.Thirteen maples (pHFIF1-13) that were detected by colony-deficient hybrids are further characterized. A physical map of the inserted clones was constructed and the orientation of the inserts in the various clones was determined.

F i žičke mape plazmida konstruisane su digerovanjem sa raznim restrikcionim enzimima (Nev England Biolabs) u 10 mM Tris-HCl (pH 7.6), 7 mM MgCl i 7 mM beta-merkaptoetanola na 37 C dobro poznatim postupcima. Proizvodi digerovanja podvrgnu se elektroforezi u 2.2% agarozi iii na 6% poliakrilamidnim gelovima u 40 mM Tris-HOAc (pH 7.8), 20 mM EDTA. Analizira ju se posle vizualizacije bojenjem sa etidijumbromidom i uporede se sa detaljnom fizičkom mapom pBR322 (J. G. Sutcliffe, gore). Koostruisu se restrlkeione mape raznih plazmida na bazi ovih šema digerovanja. Ove se prečiste sekvenclranjem DNA inserata u raznim plazmidima, suštinski po postupku koji su dali A. M. Maxam and W. Gilbert, HA Nev Method For Sequencing DNA, Proč. Natl. Acad. Sci. USA, 74 , pp. 560-564 (1977).F and wire maps of plasmids were constructed by digestion with various restriction enzymes (Nev England Biolabs) in 10 mM Tris-HCl (pH 7.6), 7 mM MgCl, and 7 mM beta-mercaptoethanol at 37 C by well known methods. Digeration products were electrophoresed in 2.2% agarose or on 6% polyacrylamide gels in 40 mM Tris-HOAc (pH 7.8), 20 mM EDTA. It was analyzed after visualization by staining with ethidium bromide and compared with the detailed physical map of pBR322 (JG Sutcliffe, above). Restriction maps of various plasmids based on these digestion schemes are co-structured. These are purified by sequencing DNA inserts in various plasmids, essentially following the procedure provided by AM Maxam and W. Gilbert, H A Nev Method for DNA Sequencing, Proc. Natl. Acad. Sci. USA, 74, pp. 560-564 (1977).

Naplavi se DNA plazmida iz raznih pHFIF-13 prema ovom pronalasku postupkom koji su dali Kahn et al., (gor»), koji je ranije koriščen za izolovanje DNA iz seta klona za testiranje. Izolovani oblik I DNA se prečisti neutralnim centrifugiranjem na saharoznom gradientu kao ranije i ograniči se sa raznim restrikcionim enzimima, suštinski kao što je preporučio proizvodjač (Nev England Biolabs).Plasmid DNA from various pHFIF-13 according to the present invention is harvested by the method provided by Kahn et al., (Gore), which was previously used to isolate DNA from a clone test set. Isolated Form I DNA is purified by neutral centrifugation on a sucrose gradient as before and confined to a variety of restriction enzymes, essentially as recommended by the manufacturer (Nev England Biolabs).

Ograničena DNA se defosforiluje tokom 30 min. na 65°C u prisustvu jedinice bakterijske alkalne fosfataze i 0.1% SDS. Posle dve ekstrakcije sa fenolom 32 i taloženja sa etanolom, DNA je 5’-terminalno markirana sa gama- P-ATP (oko 3000 Cl/romol) i sa polinukleotid kinazom (D-L Biochemicals, Inc. )·Limited DNA was dephosphorylated for 30 min. at 65 ° C in the presence of a bacterial alkaline phosphatase unit and 0.1% SDS. After two extractions with phenol 32 and ethanol precipitation, the DNA was 5′-terminally labeled with gamma-β-ATP (ca. 3000 Cl / romol) and with polynucleotide kinase (D-L Biochemicals, Inc.) ·

Za sekvenciranje, markiranim fragmentima rukoje se n* dva načina. NekiFor sequencing, the tagged fragments are handled n * two ways. Some

- 45 se preciste na poiiakrilamidnom gelu pre raskidanja sa drugim restrikcionim enzimom. Drugi se trenutno raškimi sa drugim restrikcionim enzimom. U oba slučaja željeni fragmenti se odvoje na poiiakrilamidnom gelu u Tris-borat-EDTA puferu. Slika 7 ispoljava razne restrikcione fragmente (krugovi označuj u marker a sterilicn pravac segmenti ran ja) a takodje prikazuju i strategij»! sekvenciranja koriščenjem pHFIFl, pHFIFS, pHFIF6 i pHFIF7.- 45 are purified on a polyacrylamide gel before being broken down with another restriction enzyme. Others are currently being treated with another restriction enzyme. In both cases, the desired fragments are separated on a poacrylamide gel in Tris-borate-EDTA buffer. Figure 7 shows various restriction fragments (mark the circles in a marker and sterile direction the wound segments) and also show the strategy »! sequencing using pHFIF1, pHFIFS, pHFIF6 and pHFIF7.

Fragmenti se degradiraj u prema postupku koji su dali A. M. Maxam and W. Gilbert (gore). Proizvodi se frakcionišu na pol iakril amidni m gelovima raznih konceitracija i dužina u 50 mM Tris-boratu, 1 mM EDTA (pH 8.3) na 900 V do 2000 V.The fragments are degraded in accordance with the procedure given by A. M. Maxam and W. Gilbert (above). The products were fractionated on polyacrylic amide m gels of various concentrations and lengths in 50 mM Tris-borate, 1 mM EDTA (pH 8.3) at 900 V to 2000 V.

Svaki pravac cDNA inserta sekvencira se sa obe niti i svako restrikciono mesto koje je služilo kao markirani terminus sekvencira se koriščenjem fragmenta koji ga obuhvata. Tako dobivena kompleksna nukleotldna sekvenca za nit koja kodira za IFN-beta DNA iii gen i njegova odfovarajuča aminokiselinska sekvenca opisan je na Sl. 4. Zato što nijedan od plazmida pHFIFl-13 nije sadržao kompleten gen za H ul PN-beta, Sl. 4 nastala je iz kombinacije podataka iz najmanje dva takva plazmida. U ovom pogledu, Si. 5 prikazuje odnos inserata pHFIFl, pKFIF3, pKFIF6 i pHFIF7, pri Čemu pune strelice prikazuju orijentaciju raznih delova inserata.Each strand of the cDNA insert is sequenced by both strands and each restriction site that has served as a labeled terminus is sequenced using a fragment enclosing it. The complex nucleotide sequence thus obtained for a strand encoding for IFN-beta DNA iii gene and its corresponding amino acid sequence is described in FIG. 4. Because none of the plasmids pHFIF1-13 contained the complete gene for H ul PN-beta, FIG. 4 was generated from a combination of data from at least two such plasmids. In this respect, Si. 5 shows the ratio of inserts pHFIF1, pKFIF3, pKFIF6 and pHFIF7, with solid arrows showing the orientation of the various parts of the insert.

Na Sl. 4, heteropolimerni deo inserta poravnjan je na jednom kraju segmentom koji je bogat sa T kao i zavojkom A (sto verovatno odražava poliA terminus mRNA). Radi reference insert je označen brojevima od prvog nukleotida kompleksnog inserta do nukleotida koji je dosta u netranslatiranom odeljku inserta. ATG inlcirajuči triplet u položaju 65-67 i TGA terminacioni triplet u položaju 636-628 definlžu ram za očitavanje koji je neprekinut besmislenim kodonima. Makoja druga sekvenca koja se može translatirati, n.pr., u raznim Tamovima za očitavanje, koja je poravnjana (zarubljena) sa ATG tli GTG kao i terminacioni signal je suviše kratka da kodira za polipeptid očckivane veličine IFN-betn. Zbog toga region izmedju nukleotida 65 i 625 najverovatnije uključuje nukleotidnu sekvencu kompleksne DNA sekvence koja kodira za IFN-beta prema ovom pronalasku.In FIG. 4, the heteropolymer portion of the insert is aligned at one end by a T-rich segment as well as coil A (which probably reflects the polyA terminus of the mRNA). For reference, the insert is numbered from the first nucleotide of the complex insert to the nucleotide, which is abundant in the untranslated insert section. The ATG inducing triplet in position 65-67 and the TGA termination triplet in position 636-628 define a reading frame that is continuous with meaningless codons. Other translatable sequences, e.g., in various Reading Tales aligned with ATG or GTG, and the termination signal is too short to encode for the IFN-betn size expected polypeptide. Therefore, the region between nucleotides 65 and 625 most likely includes the nucleotide sequence of a complex DNA sequence encoding for IFN-beta according to the present invention.

Ova sekvenca ne isključuje mogucnost da več nisu nastale modifikacije na genu kao što su mutacije, uključujuči proste i višestruje, zamene bata, izostavijanja, umetanja iii inverzije iii da se ove mogu koristiti kasnije da modifikuju njegove osobine iii osobine polipeptida koji se njime translatira. Niti to isključuje polimorfizam koji moženastati u fiziološki sličnim ali strukturno neznatno različitimThis sequence does not exclude the possibility that no modifications to the gene, such as mutations, including simple and multiple, replacement of the piston, omission, insertion, or inversion, have already occurred, or that these may be used later to modify its properties or the properties of the polypeptide it translates. Nor does it exclude polymorphisms that may occur in physiologically similar but structurally slightly different

- 46 -genim n iii polipepti dima nego stom je slučaj sa onima koji su navedeni na- 46 -genomic n iii smoke polypeptides than stom is the case with those listed on

Slici 4 (gore, p. 3). Na primer, drugi klon identifikovan prema ovom pronalasku ima T umesto ”č na nukleotidu 90 nukleotidne sekvence koja kodira za IFN-beta.Fig. 4 (above, p. 3). For example, another clone identified by the present invention has a T instead of a nucleotide 90 nucleotide sequence encoding for IFN-beta.

Ova promena u trecem nukleotidu kodona ne menja aminokiselinu koja ae rijime kodira. Aminokiselinska sekvenca kodirana pomoču DNA sekvence sa Sl. 4 je identična sa aminokiselinskom sekvencom koju je objavio faniguichi et al., gore.This change in the third nucleotide of the codon does not alter the amino acid encoding it. The amino acid sequence encoded by the DNA sequence of FIG. 4 is identical to the amino acid sequence published by faniguichi et al., Above.

Nair.vr.o ire a je jr.ano da klonirana cHNA \7 poli A KNA pomoču uobičajenih postupaka (A. Gfstratiadis et al., gore) može da nema 5’-terminalne nukleotide i može čak sadržati veštačke sekvence (it. I. Richard« et al., ”Molecular Cloning And Seguence Analfsis Of Adult Chicken 3eta-Globin c’3NA, Nucletc Acids Research,It is reported that cloned cHNA \ 7 poly A KNA by conventional methods (A. Gfstratiadis et al., Supra) may lack 5'-terminal nucleotides and may even contain artificial sequences (it. I . Richard "et al.," Molecular Cloning And Seguence Analfsis Of Adult Chicken 3eta-Globin c'3NA, Nucletc Acids Research,

7, pp. 1139-40 (1979)). 7bog toga nije isvesno da li je ATG lociran nn nukleotidima 65-67 ustvari prvi ATG autentične sekvence IFN-beta. Medjutim, za s vrhe sledečeg opisa podrazumeva se da je ATG ne nukleotidima 65-67 prvi ATG autentične IFN-beta raRNA.7, pp. 1139-40 (1979). 7 Moreover, it is uncertain whether ATG located nn nucleotides 65-67 is in fact the first ATG of the authentic IFN-beta sequence. However, from the top of the following description, it is understood that ATG not nucleotides 65-67 is the first ATG of authentic IFN-beta raRNA.

Unoredjivanjem polipeptida koji je kodiran pomoču ovog regiona inserta sa sekvencom cd 13 amin-terminaInIh aminokiselina autentičnog 1 j udskotj fiLroblas tnog intcrferona—NetSorTvrJ.crT.euT^uCT.ypheI-enGlnArgSerSer — koju au odredili Knight et al., gore, izgleda da je Izabrani ram za oGitavanje korektan i da nukleotidi F5-127 rogu kodirati za signalni peptid koji prethodi nukleotidnoj .sekvenci koja kodira za zreli” polipeptid.By framing a polypeptide encoded by this insertion region with the cd 13 amino acid sequence of the amino acid of an authentic 1 µl fibril intracheron — the NetSorTvrJ.crT.euT ^ uCT.ypheI-enGlnArgSerSer - that was identified by Knight et al. The selected reading frame is correct and encodes the F5-127 nucleotides by the horn for the signal peptide preceding the nucleotide sequence encoding the mature polypeptide.

Dalje, u eukariotskir.i mRPA prvi AVG triplet iz 5' terminusa je obično inicirajuče meste za sintezu proteina (M. Kozak, Hov Do Eukarvotic Sibosomes Select Tritiation Heg.tons In Pssnengar RNA?”, Celi, 13, pp. 1109-23 (1978)). Ovde je kodor. a koj^leksnon fragmentu koji odgovara pr voj aminokiaelini f ib rob las tnog 5. n ter fe j ona 22 kodona od prvog ATG. Ovo opet sugerira da DNA sekvenci koja kodira za fibroblastni interferon može prethcditi sekvenca koja cdredjuje signalni polipeptid od 21 aminokiselina. Pretpostavljena signalna sekvenca sadrži seriju hidrofobnih aninokiselina« Takva akumulacija hidrofobnih ostataka je narvno karakteristika signalnih sekvenci (c.f., B.D. Davis and P.C. Tai, The Mechanian Of Protein SecretionFurthermore, in eukaryotic and mRPA, the first AVG triplet from the 5 'terminus is usually the initiation site for protein synthesis (M. Kozak, Hov Do Eukarvotic Sibosomes Select Tritiation Heg.tons In Pssnengar RNA? ”, Celi, 13, pp. 1109-23 (1978). Here's the coder. and which ^ lexnon fragment corresponding to the first amino acid f ib slave of the lass 5. n ter fe j she 22 codons from the first ATG. This again suggests that the DNA sequence encoding the fibroblast interferon may be preceded by a sequence that mediates the signal polypeptide of 21 amino acids. The putative signal sequence contains a series of hydrophobic amino acids «Such accumulation of hydrophobic residues is naturally a characteristic of signal sequences (c.f. B. B. Davis and P. C. Tai, The Mechanian Of Protein Secretion

4? Aeross Membrane», Nature, 2S3, pp. 433-38 (1980)).4? Aeross Membranes », Nature, 2S3, pp. 433-38 (1980).

«uk.lootidna sekvenca koj-i cčevidno odgovara srclor*.’ HuIFR-beta obuhvata 435 nukleotida, hoji hodira ra l·?.; ar-irckiseliua. Pretpoetavkcm da. neiaa karooKsiterminalne prcracL·, ίχΊάιύώ-) Icofina interferonakog pciipeptida je 20065. Saetav baza sekvenca r.a kodiranje je 15% OC. Kori5Čer.jo korona nav.tar r.ckvance zn kodiranje interferona je u pri!»vs Lijivob< slaganju ca oni*?, koje jc prikvadeno ?;«t askNA sisara uopšte (R. Graothau at al., Coding Catalog Vsage And The Genome Evpothesief Nuclaic Acid» Research, 8, pp. 49-62 (1980)). Makoje rapaSene devijacije mogu se pripisati maliu vključenim brojeviiaa.«Uk.lootid sequence which is in any case corresponds to srclor *. ' HuIFR-beta comprises 435 nucleotides; ar-irckiseliua. Yes, yes. neiaa karooKsiterminal prcracL ·, ίχΊάιύώ-) Icofina interferonac pciipeptide is 20065. The saetav base sequence coding is 15% OC. The use of the corona nav.tar r.ckvance zn interferon coding is in! »Vs Lijivob <stacking ca they * ?, which is attached ?;« t askNA mammal in general (R. Graothau at al., Coding Catalog Vsage And The Genome Evpothesie f Nuclaic Acid »Research, 8, pp. 49-62 (1980)). Maca's deviations can be attributed to the small number involved.

St.rvktura polipeptida priba mnog aa Sl. 4 ?.a kompleksni fragment, neravno,, ne uziran υ obzir modifikacije za polipeptide izazvane njihovo interakcijora se in vivo entiraira, n.pr., glikozilova«je. Sbog toga, juora da ae shvati da aniaokiselinsk* sekvenca opikana na Slici 4 se mora biti identična sa HuIFK-beta proizvedenim in vivo.Fig. The structure of the polypeptide is attached to many aa. 4a., A complex fragment, unevenly, "unaffected by the modifications to the interacting polypeptides caused by it, enters in vivo, e.g., glycosyls". For this reason, the juora needs to understand that the amino acid sequence imaged in Figure 4 must be identical to HuIFK-beta produced in vivo.

nroredjivanje prvih 13 amibokisclina autantičnog fibroblastnog interferona (Knight et al., gore) i sekvence koja je izvedena iz kozrpleksnog gena ss Sl. 4 ne pokazuje razlike. Sastavi aminokiseli· cc ?. •-d.jcvJ, d.ir^nto zn autsntlcn? f.ibroblastni irtrrfcron ε jedne serune, i izvedeni iz sekvence kompleksno^ gena iz ovog proualaeka s druge strana, takodje pokazuju sužtinske sličnosti. Sl. 6 prikazuje uporedjenje ovih sastava.the sequencing of the first 13 amino acids of an authentic fibroblast interferon (Knight et al., above) and a sequence derived from the cosplay complex gene ss FIG. 4 shows no differences. Amino acid composition · cc ?. • -d.jcvJ, d.ir ^ nto zn autsntlcn? f.ibroblastic irtrrfcron ε of one serum, and derived from the sequence of complex ^ genes from this prou- alae on the other hand, also show essential similarities. FIG. 6 shows a comparison of these compositions.

pd rtVr-Hh ir motnih mr· :1.* bOjt rta početku napravljeni pr «ata overi pr on sa fibrobiastni interferon, lack-i nc snčrli komo li-hnu ·ϋ«’Λ sekvenca oni auiiita otoshedjuju horisnu sondu za testiranja kolekcija DNA sekvenci koje su urodne sa UuIF*?-beta.pd rtVr-Hh ir turbid mr ·: 1. * b O jt rta initially made pr «ata certify pr on with fibrobiast interferon, lack-i nc snchli como li-hnu · ϋ« 'Λ sequence they auiiita otoshedje choris probe for testing a collection of DNA sequences native to UuIF *? - beta.

Dalje, kombinacija delova inaerata ovih rekombinantnih DNA .rclekula ta dobivanje kompletne sekvence koja kodira za IFN-beta ja, kao ito je deeonstrirano nize, unutar znanja stručnjaka. Na primer,Further, the combination of inert portions of these recombinant .rclecle DNAs yields a complete sequence that encodes for IFN-beta, as deextracted below, within the skill of the art. For example,

-48 -iraajučj ?n ref er'-48 -iraajujj? N ref er '

*.·-? 3 c lako videti da ae Petl-Pgll xrag.:*. · -? 3 c easy to see that ae Petl-Pgll xrag .:

EcoKI-rstl fragrtftnt pLEIFS ;.tože se spojiti sr. ?stT-EccI~ fragment pEFlk’7 iii se Bglll-Pstl fragment pHFIFS može ae spojiti se P3tI-3glII fragmentom klona 7 tako da ae obratuje kom^lskcra rekvenca sa kodiranje HuIFN-beta. Spajanje ovih frameneta τ· -o*a izvršiti pre lli posla uiaetanja k Ion ir enog frcr-mta u žel jeni plazmid.EcoKI-rstl fragrtftnt pLEIFS; .will merge sr. The stT-EccI ~ fragment of pEFlk'7 or the Bglll-Pstl fragment of pHFIFS can be fused to the P3tI-3glII fragment of clone 7 so that the com ^ lskcra proverb with the HuIFN-beta encoding is used. Connect these framenets τ · -o * a before performing the job of inserting a single frcr-mt into the desired plasmid.

PRAVLJFN.7E l'L7.7.1.IS; K ZA IIuIFN-bcta 7-A GVRZiuRULESF7.7 l'L7.7.1.IS; K FOR IIuIFN-bcta 7-A GVRZiu

2A37.ŽB bOFPLKkSSU DNA SFKVFITO’ XOJA KODIRA 'FSFP.72A37.ŽB bOFPLKkSSU DNA SFKVFITO ' X THOSE CODES' FSFP.7

IJK POLIPEPTIDA KOJI ISPOLJAVAJU AKTIIJK OF POLYPEPTIDES EMITTED BY ACTS

ΆΊ03Ί unlFil-hefaΆΊ03Ί unlFil-hefa

BaJ.tarinfag lambda sadrži dva jaka promotor a, Pf * T'K, M ja je aktivnost pod kontrolom represorskog proteina, proizvoda gena faga cl.BaJ.tarinfag lambda contains two strong promoters a, P f * T ' K , M i is an activity controlled by the repressor protein, a product of the phage cl gene.

U prisustvu renresora, transkripcija iz ovoh promotora jo octpunc potisnuta. Sklanjanje represora utiče na jaku transkripciji: sa i PR (za luoncgrafiju, vidi «. Ssybalski and %. Gzvbr.K:·/ ”7 7>. .prehensive Molscuiar Map Of bacfcar iophage laisda. Gen o - 3, 217-37.· (i07>)>.In the presence of the renpressor, transcription from these promoters is further suppressed. Repressor assembly is affected by strong transcription: with and P R (for luoncgraphy, see ". Ssybalski and%. Gzvbr.K: · /" 7 7> .prehensive Molscuiar Map Of bacfcar iophage laisda. Gen o - 3, 217-37 . · (I07>)>.

Konstrv.išo ne derivati nultikcpije tlazi-ida pbk322 (F. Bolivar et al. Tonstraction Ard Characterization Of New Clonina Vohicles.Constr. No derivatives of soil-ida pbk322 nullicopy (F. Bolivar et al. Tonstraction Ard Characterization Of New Clonina Vohicles.

II. A Multiple Cloning Syetem, Gene, 2, 95-113 (1977) tako Ja se inkorporira PT promotor. Ovi plazmidl okisani sv u Pritaankej patentnoj prijavi 30.28983, kcja je podneta 8 septevibra., ljBO i inkorporirana je ovde kao referenca.II. A Multiple Cloning Syetem, Gene, 2, 95-113 (1977) so I incorporate the P T promoter. These plasmids were disclosed to St. in Patent Application Patent 30.28983, filed September 8, ILO, and incorporated herein by reference.

A· gteruktnra p?.azmida koji nn7r7? ? prcKotor plasasld y?La2311A · gteruktnra p? .Azmida that nn7r7? ? prcKotor plasasld y? La2311

Plaz . i.C pILa231i (prikazan na Gl. 8) sadrži tri Haell fragmenta. Kaj veči fraguenfc, oko 191C parova baza, sadrži P^O. reginr i.: bakteriofaga ianbda 1 rogicn Leta-laktarnaznog gena iz pPP322 (H, Gutcllffe, Complete Nucleotide Seguonce of The Fscherichia coli riacnic’ pBP.322, Cold Spring Harbor Svctt-ogium, 49, 77-90, (1979)). Llizu ovog fragmenta ja Saell fragment s? 379 porova baza izveden iz p lažmi da Col E^.The plaza. i.C pILa231i (shown in Fig. 8) contains three Haell fragments. The larger fraguenfc, about 191C base pairs, contains P ^ O. reginr i .: bacteriophage ianbda 1 rogicn Let-lactarnase gene from pPP322 (H, Gutcllffe, Complete Nucleotide Seguonce of The Fscherichia coli riacnic 'pBP.322, Cold Spring Harbor Svctt-ogium, 49, 77-90, (1979)). Near this fragment I Saell fragment with? 379 porous base derived from p lies that Col E ^.

« '«'

Poreklo raplikacije obmhrata spajanje izmedju ova dva fragmenta (A. Oka et al., Nucleotlda Seguemce of Sna 11 ColZ^ Derivati ves. Structure Of The Reglosne rssential Por Autonomons Repi ication And Coli c in Essential Por Ismunity'’i Mol. Gen. Genet., 172, 131-159 (1979)). Treči Haell fragment, dufine oko 1600 parova baza, kodira za rezistentnost na kameni cin. Ovaj fragment je originalno izveden iz plazmida pCR^ (C. Covey et al·, A Method Por The Deteotion Of Reztriction Sites Zn 2fcacterial Plazmid DKA, Mol. Gen. Genet., 145, 155-158 (1978)). Dirsikcija transkripcije iz PL promotora krede se u istem smislu kao beta-laktamazni gen. Plazmid pPLa2311 daje rezistentnost na 109 ^oc'ul karbenivilina i 50 /Ug/ml kanamicina.The origin of replication is obscured by the coupling between the two fragments (A. Oka et al., Nucleotlda Seguemce of Sna 11 ColZ ^ Derivatives Ves. Structure of the Reglossic Por Autonomons Repi cation And Coli c in Essential Por Ismunity ' and Mol. Gen. Genet ., 172, 131-159 (1979). The third Haell fragment, a duphine of about 1600 base pairs, encodes for resistance to stone cin. This fragment was originally derived from plasmid pCR ^ (C. Covey et al., A Method Por. The Deteotion Of Resection Sites Zn 2fcacterial Plasmid DKA, Mol. Gen. Genet. 145, 155-158 (1978)). Dirty transcription from the P L promoter is chalked in the same way as the beta-lactamase gene. Plasmid pPLa2311 confers resistance to 109 ^ oc'ul carbenivillin and 50 / ug / ml kanamycin.

Plazmid O-pPDaSO-pPDaS plasmid

Plazmid C3-pPLa8 (prikazan na Sl. 9) izveden je iz pPIo2311 konverzljoni Pati mesta u beta-lakfamoznem genu u BamHI mesto. Ovo ee postile pomdu tretiramja sa 8j nuk le azota Patl-otvorenog pPLa23Il posle ligaolje slepog kraja za BamHI vezivni fragment (dobiven iz Colla boratlve Research Inc., Valtham, Masa.) i reelrkulacije molekula posle BamHI raskidanja. Planil pPLa8 vile ne specificira sa rezistentnost na karbenicilin, ali 1 dalje daje optpornost na kaaamlcla.Plasmid C3-pPLa8 (shown in Fig. 9) was derived from the pPIo2311 converts Pati site in the beta-lacquamosis gene to the BamHI site. This was achieved by treatment with the 8j nuc le nitrogen of Patl-open pPLa23Il after blind ligand end for the BamHI binding fragment (obtained from Colla boratlve Research Inc., Valtham, Mass.) And re-eclculation of the molecules after BamHI cleavage. Planil pPLa8 does not specify carbenicillin resistance but 1 further gives resistance to kaaamlcla.

Plazmid G-pPIic24Plasmid G-pPIic24

Plazmid tt-pPDc24 (prikazan aa 81. 10) sadrži beta-laktamazni gen i poreklo raplikacije ii pB&322. Haell-BcoRI fragment sa 290 parova basa sadrži region is bakteriofaga lambda. Direkcija transkripcij« is P^ promotora je proz·· EooRI atesta. BooRI-Baam fragment sa 431 paro' basa kodira za mesto vezivanja ribozima i prvih 98 aaiaokisellnakih ostatak« gena bakteriofaga HS2 replikaze, koji je dobiven iz plazmida pM82—7 (R. Devos et al., Construotion And Characterization Of A Plasmid Coataining A Me_aly Full-size DMA Copy Of Baotsriophage MS2 «HA’, J· #ol« Mol» / l-S, 595-619 (1979)). Translacija MS2 proteinskoThe plasmid tt-pPDc24 (shown aa 81. 10) contains the beta-lactamase gene and the origin of replication ii pB & 322. The 290-bass Haell-BcoRI fragment contains the region and bacteriophage of the lambda. The transcription directorate «from the P ^ promoter is the prose ·· EooRI attestation. The 431-pair BooRI-Baam fragment encodes the ribozyme binding site and the first 98 aacid acid residues of the bacteriophage HS2 replicase gene, derived from plasmid pM82-7 (R. Devos et al., Construotion And Characterization Of A Plasmid Coataining A Me_aly Full-size DMA Copy Of Baotsriophage MS2 «HA ', J · #ol« Mol »/ lS, 595-619 (1979). MS2 protein translation

- 57 fragmenta replika*« ide kolinearno m transkripcijo® iz promotora.- 57 replica fragments * «go collinear m transcription® from the promoter.

B’ Pkljbivanje ?L ?rax.t(?r-ku aktlvnogul z&vjano od temperature B 'Care? L ? Rax.t (? R-ku aktlvnogul z & vjano of temperature

Transkripcija iz promotora prisutnog na plazmidima pPLa2311, pPLa8 i pPLc24 ·— repreeira se održavan jem plazmida n E. coli soju koji sintetizuju rapresorski protein. Zbog antoregulaclonog načina ainteze (H. Pt.aahne et al., Autoregnlation And Function Of A RepreaeorTranscription from a promoter present on plasmids pPLa2311, pPLa8, and pPLc24 · - is repre- sented by the maintenance of plasmids n E. coli strain synthesizing rapressor protein. Due to the antoregulaclonal mode of synthesis (H. Pt.aahne et al., Autoregnlation And Function Of A Repreaeor

In Bacteriophage lambda*, Solano» 194, 156*161 (1976), kedna kopija lizogenog soja hroiaozoica može potpuno da potisne P_ promotor koji Ju je prisutan na multikopiji plazmida.In Bacteriophage lambda *, Solano »194, 156 * 161 (1976), a ceded copy of the lysogenic chroiaozoic strain can completely repress the P_ promoter present on the multicopy of the plasmid.

Sojevi koriščeni u ovom pronalasku bili eu E. coli K 12^31 (KI 2 M72 lac^AtrpBAŽ SmR (\cI857 ^717^53 HI bio); C. Bernard et al., Construction of Plaamid Cloning Vehiclea That Promote Gene Expreealon Prosi The Bacteriophage lambda P^ Promctar, Gene7 5, 59-76 (1979)) 1 E- ggU MS219 (K12 K72 lac^trp^Sn* (>01857 AHI bio252)i H. Greer. The kil Gene Of Bacteriophage lamda, Virologp, 66, 589-604 (1975))· Oba soja izradjuju defektivan, nesecivi profag lambda koji nosi mutant cl gena. Mutant gena kodira za temperaturno oaetljivl repreaor, tako da se omogučuje traknekripcija iz P^ promotora pameranjem temperature — na 28°C repreaor jo aktiven i repreaira transkripciju aa PL promotora ali na 42°C repreaor je inaktiviran i transkripcija sa Pj, promotora j- cilj učena.The strains used in the present invention were eu E. coli K 12 ^ 31 (KI 2 M72 lac ^ AtrpBAŽ Sm R (\ cI857 ^ 717 ^ 53 HI bio); C. Bernard et al., Construction of Plaamid Cloning Vehicle That Promote Gene Expreealon Millet The Bacteriophage lambda P ^ Promctar, Gene7 5, 59-76 (1979) 1 E - ggU MS219 (K12 K72 lac ^ trp ^ Sn * (> 01857 AHI bio252) and H. Greer. The kil Gene Of Bacteriophage lamda. Virologp, 66, 589-604 (1975)) · Both strains produce defective, incomplete lambda profag carrying a cl gene mutant. The gene mutant encodes for a temperature-sensitive repreor, so that it allows tracecryption from the P ^ promoter by shifting the temperature - at 28 ° C repreaor still active and repreacts the transcription of aa P L promoter, but at 42 ° C the repreor is inactivated and transcription from the Pj promoter j- the goal of the learned.

A El izoatavljanje is profaga odvaja deo oro gena i sve druge gene dalje udeano od ero (H. Ceste laz z i et al. Isolation And Characterlsation Of Deletlone Zn Bacteriophage lambda Residing Aa Prcphage I E. coli K12, Mol. Gen. Cepet, 117, 211-218 (1972)). Izoatavljanje ero gena je podesno zato što je poznati» da akumulacija ero proteina repreaira trasnskripeijo sa P^ promotora (A. Johnson et al·, hlechanlam Of Aetion Of The pro Protein of Bacteriophage lambda. Proč.A El isolation from the prophage separates part of the oro gene and all other genes further away from ero (H. Roads laz zi et al. Isolation and Characterization of Deletlone Zn Bacteriophage lambda Residing Aa Prcphage I E. coli K12, Mol. Gen. Cepet, 117 , 211-218 (1972). Isolation of ero genes is appropriate because it is known that the accumulation of ero proteins repre- sents trascriptomy from the P ^ promoter (A. Johnson et al., Hlechanlam Of Aetion Of The Pro Bacteriophage Lambda Protein.

Mati» Acad. Sel, O.S.A., 75, 1783-1787 (197?)). Soj IJ5219 dalje sadrži bio252 izo3tavljonje koje odvaja sve gene na levo od cIU, uključujuči kil.Mother »Acad. Sel, O.S.A., 75, 1783-1787 (197?)). Strain IJ5219 further contains a bio252 isoform that separates all genes to the left of the cIU, including kil.

Posle temperatura« indukcije soj H5219 izražava funkcionalni proizvod HHgena. Soj K12deltaHX s druge strane ima dve auber mutacijo u K fito ga Sini funkcionalno l£-nsgatlvnim. Poznato je da proizvod gena dejstvu j e kao anti-terainator u baktoriofagu lanbda (J. W. Roberts, Transcription Tenaination And Late Control In Pbage lambda,After induction temperature, strain H5219 expresses the functional product of HHgen. The K12deltaHX strain, on the other hand, has two auber mutations in K phito ga Sini functionally l £ -nsgatlvnim. The gene product is known to act as an anti-terainer in the lactic bacteriophage (J. W. Roberts, Transcription Tenaination And Late Control In Pbage Lambda,

Proč. Natl, Acad.. Sci, U.S,A,, 72, 3300*3304 (1975)). Antl-tarmiaa· elani efekat je takodje zapalen sa tenainatorakia sekvencama koje nisu prirodno prisutne na fagu lambda DHA (n.pr., prirodni stop na kraju trp operona), pod uslovom da RNA transkrlpt startuje na PL proeotoru. Dalje, efekti polatnostl, uvedeni prisustvo« noasens kodona u P^ transkriptu, os lobod jeni su dejstvom proteina N-gsna (sa monografijo vidi N. Franklin and C. Tanofsky, The N Protein Of lambda* Evidence bsarlng On Transcription Tenaination, Polarity And The Alteration Of SiJSSll Peljmerase* in RNA Poivmergae (Cold Sprlng Harbor Laboratory, 1975) pp. ί93-70β).Away. Natl, Acad .. Sci, US, A ,, 72, 3300 * 3304 (1975). Antl-tarmiaa The desired effect is also inflamed with tenainatorakia sequences that are not naturally present on the phage of the DHA lambda (e.g., natural stop at the end of the trp operon), provided that the RNA transcript begins at the P L proeitor. Further, the effects of polarity, introduced by the presence of «noasens codons in the P ^ transcript, were oscillated by the action of the N-gsna protein (with monograph see N. Franklin and C. Tanofsky, The N Protein Of Lambda * Evidence bsarlng On Transcription Tenaination, Polarity And The Alteration Of SiJSSll Peljmerase * and the Poivmergae RNA (Cold Sprlng Harbor Laboratory, 1975) pp. Ί93-70β).

Zbog toga, pošto jan je ranije spomenutih plazmida u termo-indukeloao baktarijskoj oj, osnovi omoguduje eksperimentalno uključivanje iii isklju č Ivanje aktivnosti P^ promotora. I izbor K12deltaHI ill M5219 omoguduje transkripciju da ce vrfil lli u otsustvu iii u prisustvu proizvoda, jg-gena. Poslednje meže biti podesno kao fito jc opisano gore, u slučajevima kada su DNA reglonl koji treba da se transkrlbuju oni koji sadrže tranckripcione sekvence slične tenainatorima ill usporavajuda sekvence za RNA polimerasu.Therefore, since the aforementioned plasmids are in the thermo-inducible bacterial oj, the base permits experimental inclusion or exclusion of P ^ promoter activity. And the choice of K12deltaHI or M5219 allows transcription that vrfil lli will be absent or in the presence of the product, the jg gene. The latter may be suitable as the phyto described above, in cases where the DNA reglonl to be transcribed are those that contain transcription sequences similar to tenainers or retard sequences for RNA polymers.

C. Konstrukcija Klona koji imaju DNA sekvencu koja kodira za HuIFN-beta umotr.ut u plasmid koji sadrži preraetorC. Construction of Clones having a DNA Sequence Coding for HuIFN-Beta Considered in a Plasmid Containing a Pre-Eter

U sledečem opisu, izolovanje plazmida Kft, zestrlkdona analiza DNA 1 ligaeija DSA firagmmata vrisal eu kao fito je opisano gora saIn the following description, isolation of plasmid Kft, zestrlkdona DNA analysis of 1 ligaei DSA firagmmata screamed eu as phyto is described above with

Ε&ίΑ sa dvostrnkom niti. Paza transformacije bila je takodje kao što je opisano gore izuzev Što je, kada sa sojevi El2deltaFT iii M521® kore te kao domačin, toplotni Sok vršen na 34°C toka«*. 5 minuta i transforadsane čelije se inkubiraju na 28°C.Ε & ίΑ with double thread. The transformation step was also as described above except that when with El2deltaFT iii M521® bark strains and as a host, the Heat Juice was carried out at 34 ° C flow *. For 5 minutes, transforads were incubated at 28 ° C.

1- Konstrukcija plazmida G-PPLa-^I?-67-31- Construction of G-PPLa- ^ I? -67-3 Plasmid

Razlog za ovu kane trakci ju bio je zapažanje da kombinacija odgovara jučih restrikcienih fragmenata lz klana ti-pBR322 (Pst)/HFIP-6 i G-pBR322(Pst)/HPIP-7 omogučuje rekonstrukcija kompletne, kontinualna sekvence za kodiranje IPlf-beta. Protok izvedenih fragmenata kroz nekoliko konstrakcionih faza prikazan je shematski aa Sl. 8. Plazaid G-pBR322(Pst,/HPIP-6 se rasklne sa EcoRI 1 Pstl 1 vezan je za plazmid G-pSK322(Pst)/HFIP-7 koji je bio raskinut sa Pstl i Pvul. Posle liga* cije smeša se digeruje sa EcoRI i Haell. /-Struki molarnl višak ove smeše se tada spoji za plazmid G-pPLa2311 koji je bio dlgerovaa «a HfteXI i EcoRI. Dobivaju se transformantl u soju CGOOr^aJflambda) (koji je koriščen zbog njegove relativno visoke transformacione sposobnosti i zato Sto sadrži cl gen divljeg tipa) se lekcij osa na rezistentne st na kanaaicin. Od 15 testiranih transformanata. dva su izgubila rezistentnost na ksaamtmta karbenicilin. Restrikciona analiza DNA izolova ne iz plazmida ovih transforaanata otkrlla je da je jedan imao šel jenu struktura G-pLa-HFIF-67-1 opisanu na Sl. 8. Ovaj plazaid sadršao je j edinstveno EcoRI mesto i jedinstveno Pati aaeto. Kaabnovana EcoRI-Pstl digestija prolzvela ja dva fragmenta — stanji od ovih je koaigrirao sa fragmentom koji je doblven posle EgoRl-Pstl raakidanja <S-pBR322(Pst)/HPIP-6. RglU digestija raskinula je mali fragment od oko 650 parova baza. Velišina poslednjeg fragmenta konsistentna je sa očekivanom veliSinoa posle spajanja susednog Bglll—Pstl fragmenta klona G-pBR322 (Pzt)/HPIP-6 za «daljen! Patl-BglI deo G-pBR322(Pzt)/ HPIP-7. HlncIIdigestiia je prolzvela tri fragmenta kao što je oSekl- 53 vare na osnovu prisustva BincII ms*ta u P^ reglonu, amino-torKsinano« delu beta- lak tanamog gena i ae trans latiraoog 5* kraja DNA sekvence EuIFN-beta. Ovaj plazald označen je G-pPL&-KFIF__S7-l.The reason for this henna was her observation that the combination of the corresponding restriction fragments from the ti-pBR322 (Pst) / HFIP-6 and G-pBR322 (Pst) / HPIP-7 clans allowed the reconstruction of a complete, continuous IPlf-beta coding sequence. The flow of the derived fragments through several contraction phases is shown schematically aa. 8. Plazaid G-pBR322 (Pst, / HPIP-6 cleaves with EcoRI 1 Pstl 1 bound to plasmid G-pSK322 (Pst) / HFIP-7 which was broken with Pstl and Pvul. After league * the mixture is digested. with EcoRI and Haell. / - The high molar abundance of this mixture was then coupled to the plasmid G-pPLa2311, which was dlger's and H fteXI and EcoRI. Transformantl in the CGOOr ^ aJflambda strain was obtained (which was used because of its relatively high transformation ability and that is why it contains the wild-type cl gene) is a lesson in resistant to kanaaicin. Of the 15 transformants tested. two lost their resistance to xaamtmta carbenicillin. Restriction analysis of DNA isolates not from plasmids of these transforants revealed that one had the G-pLa-HFIF-67-1 structure described in FIG. 8. This plazaid contained j unique EcoRI site and unique Pati aaeto. Caabnovated EcoRI-Pstl digestion produced two fragments - one of which co-mapped with the fragment obtained after EgoR1-Pstl cleavage <S-pBR322 (Pst) / HPIP-6. RglU digestion ruptured a small fragment of about 650 base pairs. The size of the last fragment is consistent with the expected size after fusion of the adjacent Bglll-Pstl fragment of G-pBR322 (Pzt) / HPIP-6 clone for further! Patl-BglI portion of G-pBR322 (Pzt) / HPIP-7. HlncIIdigestiia shed three fragments such as sec- 53 on the basis of the presence of BincII ms * ta in the P ^ reglon, the amino-torxinano portion of the beta-lacquered tan gene and ae trans lated the 5 * end of the EuIFN-beta DNA sequence. This placard is designated G-pPL & -KFIF__S7-l.

Na basi ranije sponenute karakterizacije anali«csn reetrikcionin enziiaon, plazmid G-pPLa-flFIF-67-1 treba da sadrži konpletnu sekvencu za kodiranje HuIFN-beta. Pravac željen® transkripcije kreda se kolinearno za onom iz P^ promotor«.. Izmedju P^ i HuIFN-beta sekvence gena za kodiranje plazmid i dalje sadrži poli(A) rep i invertovanl 3* kraj fragmenta kao u 3-pBF322(Pst)/HFIF-C.Based on the previously sponsored characterization of the analgesic reetriction enzyme, plasmid G-pPLa-flFIF-67-1 should contain the HuIFN-beta coding sequence. The desired transcription direction of the chalk is collinear to that of the P ^ promoter «.. Between the P ^ and HuIFN-beta sequences of the coding gene, the plasmid still contains the poly (A) tail and the inverted 3 * end of the fragment as in 3-pBF322 (Pst). / HFIF-C.

2. Konstrukcija plaaaalda G-pPLa-ETIF-67-122. G-pPLa-ETIF-67-12 plaaaald construction

Sledeča faza u konstrukcijama bila je usaarona na odvajanje is G—pPLa—HFIF-67—1 poli(A.T) repa i dela invertovanog 3' krajnjeg fragmenta (vidi S liku 9). G-pPLa—HFIF-67-1 DNA je rasklnuta sa Bglll i Bpall. Pošto sekvenca sa kodiranje HuIFN-beta ne sadrži Hpall mesto ovo tretiranje dovodi do Bgill fragmenta koji sadrži čelu sekvencu za kodiranje IFN-beta i istovremeno inaktivira preostali deo vektora. Dobiveni Bglll fragment je spojen za plazmid C-pPLa8 koji je bio digerovan s& BamEI. Enzimi Bglll i BamHI čine identične zaklenjene krajeve tako da se Bglll krajevi mogu vezati sa otvoreno BamHI mesto i obmuto. Takvo r ok on s truisan o mesto više nije supstrat sa Bglll iii BažEI ali s® raspoanaje poaocu enzima Sau3Al (Mbol) (v. Pirrotta, ’’Two Restrocticn Endonucleaceb From Escllius globigii, Huoleic Aclds ges.> 3, 1747-1760 (1976)). Prale ligacije Brneča se ponovo raškima sa BamHI tako da co eliraiuiŽu oni G-pTLaS molekuli koji su kili prosto recirkularlzovani. Ponovo se debi vaju trans foman ti u C600r^^( lambda) izborom na rercistentnost na kanaaicin.The next phase in the structures was focused on the separation of the G-pPLa-HFIF-67-1 poly (A.T) tail and part of the inverted 3 'end fragment (see S of Figure 9). G-pPLa — HFIF-67-1 DNA was digested with Bglll and Bpall. Since the HuIFN-beta coding sequence does not contain the Hpall site, this treatment results in a Bgill fragment containing the forehead IFN-beta coding sequence and inactivates the remainder of the vector. The resulting Bglll fragment was fused to plasmid C-pPLa8 which was digested with & BamEI. The Bglll and BamHI enzymes form identical locked ends so that the Bglll ends can bind to the open BamHI site and circumferentially. Such a site is no longer a substrate for Bglll III BJEI but s® clears the enzyme Sau3Al (Mbol) (see Pirrotta, '' Two Restroctic Endonucleaceb From Escllius globigii, Huoleic Aclds ges.> 3, 1747-1760 ( 1976). The washings of the Brnec ligation are reshaped with BamHI so that those G-pTLaS molecules that are simply recirculated are co-eluted. The trans foman ti in C600r ^^ (lambda) is again debuted with the choice of kanaaicin resistance.

Transformaati se taatiraju odredjivanjom veličine neraskinute DBA na agarozaese gelu, kao ito je opisano gore# sa karakterisaciju IFU-bsta-oslobodjeaih reksuabiaantain plazaida. kloni koji su bili neznatno vadi od Q-pPEa8 roditelja s« dalje podvrgnut! reatrikeionoj — 54 — ;Transformates were titrated by determining the size of unbroken DBA on an agarose gel, as described above with the characterization of IFU-bsta-released rexuabiaanthine plasaids. clones that were slightly removed from the Q-pPEa8 parent with «further subjected! reatrikeionoj - 54 -;

analizi bile aa FatI 111 BineII. Sadje» je jsfa^ Vlr^ koji je zadrlao jedne FatI maato 1 tri gladi nesta. Jedan frater t ovog klona ja kcmlgrirao aa Hladi fragmentom lz pFLaS koji je izveden 1? P. do bera-laktamazaeg regi ona. Dragi mali fragment klona nerio jo oko 400 parova baza — konsistentno aa umetanjem Bglll fragmenta n G-pPLaO u orijeataciono» smislu u odnosu na prosaotor. Ovaj nlazmld označen je sa G-pPLa-HFIF—67—12. Faze koje au koriiene u konstrukciji ovog piasmida prikazane su shematski na Sl, 9. Detaljnija mapa evec plazmida prikazana je na 81. 11. Veličina plazmida (oko 4400 parova baza) procenjena je na oenovu veličine njegovih konstituectnlh fragroenata, koji au opet pr ocen jeni z»a osnovu relativne mobilne?*l posle elektroforeze na ag&roznlm gelovima.analysis were aa FatI 111 BineII. The fruit »is jsfa ^ Vlr ^ which has quenched one FatI maato 1 three famines disappeared. One frater t of this clone I ccmlgrated aa Cool the fragment of lz pFLaS which is derived 1? P. to bera-lactamazaeg regi on. Dear little clone fragment nero about 400 base pairs - consistently aa by inserting the Bglll fragment n G-pPLaO in the oriatational sense relative to the prosaotor. This nlazmld is designated G-pPLa-HFIF — 67—12. The phases that au roots in the construction of this piasmid are shown schematically in Fig, 9. A more detailed map of the evec plasmid is shown in 81. 11. The size of the plasmid (about 4400 base pairs) is estimated at the size of its constituent fragments, which are again estimated z »a basis of relative mobile? * l after electrophoresis on ag & roznlm gels.

E. coli K12deltaHI 1 Χ5219 se tada transformiču sa karakteciaani* plazoidom G-pPLa-HFIF-57~l2.E. coli K12deltaHI 1 Χ5219 is then transformed with the caracteciaani * plasmid G-pPLa-HFIF-57 ~ l2.

Inšpekcija odredjene nukleotidne sekvenco okolo Bglll/panfil spajanja u G-pPLa-HFIF-67-12 otkrlla je interesantnu karakteristika. Polipeptid inioiran na AOG sekvence za kodiranje beta- lak tarna*« tog plaanilda zavrfiava ae na dvogubom amber kodonu koji je lociran unutar 5' kraja (netranslatiranog) sekvence za kodiranje BoIFft-beta. Ovi termi nacioni locirani su 23 nukleotida pre inicirajudeg AOG HuIFM-beta algnalnog peptida, t.j.»Inspection of a particular nucleotide sequence around Bglll / panfil junction in G-pPLa-HFIF-67-12 revealed an interesting feature. The polypeptide iniated to AOG sequences for the coding of the beta-lacer * of that plaanild terminates on a double-stranded amber codon located within the 5 'end of the (untranslated) BoIFft-beta coding sequence. These termini are located 23 nucleotides before the initiation of the AOG HuIFM-beta algal peptide, i.e. »

-.1-u Spajanje-. 1-in Merger

ISTŠ| BamHI/BglllISTŠ | BamHI / Bglll

CCcicGG.AOC.UUC.AGn.UOC.GGA.GGC.AAC.CnU.nCG.AAG.CCOCCcicGG.AOC.UUC.AGn.UOC.GGA.GGC.AAC.CnU.nCG.AAG.CCO

Pro-JAr g-I le-Phe-Ser-?he-Gly-G ly-Aan-Le u-Ser-Lys-Pr oUUG-CUC. UGG. CAC . AAC . AGG. UAG. HAG GCGACACOGCOGGOGOUGOCAACPro-JAr g-I le-Phe-Ser-? He-Gly-G ly-Aan-Le u-Ser-Lys-Pr oUUG-CUC. UGG. CAC. AAC. AGG. UAG. THE HAG GCGACACOGCOGGOGOUGOCAAC

Leu-Leu-Trp-His-Asn-Arg am amLeu-Leu-Trp-His-Asn-Arg am am

AOG-(HuXFN-beta signalna sekvenca za kodiranje peptida)-AOG-(sekvenca sa kodiranje zrelog HuIFR-beta)AOG- (HuXFN-beta peptide coding signal sequence) -AOG- (mature HuIFR-beta coding sequence)

Cifra u ogradi odnosi ae na broj aminokisellnskog ostatka υ beta-lakta· mazncni proteinu pBR322 (j, Sutellgfe, gore). Svesdlca (♦) označuj® da je CCU kodon prisutan u ovom položaju na pBR322 promenjen u CCC zbog konverzije Pati mesta u pPLa23ll u BaajKI mesto u pPLaS (vidi gora) ·The figure in the enclosure refers to the number of amino acid residue υ beta-lactate · the fatty protein pBR322 (j, Sutellgfe, above). Mark (♦) indicate that the CCU codon present in this position at pBR322 has been changed to CCC due to the conversion of the Pati site in pPLa23ll to the BaajKI site in pPLaS (see above) ·

Zbog toga ova konstrukcija otvara mogučnost reinicirauja ADG HuIFN-betA signalnog peptida i zato moguču ekspresiju IPN-beta kondenzovanog za njegov signalni peptid, ali ne kondenzovanog za deo betalak tarnate. Takvo interno reiniciranje posle prevremene terziinacije zapaženo je u represorekm genu laktosnog operona E. coli (T. Platt et t * Trans la ti opal Restarts: AUG Rainitiation Of A lac Rpreesor Fragment*, Proč. Bati* Aoad, Soj, U.3.A., 69, 897-901 (1972)). Ova konstrukcija omogučl la je izluč Ivanje zre log IFN-beta korektnim bakterijskim raepoznavanjem HuIFN-beta signalne sekvence·Therefore, this construction opens the possibility to reinitiate the ADG HuIFN-betA signal peptide and therefore the possible expression of IPN-beta fused to its signal peptide but not fused to a portion of the betalak tarnate. Such internal reinitiation after premature tertiization has been observed in the repressor gene of the E. coli lactose operon (T. Platt et t * Trans la ti opal Restarts: AUG Rainitiation Of A lac Rpreesor Fragment *, Proc. Bati * Aoad, Soj, U.3. A., 69, 897-901 (1972). This construction enabled the secretion of mature IFN-beta by correct bacterial recognition of the HuIFN-beta signal sequence ·

3. Konstrukcija plazmida G-pPLa-HFIF-67-12daltal93. Construction of plasmid G-pPLa-HFIF-67-12daltal9

Is poznate sekvence pBR322 i HuIFN-bete sekvence za kodiranje može se zaključiti da i sestavljanje is G-pPLa-HFIF-67-12 raalog HincII fragmenta (od unutar beta-laktamazs pa do 3 nukleotida ispred inicirajučeg ABG HuIFN-bota signalnog peptida) dovodi do fcontinualnog rama sa oSit&vanje polazeči na ASG beta-laktamaze i savrSavajučl posle sekvence sa kodiranje HuIPN-beta. Predvidja se zato da ova kcnstr cija kodira za polipeptid koji sadrži 82 aminokiselinska ostatka od sekvence sa kodiranje beta-lsktamaze, jednu aminokiselinu kodirana na kondenzovanom HincII mestu, HuIFB-beta signalni peptid i zreliFrom the known pBR322 sequence and HuIFN-beta coding sequence, it can be concluded that the assembly of the G-pPLa-HFIF-67-12 straight HincII fragment (from within beta-lactamases to 3 nucleotides in front of the initiating ABG HuIFN-bot signal peptide) to the fcontinual frame from the assay starting with ASG beta-lactamases and perfecting after the HuIPN-beta encoding sequence. It is contemplated that this coding will encode for a polypeptide containing 82 amino acid residues from the beta-lsctamase coding sequence, one amino acid encoded at the fused HincII site, a HuIFB-beta signal peptide, and mature

HuIFN-beta, t.j.:HuIFN-beta, i.e.:

—7—7

GOt.MC.AUG-inuTFF-Beta oinnnlni peptid fcocran r.rkvercoro)-ΑΠΟValkAan-Met ” (sekvenca za kodiranje zrelog HuSV-beta)GOt.MC.AUG-inuTFF-Beta oinnnl peptide fcocran r.rkvercoro) -ΑΠΟValkAan-Met ”(coding sequence for mature HuSV-beta)

Cifra u ogradi odnosi se ne brej aminokisellnskog ostatke u betalaktamaznom proteinu pBR322 (J. Suteliffe, gore). Zbog toga ova konstrukcija može da omogoči ekspresija koodenzovanog polipeptida koji * 36 sadrži deo beta-laktasaze kondenzovan* prek*' jedre srlnokiscline za HuIFN-beta signalni peptid koji je sw kond*nzo«z?^. za zrsli EuIFH-bet Takav kondenzovan protein može se islučiti i3 čelije.The figure in the enclosure refers not to the amino acid residue in the beta-lactamase protein pBR322 (J. Suteliffe, above). Therefore, this construct can be facilitated by the expression of a co-fused polypeptide that * 36 contains a portion of beta-lactasease fused * via * 'a core src acid for a HuIFN-beta signal peptide that is a sw cond * nzo «z? ^. for mature EuIFH-bet Such a fused protein can be secreted i3 cells.

G—pPLa—HPIF-67-12 je parcijalno dig^rovan au HincII* Zocle ligacije pri DNA koncentraciji oko 0.01 w?A ae ruskine sa Korll, izot ah izomer Pvul koji proizvodi 3* »robi ja jndn krnjovc (R. Waiig et al., Blochi». Blophvs. Aota, u B tangi) 1 ponovo se podvrcne ligaciji pri niskoj DNA koncentraciji. Roditeljaki c-p?La-5FIF-$7-12 sadrži dva Korll metat jedno »ento inaktivira gen kanamicina a drugo jo locirano u HiacII fragmentu koji treba da ee izostavl Iz p las:, «id a. Svrha faze Korll-digerovanje-religacija je da se elladnlBu roditeljski DNA molekuli ne raskiauti sa HincII enzimoru. Takvi molekuli poseduju dva Korll mesta i pod uslovima koji se koriste *% llg&ciju, dva fragmenta de se krajuje neverov&tno ponovo spojiti. Transfoncanti se dcbivaju u ceOOr”.^*(.laabda), selekcijam za kanamicin, 1 seju se reatril-cionoa analizo» na prisustvt Jednog Pvu nosta. Dalja analiza klona vršena je koriščenjem HincII digerovanja. Tedan klon nedostaje iz najmanjeg HincII fragmenta, ali je ineče identičen sa G-pPLa-SFTF—67-12 I označen je Q-pPLa-HFir-07-12deltal9. Faze tej* eu koriSdene u konstrukciji ovog plazmida prikasane su shematski ne si. 9. Dateljni ja mapa ovog plazmida prikazana je aa sl. 12. Veličina plazmida (oko 4059 parova baza) procenjvtiu jc šahiranja» veličine njegovih kratetitučntaih fragmenata, koji $u opet proceajeai njihovam relativnost mofcilnožču pri elektroforezi na atjaro.inoin gelu. coli X12deltaHI 1 115219 so tada transforaiSu sa karakteriaonim plazmido&i G-pPLa-HFIF-67-lldcltal9.G-pPLa-HPIF-67-12 is partially digested in HincII * Zocle ligation at a DNA concentration of about 0.01 w? A ae ruskine with Korll, an isot ah isomer Pvul that produces 3 * »commodities and a jndn krnjovc (R. Waiig et al., Blochi ». Blophvs. Aota, in B tang) 1 again undergoes ligation at low DNA concentration. The parent's c-p? La-5FIF- $ 7-12 contains two Korll methates, one ento inactivating the kanamycin gene and another located in the HiacII fragment that should be omitted from the p las :, id. The purpose of the Korll-digestion-religion phase is not to break the parent DNA molecules with the HincII enzyme. Such molecules have two Korll sites and, under the conditions used *% lgg & c, two fragments will eventually reunite. The trans- fonants are digested into ceOOr ". ^ * (. Laabda), with selections for kanamycin, 1 are seeded with a reatrionation assay" for the presence of One Purity. Further clone analysis was performed using HincII digestion. The week clone is missing from the smallest HincII fragment, but is otherwise identical to G-pPLa-SFTF-67-12 and labeled Q-pPLa-HFir-07-12deltal9. The phase stages used in the construction of this plasmid are schematically different. 9. The map map of this plasmid is shown aa fig. 12. The size of the plasmid (about 4059 base pairs) is estimated to be the magnitude of the size of its short-fragment fragments, which again percolate through their relativity to the electrophoresis on the atjaro.inoin gel. coli X12deltaHI 1 115219 is then transforaiSu with the characteristic plasmid &lt; RTI ID = 0.0 &gt; and &lt; / RTI &gt; G-pPLa-HFIF-67-lldcltal9.

4. Konstrukcija pelazoida G-pPLc-HFIF-67-84. Construction of G-pPLc-HFIF-67-8 Pelazoids

Plazraid O-pFLc24 pruža drugu mogudnost za uar.atanje HuIFN-beta sekvenci na takav ančin da se potencijalno »ože nintctlzevntl drugi kondenzovan! poiipeptid. Unetanje BglTI fragmenta Iz r!-pPT.a-I’Tr-57—1Plazraid O-pFLc24 provides another opportunity to capture HuIFN-beta sequences at such an anchin that they can potentially »narrow nintctlzevntl another condensed! poiipeptide. Insertion of the BglTI fragment From r! -PPT.a-decidedTr-57—1

- s? u zvssto C-p-7.c24 dovodi do kcntlnualnog ra»»a o*Ifavanja koji kodira za, 93 aziinokiaolinskih outataka is gena *\S2 replika«« (V.- s? at C-p-7.c24 leads to a ccntlnual ra »» a o * Ifavan encoding for, 93 aziinoquiaolin outlets and a * \ S2 replica gene «« (V.

Fiers et al. Complct® iTuolootiAe Se^uenc« Cf Pacteric^hage MS2 SMAt Priciary And 5econdary Štructurc Of The Hcplicasc Gene, Mature, 260, 500-507 (1976)), pri Čemu ja 27 aninokleelina kodirano sekvencama izcedju Bglll mesta i inieirajudeg ACG signalne sekvence HuIFN-beta, posle HuIFN-beta signalno? peptida i arelog HuIFN-beta, t.j·:Fiers et al. Complct® iTuolootiAe Se ^ uenc «Cf Pacteric ^ hage MS2 SMAt Priciary And 5econdary Structurc Of The Hcplicasc Gene, Mature, 260, 500-507 (1976)), whereby 27 aninocleelins encoded by sequences leach Bglll sites and initiate ACGN signaling HuG sequences -beta, after the HuIFN-beta signal? peptide and areotype of HuIFN-beta, i.e. ·:

IS~IS ~

UGG GAU.t^CD.CAC.DDU.CGG.AGC.CAA.CCU.UVC.GAA.GCC.DUC.CCUUGG GAU.t ^ CD.CAC.DDU.CGG.AGC.CAA.CCU.UVC.GAA.GCC.DUC.CCU

Trp· Asp-Leu-Gln-Fhe-Arg-Arg-Gln-Pro-Phe-Glu-Ala-Phe-AlaCOG .GCA.CAA.CAG. GCJA.GDA.GGC.GAC . ACO .GVO .CGD .GOD .GOC .AAC.Trp · Asp-Leu-Gln-Fhe-Arg-Arg-Gln-Pro-Phe-Glu-Ala-Phe-AlaCOG .GCA.CAA.CAG. GCJA.GDA.GGC.GAC. ACO .GVO .CGD .GOD .GOC .AAC.

beu-Ala-GlB-Gln-Val-Val-Gly-Asp-Thr-Val-Arg-val-Val-AsnAOG-(sekvenea sa kodiranje HuIFP-beta signalno? peptida)-AUG-(sekvenMet ea sa kodiranje srelog HuZFN-beta}beu-Ala-GlB-Gln-Val-Val-Gly-Asp-Thr-Val-Arg-val-Val-AsnAOG- (Sequence with HuIFP-beta signaling peptide encoding) -AUG- (SequenceMet with Encoding of Happy HuZFN- beta}

Cifra u zagradi odnosi st: na broj nninokiselinskih os ta taka u proteinu gena wS2 replikese (H. Devoe et al., gore» W. Flere et al., gore).The figure in parentheses refers to the number of non-acidic axes thereof in the protein of the wS2 replicase gene (H. Devoe et al., Above »W. Flere et al., Above).

Zbog toga ova konstrukcija mc5e davati ekspresiju kondenzovanog polipeptida koji sadrži deo MS2 replika««, kondenzovan preko 27 aninokieellna sa HuIFN-beta signalni peptid koji je san kondensovan za zreli HuIFN-beta.Therefore, this construct mc5e expresses a fused polypeptide containing a portion of the MS2 replica, fused over 27 aninokieelles with a HuIFN-beta signal peptide that is fused to mature HuIFN-beta.

C-pPLa-Hrir-57-l se čigeruje ac EgiII i izvrši ne liga«!ja ea -uaskiiiutorc pPT.c2< MOT. Ligadona mneila se reinoče ca SamHT tako fin se cliainišu roditeljski pFIe24 x)olekuli i transforvdžu se u C6CCr^r^(larhda) selskcijcr na rezsitertnost za karboniallin. TransfoiTaaiiti se analizira ju zartrikcijcn na HfncTI. Ir poznatih položaja reetrikcionih nesta ne pPLc?‘* nolo s» predvideti da uma tanje 5al«_ IFK-beta fragment?, u snilsln erijontacijo u odnocu na P^ treba da proizvede ekstra ΠίησΤί fragnvtnt od oko *5n parova basa. Reprezeatativi klon koji ispoljava ovu konfiguraciju označen je kao pPTx:-HFIF-67—8. Faze koje su koriščen« w konstrukciji ovog plazmida prlkasane eu .58 ·?C-pPLa-Hrir-57-l tigers ac EgiII and execute no league «! I ea -uaskiiiutorc pPT.c2 <MOT. The ligadon mnails are reinocciated by SamHT so fine they cliain the parental pFIe24 x) olecules and are transforced into the C6CCr ^ r ^ (larhda) selccier to the carbonityallin resistance. Transfoils are analyzed by the HfncTI assay. Ir known positions of reetriction nests do not pPLc? '* Nolo s »to predict that it thinner 5al« _ IFK-beta fragment ?, in snilsln erythntation in relation to P ^ should produce extra ΠίησΤί fragnvtnt of about * 5n pairs of bass. The reprepositive clone exhibiting this configuration is designated pPTx: -HFIF-67-8. The phases used in the construction of this plasmid are deflected in .58 ·?

shematski na Sl. 1«. Uetaljnija «epa ovog plasmida prikazana j« na Sl. 13. Valičiaa ^laziida (oko 3650 parov* naša) prooeaje&a je šahiranj srt veličine koastituentnih fragsienata, koji su opat prooea jeni njiliovoar« relativnou laobilnošžeu A;o^la eiaztroioraze na agaroznoia gelu.schematically in FIG. 1 «. A more detailed epi of this plasmid shown in FIG. 13. Valichiaa laziida (about 3650 pairs * of ours) is a cheah srt of the magnitude of coastituent fragments, which are the abbot of the studied nioliovoar «relative to the la apoil of A ; o ^ la eiaztroioraz on agarose gel.

B. coli »12deltakl i R3i.U transicriiisaae su sa karaktarisanim plazmidcm G-pBLc-rr?ir-f 7-n.B. coli »12deltakl and R3i.U transicriiisaae are with characterized plasmidcm G-pBLc-rr? Ir-f 7- n .

5. Konstrukcija platmida g-pPla—BF1F—67—I2delta279T5. Construction of the g-pPla-BF1F-67-I2delta279T Platinum

Plamaid pKT279 (poklon od K. Tahtadijej pKT279 je derivat pBS322 koji ima izoatavljen deo gena za beta-laktamazu I iaa Poti mesto konstruiaano na aminokiselini 4 bota-laktanase) digeruje se sa Pstl 1 3' terminalna aciino eksteuzija ee odvoji 1 fragmen ae spoji na «lepi« Jerajevima tre ti ran jon ea %. coliUKA poliaerazoet I (Klenovfrags«snt) u obsustvu decksinukleotid-fosfata. Linearisovan Pati i fragment PiiA sa 3* slepi» krajevi»« pKl’279 ze tada digeraju sa ScoRI tako da se prot zvoni fragment koji izmedju ostalog kodira sa signalna sekvencu oeta-laktai-aze i za prve 4 aminokizellne zrelog proteina.Plamaid pKT279 (gift from K. Tahtadijej pKT279 is a derivative of pBS322 that has a distinct part of the gene for beta-lactamase I and aaa Poti site constructed on the amino acid 4 of botanical lactanase) is digested with Pstl 1 3 'terminal acyanic extestion and fused to 1 fragment «Beautiful« Jerajev tre ti ran jon ea%. coliUKA poliaerazoet I (Klenovfrags «snt) in the absence of decxinucleotide phosphate. The linearized Pati and PiiA fragment with 3 * blind "ends" "pKl'279 are then digested with ScoRI so that the prot ringing fragment encodes, among other things, the oeta-lactai-aase signal sequence for the first 4 amino acid mature proteins.

Ovaj naJLi fragment se tada koristi za zamenv. KpaI-P.coRI fragmenta j^La-BFIF-67-12deltal9 (Upal mesto nastaje zbog gore opisanog izostavljanja ls G-pPLa-HFIF-67-12) ligačijom Hoal-EcORl ograničenog pPla-HFIP-67-l2daltal9 sa tim fragment©» u prisustvu T4 PHA ligaaa·This NA fragment is then used to replace. KpaI-P.coRI fragment j ^ La-BFIF-67-12deltal9 (Inflammatory site is due to the above-described omission of ls G-pPLa-HFIF-67-12) by ligation of Hoal-EcOR1 restricted pPla-HFIP-67-l2daltal9 with that fragment © »In the presence of the T4 PHA league ·

Predrta jen* sekvenca na Pati (alepl-kraj evi)-Ppal spajanju jei (sekvenca za kodiranja beta-laktamasnog eignalnog peptida)-CAC.CGC«AAC· Mis-Arg—Asn—Broken jen * sequence at Pati (alepl-end evi) -Ppal fusion jei (sequence for encoding beta-lactamase eignal peptide) -CAC.CGC «AAC · Mis-Arg-Asn—

AUU-(sekvenca za kodiranja HuIF^-bet?. sigualnog pe-*ida)-AUGMet (sekvenca sa kodiranje zrelog MuIFU-bet*)AUU- (HuIF ^ -bet coding sequence); -AUGMet (mature MuIFU-bet * coding sequence)

Zbog toga konstrukcija dovodi do IFH-bete kojem pre th ode dve signalne sekvenca υ tandemu — bakterijska signalna sekvenca (betalaktamaza) i signalna sekvenca IFN-beta — spojena sa nekolikoTherefore, the construction results in an IFH-beta which is preceded by two signal sequences in tandem - a bacterial signal sequence (beta-lactamase) and an IFN-beta signal sequence - coupled to several

- 59 aminoklaellna. Sbog toga ova konetmkcijn r»5e davati represij’.·', zre log HuIFF-beta kouden rovar og za rtra sigrolnn popt*da 115. ako je tandea kombinacija bakterijske signalna eekvonco .1 Γα?-^-' «ota signalne sekvenca shvadena bakterijama i korektno raškim*·», konstrukcija noš« davati ekspresi ju zrelo«? HuIPP-heta i njegovo izlučivanje iz čelije·- 59 amino acids. For this reason, this conjecture r »5e give repression '. ·', Mature log HuIFF-beta kouden rovar og for rtra sigrolnn popt * da 115. if the tandea combination is a bacterial signal eqvonco .1 Γα? - ^ - '«ota signal sequence understood by bacteria and correctly rash * ·», the construction of the knife "express it mature"? HuIPP-hat and its excretion from the cell ·

8. goli F15219 se trans formi.?* sa pPI.»-nFIF-67-12<.'elt<i27ST.8. the bare F15219 is trans formed.?* with pPI. »- nFIF-67-12 <. 'Elt <i27ST.

C. Tonatrniclja plamida G-^PLa-KriF-67-12delta218KlC. T-Plate Toner G- ^ PLa-KriF-67-12delta218Kl

B. Konstrukcija plasrcida G-pPLa-tTTTr>-57-l2dQlta21S:;'lB. Construction of plasmid G-pPLa- t TTTr > -57-l2dQlta21S:; 'l

Plazmid pKT218 (poklon od K. Trlnadgoj pK7215 je derivat pB5322 koji ima deo gena za beta-laktamazu i njegovu signalnu sekvencu izostavlj ne i ina Pati mesto konetruieano na cninokisellni 4 signalne sekvence beta-laktamaze) digeruje se s a SeoRi 1 AluT tako da se proizvodi fragment koji kodira iasadju oatalog za poSetni deo eignaluog peptida betalaktamaze. Ovaj fragment se podvrgne ligaeiji n prisustvu 74 DNA ligaze ea fragmente» koji je napravljen iz pPLa-apzp-67-13deltal9 pomoču Aid digestije u prisustvu aktinoaaicJLna D (0.05 rali) (do eignalnog peptida) .t vrši ae .restrikcija s a Kcek.I.Plasmid pKT218 (a gift from K. Trlnadgoj pK7215 is a derivative of pB5322 that has part of the beta-lactamase gene and its signal sequence is omitted and the patient site conjugated to the amino acid 4 beta-lactamase signal sequences) is digested with SeoRi 1 AluT a fragment encoding an oatalog glass for the initial portion of the betaignactamase eignal peptide. This fragment undergoes ligaeia in the presence of 74 DNA ligase ea fragments »made from pPLa-apzp-67-13deltal9 by Aid digestion in the presence of actinoaaicJLna D (0.05 rally) (up to the eignal peptide) .t performs ae. Restriction with Kcek.I .

Dobiveni plazmid, osrečen pPLa-riFTF-C7-12delt.3?.lfiitl, sadrfao je početnl deo gena koji kodira sa signalni peptid beta-laktamaze, dec gena koji kodira sa signalni peptid RuTTH-beta i gor koji kečira za zreli HuZFk-beta. tredvidjene sekvence ©drevzrajuder reg!ora plazrida je:The resulting plasmid, depleted by pPLa-riFTF-C7-12delt.3 ?.lfiitl, contained the initial portion of the gene encoding the beta-lactamase signal peptide, the dec gene encoding the RuTTH-beta signal peptide, and upregulating the mature HuZFk-beta . The predicted sequences of the plasmid regrowth drevzrajder are:

caaI i WwL* · VWv«kV ii. (sekveeca za kodiranje zrelog nuIFS-beta)caaI and WwL * · VWv «kV ii. (sequences for encoding mature nuIFS-beta)

SlarAle-Lee-Sez—MefcCifra u ogradi odnosi ae n3 broj axiucltisali.'<:jkog ostatka u signalnem peptida beta-lakta«.’zo ’bog toga, ova konstrukcija »ose oaioguditi ekspresijo zrelog Sul^-beta b.oalonsovaiog za deo bakterijske signalne sekvenco i deo njegove sopstvonc signalne iekvence. Opet, ako bakterijski domačin rasposnaje i korektno raskida tandai’ signalnu eakvenou, noše ea izraziti zreli HuTRT-fceta ia ovog· piazr.-ida i islučitiSlarAle-Lee-Sez — MefcThe figure in the enclosure refers ae n3 the number of axiucltisali. '<: Y residual in the beta-lact signal peptide.' 'For the sake of this, this construction' axis oaugulate the expression of the mature Sul ^ -beta b.oalonsoviog for the part bacterial signal sequence and part of its co-signaling sequence. Again, if the bacterial host recognizes and correctly disrupts the tandai signal response, it will express the mature HuTRT-fceta and this · piazr.-id and excrete

- 60 is delije« g» coliM52I9 ee tranaformiše se pPLa-aFIF-67-12delta21gMl.- 60 and more "g" coliM52I9 ee is transformed with pPLa-aFIF-67-12delta21gMl.

7. Konstrukcija plasmida G-pPXjt-Hgiy-67-12deitaMl7. Construction of plasmids G-pPXjt-Hgiy-67-12deitaMl

Plasmid pPLa-HFIF-67-12delt*l> se linearisuje kao ranije aa Alul u prisuatvo aktinamicina D (0.05 mM) tako da aa generiie presek na Alul mestu u signalno» peptidu BuIPIHbeta· Posle digerovanja sa Bpal,Plasmid pPLa-HFIF-67-12delt * l> is linearized as before aa Alul in the presence of actinamycin D (0.05 mM) such that aa generates a cross-section at the Alul site in the BuIPIHbeta signal peptide · After digesting with Bpal.

DHA ae recirkularisuje u prisustvu T4 PSA ligase. Dobivaai plasmid, osnafien pPLa-HFIF-€7-12deltaMl, laso je samo mali deo IFK-beta signalne sekveaae kojoj prethodi DMA aekvanoa koja kodira sa zreli IFN-beta.DHA ae recirculates in the presence of the T4 PSA ligase. The resulting plasmid, a potent pPLa-HFIF- € 7-12 deltaMl, lasso is only a small fraction of the IFK-beta signal sequence preceded by a DMA sequencer encoding mature IFN-beta.

Fredvldejeaa sekvenca spajanja jetFredvldejeaa jet coupling sequence

GOU CUC.OTU.CCA.USA Val· leu-Phe-Pro-STOPGOU CUC.OTU.CCA.USA Val · leu-Phe-Pro-STOP

ΓαΠΟ-( sekvenca sa kodiranje srelog HuIFN-beUaJlΓαΠΟ- (sequence with the encoding of the lucky HuIFN-beUaJl

Versikalno ogradjena cifra odnosi ae na brej aminokiselinakog ostatka u beta-laktamasi. Sorisontalno ogradjena eifra odnosi ae aa sekvencu u drugom rama oči tavanja. Zbog toga, translacija sekvence koja kodira sa beta-laktamasu i preoetalog dela sekvence sa kodiranje sa signalni peptid IFK-beta jeste sarobljene na UGA-saustavnom kodonu. Medjutim, stratni kodom (A06) aa sreli IFK-beta prisutan je aa istom mostu, mada u rasliSltam rama aa ofiitaoaaje, Zbog tega ae može vrliti reiniciraajo traaakaoije aa toj tački tako da ae proisvod! sreli BuZFH-beta.The vertically encircled figure refers to the amino acid residue of the beta-lactamase. The horizontally fenced episodes refer to a sequence in the second frame of the eye. Therefore, translation of the sequence encoding the beta-lactamase and the preoetal portion of the sequence encoding the IFK-beta signal peptide is captured on the UGA-codon. However, bar code (A06) aa encountered IFK-beta is present in the same bridge, although in the frame growth aa ofiitaoaaje, therefore it may perform a reinitiation of tracakia at that point so that the product! met BuZFH-beta.

8. coli M5219 transformisana je aa pPLe-aFIF-67-12deltaMl. t. Konstrukcija plasmida 3-rf?im-BFiy-57-12deital9 ΒΧ-28. coli M5219 was transformed with aa pPLe-aFIF-67-12deltaMl. t. Plasmid construction of 3-rf? Im-BFiy-57-12deital9 ΒΧ-2

Plasmid pFLa-8PZF-<7-12deltal9 oe linearisuje oa Bpal i tretira ae am egrsooukleasom BAL 31 tako da ae uklone parov! basa aekvencijalno ea kraja linearisovanog DMA fragmenta (B. Grap et al·, “BrtraeellularPlasmid pFLa-8PZF- <7-12deltal9 oe linearizes oa Bpal and treats ae ammgracoucle BAL 31 to remove vapors! bass sequentially ea the end of a linearized DMA fragment (B. Grap et al ·, “Brtraeellular

Mueleaoeo Of Paeudomoaaa Bal 31 I. Cbaraeterisatiom of Single BtrandSpeelfie Deoajribendenualease·, Buoleic Acida Boo., 2, pp. 1459-92 (1975))· Variranjem vremena a i uslova ua tretiranje egsonukleasom aože ee konstreisati serija fragmeaata koji imaju rasne brojeve nukleotida is sekvence sa kodiranje signalno? peptida BuZFK-beta, ako je iaa, koja prethodi ADG startnem kodonu zrelog HulTB-beta. Ovi fragmenti se mogu tada koristiti da se konstruiše ribosomna mesta vezivaaja na rasnim razdalj inama od atartmog kodona i da se dobije Sel j ena sekundarna struktura blizu onog kodona za pojaSavanje ekspresije zrelo? HuIFSF-beta.Mueleaoeo Of Paeudomoaaa Bal 31 I. Cbaraeterisatiom of Single BtrandSpeelfie Deoajribendenualease ·, Buoleic Acida Boo., 2, pp. 1459-92 (1975)) · By varying the time a and the conditions of aa exonuclease treatment, will a series of fragments that have racial nucleotide numbers and signal-coding sequences be construed? of the BuZFK-beta peptide, if iaa, that precedes the ADG start codon of mature HulTB-beta. These fragments can then be used to construct ribosomal binding sites at racial distances from the atartic codon and to obtain a selective secondary structure near that codon to enhance expression of the mature? HuIFSF-beta.

EgsonukleazoiB-tretiranl fragmenti se veSu na »lepim krajevima sa *-» ooll DSR polimarasom I (Klenov fragment) u prisustvu dATP i dGTP tako da se popune makojl 5' prebijajoči krajev!. Kasnije se Khol vezivni element, koji ima eekvencu 5'-CCTCGAGG-3* (Collaberative Research), spoji na slepim krajevima SRR frageenata. Ovi fragmenti se tada efczfciabafa produSe ea Rcoai vezivnim elementom sa dvo· trnke® niti, koji Ima sekvence 5*-CCGM«TCea-3' (Kollaborative Research).The exonuclease and B-treated fragments are attached at the "beautiful ends" with * - "ooll DSR polymaras I (Klenov fragment) in the presence of dATP and dGTP by filling in the macojl 5 'puncturing ends !. Subsequently, the Khol binding element, which has the 5'-CCTCGAGG-3 * (Collaberative Research) efficiency, is fused at the blind ends of the SRR fragments. These fragments are then efcfciabafa elongated with a Rcoai double-strand® bonding element having 5 * -CCGM «TCea-3 'sequences (Kollaborative Research).

Posle digerovanja sa RopRI, fragmenti koji imaju lepljive* RcoRI krajeve se redrkularizuju sa B» coli DNK llgazcm. Koriščenje ove ligaz mesto T4 DBA ligaze, utiče da se izbegava reeirkularisaelja fragaenata sa slepim krajevima·After digesting with RopRI, fragments having sticky * RcoRI ends are redcrularized with B »coli DNA lgazcm. The use of these ligases by the T4 DBA ligase site, avoids the reeucularisation of the fragile ends with blind ends ·

Zsabere ee jedan plasmid i označen je kao pPLa-HPIP-67-12deltal9 BK-2. trna KboZ mesto od oko 25 parova baza izpred KOG startno? kodona srelog BuZPB-beta. Ihol anto je isa BooRI mesta koje je generlsano ligadjom EcoRI vezivno? elenenta Bpal fragmenta za BooRI mesto tečno ’ P^ preaotora u pPLa-BFXF-<7-12daltal9 · Sbog toga je isostavljena sekvenca koja kodora sa beta-laktamazu. Dalje, zato što je odvojen berem deo BuZFB-beta signalno sekvence, atoguda je ekspresija samo srelog BuZPB-beta.Zsabere ee one plasmid and is designated pPLa-HPIP-67-12deltal9 BK-2. thorn KboZ site of about 25 base pairs in front of WHO starting? codons of the happy BuZPB-beta. Ihol anto isa iso BooRI site generated by EcoRI ligament binding? element of the Bpal fragment for the BooRI site of the liquid 'P ^ preator in pPLa-BFXF- <7-12daltal9 · Therefore, the sequence encoded by beta-lactamase is omitted. Furthermore, because it is a separate read portion of the BuZFB-beta signal sequence, only the happy BuZPB-beta expression is expressed.

B. polt K12deltaHX je tranafozmisana sa pPLa-HFIP-67-12deltal9B. complex of K12deltaHX is transafter mixed with pPLa-HFIP-67-12deltal9

ΒΧ-2.ΒΧ-2.

- 6? iiodpvahjk χ Ki^T^iutfijA Huzrp-beta haphatomco basmioisa A- Pravljenje bakterijskih eks traka ta- 6? iiodpvahjk χ Ki ^ T ^ iutfijA Huzrp-beta haphatomco basmioisa A- Making bacterial ex bands ta

1. Indukcioal postupak1. Inductioal procedure

Alikvot is stok kultura (samrsnute na -80°C u 501 glicerinu501 LB podloži), ukljudujudi stok kulture sojeva K12deltaHX i M5219 transformisane sa plasmidima koji sadrže ZTR-beta fragmente, opisane gore, inokulira ee u svežu LB podlogu sa žaljenim antibiotikom 1 kultiviže se do sasidenja na 28°C. Dve partije od 500 ml LB podloge bes antibiotika inokuliraju ee ea po 1 ml sasidenih delija 1 kultiviSu ae aa analnim madkanjem aa 28°C de guatine dalija 2 z 10® ml.An aliquot from stock cultures (crushed at -80 ° C in 501 glycerin501 LB media), including stock cultures of strains K12deltaHX and M5219 transformed with plasmids containing ZTR-beta fragments described above, were inoculated into fresh LB medium with stained antibiotic 1 cultured until dried at 28 ° C. Two batches of 500 ml LB anti-rabies antibiotics inoculated ea ea per 1 ml of dried delia 1 by culturing with anal agitation aa 28 ° C de guatine dahlia 2 with 10® ml.

Jedna partija ae prebaoi na 42°C i nastavi da se mndka. Saviano od koriždeaog plasaida, kultura se bere a rasnim bremanima posle pomeranja na 42°C. Kontrolna kultura koja ostaja na 28°C se obare u isto vreaa kao kultura na 42°C. dalija ae sakupe uantrifugiranjem u OSA rotoru I (Sorvall) aa 800 rppm tokom 10 minuta· Oranala aa isperu a 20 al 50 mM Tria HCI (pH 7.4), 30 aMEHaCl i regranuluju sa u 8S34 rotoru (Sorvall) tokom 10 minuta aa 10,000 rpm· Grenela aa brso saarsne u smeli suvi lad-metanol i stokira sa na -80°C. Kada se žali isvržiti osmotski Sok na obranim dalijama fasa samrsavanja aa isostavi.One batch will be transferred to 42 ° C and continue flashing. Bended from the used plasaid, the culture is harvested with racial burdens after moving to 42 ° C. The control culture remaining at 28 ° C was harvested in the same bag as the culture at 42 ° C. the longia were collected by uantrifugation in OSA rotor I (Sorvall) aa 800 rppm for 10 minutes · The oranals aa washed with 20 al 50 mM Tria HCI (pH 7.4), 30 aMEHaCl and regranulated with an 8S34 rotor (Sorvall) for 10 minutes aa 10,000 rpm. · Grenella aa rapidly saars in bold dry lad-methanol and stokes at -80 ° C. When complaining about osmotic Juice on the defended dahlias, the slithering facet aa deliver.

Korifidaaa au dva raslifiita postupka sa raakidanje i ekstrakcija bakterija.Corifidaaa and in two raslifiit procedures with rakacid and bacterial extraction.

2. gkstrakclonl postupci dalija aa resuspenduju u fiaalnoj sapreminl od 4 ml gore opisanog pufera i doda aa lisosom (Sigma) do 1 mg/ml. Inkubaeija ja bila 30 mineta na 0°C. Suspenzija aa podvrgae dvema ciklusima samrsavanjeodarsavaaje sekvmaoijalnim Branjenjem u amefiu etanol-CO^ (-80°O i a vodeno kupatilo na 37®C. 8-100 frakcija se napravi ultracentrifuglranjea raakinutih bakterija (4 sil) u Beckman 8W60 Tirotor-u tokom 1 časa aa 60,000 rp» & *°c· poni« čega «e dalje koristi supernatant.2. Extra-clonal procedures of Dalia aa were resuspended in a phial sapremin of 4 ml of the buffer described above and added aa by lysosome (Sigma) to 1 mg / ml. The incubation was 30 min at 0 ° C. Suspension aa undergoes two self-priming cycles by sequential defending in an ethanol-CO 2 (-80 ° O amoeba) and in a water bath at 37 ° C. 8-100 fractions were made by ultracentrifugation of the raked bacteria (4 forces) in Beckman 8W60 Tirotor for 1 hour aa 60,000 rp »& * ° c · pony« which is still used by the supernatant.

Raskidanie BTermination B

Raakidaaje B se vrii kao Sto je opisano gore (raakidaaje λ) izuzev Sto je rastvor 50 aM Tris-HCl (pH 8.0)-30 aU NaCl saseajen sa 50 »H HEPES (Signa)- NaOH (pH 7.0), 30 »H NaCl, 3 »K beta-nerkaptoetanola 1 3% seruna novorodjenog teleta (Gibco).Raakidaaje B is as described above (raakidaaje λ) except that the solution is 50 aM Tris-HCl (pH 8.0) -30 aU NaCl is seeded with 50 »H HEPES (Signa) - NaOH (pH 7.0), 30» H NaCl , 3 »K beta-nercaptoethanol 1 3% serum of newborn calf (Gibco).

Osaotski SokOsaotic Juice

Neposredno posle Setve i ispiranja, delijeka granula ae resuspenduje u 20% saharota, 100 eM EDTA, 100 nM Trie HCI (pH 7.4) pri »aksinalnoj gustini dalija 1 a 10l0/»l. Suspenzija ee drli ae ledu toka» 10 minuta i tada se centrifugira 10 ziinuta ne 10,000 rp» u Sorvall SS34 rotoru· Saharozni rastvor se pailjivo očedi is epruvete 1 granula ee resuspenduje u jednako J zapremini vode (gustina dalije je 1 x 1010/»l). Resuspendovane delijo su ostale na ledu 10 »in. i tada se ponovo podvrgnu centrifugiranju na 10,000 rp» toke» 10 aiauta u 8834 rotoru (Sorvall). Supematant ee depunl aa 3% aeru»a fetusa teleta, 50 uHImmediately after sowing and rinsing, some granules are resuspended in 20% sucrose, 100 eM EDTA, 100 nM Trie HCl (pH 7.4) at an axial density of dahlia 1 and 10 l0 / l. Suspension of the ee is kept on ice for 10 minutes and then centrifuged for 10 minutes not 10,000 rp »in the Sorvall SS34 rotor · The sucrose solution is carefully filtered off from the test tube 1 pellet is resuspended in J volume (further density is 1 x 10 10 /» l). The resuspended divisions remained on ice 10 "in. and then they were again centrifuged at 10,000 rp toke 10 aiauts in an 8834 rotor (Sorvall). Supeant ee depunl aa 3% aeru »a calf fetus, 50 uH

HEPES pufera (pH 7), 30 »M NaCl i 3 bM beta«*nerkaptoetaaola. Supematant ee sove aupernatant posle osnotskog Soka. Stokira ee aa eeC.HEPES buffers (pH 7), 30 M NaCl, and 3 bM beta * nercaptoethanol. The supervillain ee owls aupernatant after Osnotski Sok. Stokes ee aa e e C.

3. T»l<>tw»i« «»»0.113. T »l <> tw» and «« »» 0.11

al (NH* )200| rastvora, saslden aa sobnoj teuperaturi, doda ee na 0.5 »1 kontroluog rastvora lli na S-100 ekstrakt, ova eaeBa ee drli na ledu aajaanje 30 »inuta, poale čega se talog granuloje u Bppendorf centrifugi toke» 10 nimata na sobnoj teuperaturi. Granula ae ponovo rastvori u PBS (elani raatvor ea fosfatni» pufero») ·al (NH *) 2 00 | of the solution, added to room temperature, added to 0.5 1 1 of control solution or S-100 extract, this eaeBa kept on ice for 30 in minutes, and then the precipitate was granulated in the Bppendorf centrifuge until 10 ata were not present at room temperature. The granule will be redissolved in PBS (eluent phosphate buffer solution) ·

b. j» lnt.rf.roMb. j »lnt.rf.roM

l. Direktni antiviruani testl. Direct antivirus test

HuIFN-beta ee testira na »ikrotitarakia plltloaaa (Sterilin ponodu tehnike inhibiranje CFE (oltopetakl efekat) na ljudski» fibroblaatiaaHuIFN-beta ee tested for »icrotitarakia plltloaaa (Sterilin pono technique inhibition of CFE (oltopetal effect) on human» fibroblaatiaa

- ¢4 — koji »u trizemnl sa kromosom 21. dalija sa peleuju jedan dan pn kerlždenja, inkubiraju aa sa a«rijakim raSblaženjlma (log^o *β·5) usorka 1 tokom 24 časa i zarase sa aa virusom vezikularnog stomatitiea (Indiana •oj) tako da stok sadrži 10^ razblaženja sa 10**$ jedinlea/ml koje obrazuju miije C-929 ploči ce. GHt se bele Sl 24 časa posla V8V zarase i krajnja tačka interferona se definiže kao razblaženje uzorka koje izaziva 509 smanjenje virusno? CPS. 3oi tastovi uključivali au interni standard HuIFN-beta koji je sem kalibriaan naspram NIH ljudske fibroblastne reference GO23-902-527.- ¢ 4 - which, in the triangles with chromosome of the 21st dahlias, pellaged one day pn the cretaceous, incubated aa with a? Ry dilution (log ^ o * β · 5) of sample 1 for 24 hours and infection with aa vesicular stomatitis virus (Indiana • oj) so that the stock contains 10 ^ dilutions with 10 ** $ units / ml forming my C-929 plates. GHt is white Sl 24 hours of work V8V is infected and the interferon endpoint is defined as a sample dilution causing a 509 decrease in viral? CPS. The 3oi tasters included the HuIFN-beta internal standard, which was calibrated in addition to the NIH human fibroblast reference GO23-902-527.

čelijska linija trlzoana sa kromosom 21 (pa sa zato otaada sove ?2p Izvedena je biopsije· kožo Žemakog paeijanta aa Dcvn sindromom. Utvrdjen je a jen karlotip 1 dokazana je dlploldnost sa sve hromozoma izuzev hromozoma 21 (trisomnl). Sensltivnoat ove čelijske linije na interferon izgloda de ee može «porediti sa sensitivnoidu čelijske linije koja je trisomna za hromoaom 21 kao Sto je opisano u Clerog et al., Nea-antlvlral Aetlvitle« Of Interferon kre Kot Controlled By Chromoaoma 21, Nature, 256, pp. 132-134 (1975) 1 F. D. Cleroq et el·, Chromnoeme 21 Does Not Cede For An Interferon Receptor·,trlzoan cell line with chromosome 21 (hence why owls? 2p Biopsies · skin paeianth aa Dcvn syndrome was performed. Yen charlottype 1 was found to be prolific with all chromosomes except chromosome 21 (trisomnron). starvation de ee can «compare with the sensitivid of a cell line trisomous for chromoa 21 as described in Clerog et al., Nea-antlvlral Aetlvitle« Of Interferon Cre Controlled By Chromoaoma 21, Nature, 256, pp. 132-134 ( 1975) 1 FD Cleroq et al ·, Chromnoeme 21 Does Not Cede For An Interferon Receptor ·,

Nature, 264, 249-252 (1976).Nature, 264, 249-252 (1976).

U drugim tastovima kerlždena je deli jeka linija Βχ8Μ (A. Billiau et al., *Humen Fibroblast Interferon For Clinioal TrialsT Froduetion, Partial Purufueation And Characterization, Anti-mlcrobial Agenta And Chemctheranv. 16, 49-55 (1979)). Ovu če lijaka linija je dlploidna fibroblastne i disomska sa hromosem 21 a Izvodi se od čovočjeg fetusa starog 2 meseca. D pored jen ju ea deli jakem linijom, EjSM je manje senzitivna na HuIFN-beta sa faktor 10.In other tastes, the erosion of the lineage Β χ 8Μ (A. Billiau et al., * Humen Fibroblast Interferon For Clinioal TrialsT Froduetion, Partial Purufueation And Characterization, Anti-mlcrobial Agent And Chemctheranv. 16, 49-55 (1979)). This funnel line is dlploid fibroblastic and dysomic with chromosome 21 a. It is derived from a 2-month-old human fetus. In addition to the strong line, EjSM is less sensitive to HuIFN-beta by a factor of 10.

2. Test 2>5-sintetase2. Test 2> 5-synthetase

Drugi poetupak sa detekcije prisusstva interferona jeste korlždenje testa sa 2,5-A slntetascm. Pokazano je da interferon indukuje ovajAnother step in detecting interferon presence is using a 2.5-A slntetascm assay. Interferon has been shown to induce this

- 65 ensim, koji prevodi ATP u trimere (i um manjoj meri dimera, tetramsre i mmltlmere) 2,5-A (A. Kimshi et al·, Kinetics Of The Zaduetiem Of Three Translation-Regulatery Enzyraee By Interferon, Proč, Natl« Agad» Sel. U.S,A , 76, 3208-3212 (1979).- 65 ensim, which translates ATP into trimers (and to a lesser extent dimers, tetramers, and mmltlmers) 2,5-A (A. Kimshi et al ·, The Kinetics Of The Zaduetiem Of Three Translation-Enzyraee Regulators By Interferon, Away, Natl « Agad. Sel. US, A, 76, 3208-3212 (1979).

Konfluentni baloni od 25 om koji sadrže kulture E^SM čelija (A. Billiau et al., gore) tretiraju ae 20 časova sa 1*6 razblaienjem bakterijskih ekstrakata lli kontrolnim interfaroaam u MBM-10% seruma fetusa teista. Kulture ss odvoje sa trlpslaom (0.25%), EDTA (0.17%) i obilno ss ipsperu sa 140 mM KaCl u 35 mM Tris pufera (pH 7.5). Sv e kasnije operacije vrče se na 4®C. Čelija sa homogenisuju u 1.5-2.0 zapr 20 mM BBPBS pufera (pB 7.4) koji sadrži 10 sM ECI, 1.5 mM nagmesijumacetata 1 0.5 oM ditiotreitola Ipufer sa raskidanja Z*) n Douneed steklenem homogenisatoru. Bosmgenat se oentrifugira tokom 20 min. na 10,000 z g 1 supernatant (S10) ee stokira u tečnom azotu kada se ne koristi odmah.25 µm confluent balloons containing E ^ SM cell cultures (A. Billiau et al., Above) were treated for 20 h with 1 * 6 dilution of bacterial extracts or control interfaroaam in MBM-10% serum of the theist fetus. The ss cultures were separated with trlpsla (0.25%), EDTA (0.17%) and abundant ss ipsper with 140 mM KaCl in 35 mM Tris buffer (pH 7.5). All subsequent operations return to 4®C. Cells were homogenized in 1.5-2.0 for 20 mM BBPBS buffer (pB 7.4) containing 10 sM ECI, 1.5 mM nagmisacetate 1 0.5 oM dithiothreitol Ipufer from dissolution Z *) n Douneed glass homogenizer. The Bosmgenate was centrifuged for 20 min. at 10,000 z g 1 supernatant (S10) ee stacks in liquid nitrogen when not used immediately.

SS

Konfluentne mikrotitarske pločlce sa 96 rupa (10 dalija u 0.2 ral na 0.28 cm ruplee) tretiraju se sa interferenčni iii odgovaraju bakterijskim ekstraktima kao gore. Posle 20-Čaaovnog tretiranje, poločioe se sakupe na ledu, isperu se tri puta sa 140 mM Kad u 35 mM Trla pufera (pfi 7.5)· Kulture se tada raakinu dodavanjem u svaku ruplcu 5 /Ul rastvora koji sadrži 0.5% Nonidet P40 i 1 mM fenilaetansulfonilflaorlda (PMSP) u pufer za raskidanje z. Posle snaSnog mečkanja tokom 20 minuta na ledu, 11nati čelija se sakupe i oentrifugiraju tokom 20 minuta na 10,000 z g kao gore.The 96-well confluent microtiter plates (10 dalia in 0.2 acre per 0.28 cm ruplee) were treated with interference or bacterial extracts as above. After a 20-hour treatment, the wells were collected on ice, washed three times with 140 mM When in 35 mM Trla buffer (pfi 7.5) · The cultures were then raked by adding 5 / Ul solution containing 0.5% Nonidet P40 and 1 in each well. mM phenylethanesulfonylflaorld (PMSP) in dissolution buffer z. After vigorous shaking for 20 minutes on ice, the 11 cells were collected and centrifuged for 20 minutes at 10,000 z g as above.

3.5 /Ul lisata, napravljenog kao fito ja naznačeno gore, (raskida nje A 111 raskidanje B) inkublra se 2 čaea na 31°C u 6 /Ul iakubaolon amefie koja sadrži 108 mM kalljum-aoetata, 25 mM magnesljum-meetata, mM HPBSE/KOT (pfi 7.4), 5 mM ATP, 4 nM fruktoze 1,6-bls-foafata, zM ditiotreitola 1 20 /ug/nl poli (I) .poli (C) 1 2 /«Ci liofiliziranc3.5 / Ul lysate made as a phyto I indicated above (cleavage A 111 cleavage B) was incubated for 2 h at 31 ° C in 6 / Ul iacubaolone amoeptie containing 108 mM potassium aoetate, 25 mM magnesium meetata, mM HPBSE / KOT (pfi 7.4), 5 mM ATP, 4 nM fructose 1,6-bls-foafate, zM dithiothreitol 1 20 / ug / nl poly (I) .poly (C) 1 2 / «Ci lyophilized

- 66 (al£a-32j>)-ATP (400 Cl/znol, od Radiochasiical Cenre, Aaorshaa, O.K.). Posle zaus taval jan ja reakcije zagrevanjem toka» 3 min. na 95 C 1 bistrenja tokom 2mlnuta na 9,000 x g, usorcl se tretirajn sa 150 0/ml alkalne fosfstaze iz čreva teleta (Boehrlnger, Mannheim, oat. no. 405412) tokom 1 Sasa na 37°C., ponovo se bistre 1 nanesu kao mrlja (1 /Ul po uzorku) na tankolojne ploSe pod polietilenlmin-eeluloze (Polygram, cel 300 PEI 20 x 20 cm od Macherey-Hagel Co., Duren Senany). PloSe se isperu u vakumu pre hromatografije u 1 M sirdetnoj kiselini tokom 2-3 Sasa. Posle sušenja one se podvrgnu autoradiografiji tokom 1-24 Sasa.- 66 (al £ a-32j>) - ATP (400 Cl / znol, from Radiochasiical Cenre, Aaorshaa, O.K.). After stopping the reaction by heating the flow »3 min. at 95 C 1 clarification for 2 ml at 9,000 xg, usorcl was treated with 150 0 / ml alkaline phosphostase from calf intestine (Boehrlnger, Mannheim, no. no. 405412) for 1 hour at 37 ° C., again clarified 1 as stain (1 / Ul per sample) on thin-film plates under polyethyleneamine-cellulose (Polygram, cel 300 PEI 20 x 20 cm from Macherey-Hagel Co., Duren Senany). The plates were washed in vacuo before chromatography in 1 M sulfuric acid for 2-3 hours. After drying, they undergo autoradiography for 1-24 hours.

C. Detekcija Huir»-beta aktivnosti u bakterijskim ekstraktimaC. Detection of Huir »-beta activity in bacterial extracts

1. Kontrolni eksperimenti1. Control experiments

Ha glavne probleme nailazi se u vršenju gore opisanih testova.The main problems are encountered in performing the tests described above.

Oba su vašna za interpretaciju podtaka iz testa. Bakterijski ekstrakti (ukljuSujuči kontrolne ekstrakte) koji nastaju raskidanjem pcmodu gore opisanih postupaka igleda da ukljuSuju faktor koji nije srodan sa interference koji ispoljava antivirusnu aktivnost u testu. Rije jasno da li je sa» faktor antivirusno sredstvo, iii da 11 je faktor indukovao antivirusnu supstanca, n.pr., Interferon, pod uslovima testa. Prisustvo faktora detektovano je ponovoljeao u 8100 ekstraktima. Aktivnost faktora bila je, solda zbog gustine delija, Šesto viša u kontrolni* esktraktiaa K12deltaHZ iii M5219 bakterija, gde je aktivnost faktora «vek bila aanja od oko 0.7 log^/ml. Zz nekog razloga, antivlrusna aktivnost faktora je smanjivana i ponekad Sak eliminisana poptuno taloženjem sa (KH^ )^80^ pod uslovima koji takodje talože interferon u kontrolnim eksperimentima.Both are important for interpreting the test data. Bacterial extracts (including control extracts) produced by termination by the methods described above appear to include a non-interference factor that exhibits antiviral activity in the assay. It is clear whether the factor is an antiviral agent, or that the factor 11 is an antiviral agent, e.g., interferon, under test conditions. The presence of the factor was detected again in 8100 extracts. The activity of the factor was six times higher in the control * extraction of K12deltaHZ or M5219 bacteria, where the activity of the factor was a lifetime of about 0.7 log ^ / ml. For some reason, the antiviral activity of the factor was diminished and sometimes Sak was eliminated completely by precipitation with (KH ^) ^ 80 ^ under conditions that also deposited interferon in control experiments.

Sbog antivirusno aktivnosti koja se mole pripisati kontaminira** judsa fak toru, tetko je da se izreku zakljuSei o prisustvu minoraih kollSina interferona u bakterijski* ekstraktima. Medjutim, bilo je mogude da ae napevi razlika izmedju antivirusno aktivnosti faktora «c 67 i aktivnosti autentišnog interferona koriščenjem diploidnih fibroblast« EjSM. Ove čelije sn sanje osetljIve na HuIPN-beta nego uobičajene čelije trizoane sa hronozc» 21. Ali, čelije su mnogo osetljivije na faktor, aego Sto je to interferon. Na primer, koriščenjem pMS2-7 (R. Devos st al., Construction And Charaeterlzation Of A Plasrnid Contaiaing A Neraly Full-Slze DNA Copy Of Bacteriophage MS2 RNA*, J. Mol, Biol.Because of the antiviral activity that can be attributed to the contaminating factor, it is difficult to draw conclusions about the presence of minor Collins interferons in bacterial * extracts. However, it was possible to distinguish between the antiviral activity of factor C 67 and the activity of authentic interferon using diploid fibroblast EjSM. These dream cells are more sensitive to HuIPN-beta than conventional chrysozoid trizoan cells. 21. But the cells are much more sensitive to the factor, such as interferon. For example, using pMS2-7 (R. Devos st al., Construction And Charaeterlzation Of A Plasrnid Contaiaing A Neraly Full-Slze DNA Copy Of Bacteriophage MS2 RNA *, J. Mol, Biol.

128. 595-619 (1979) n B. coli RB191 (H. Bo/er and D. Rouland-Dussoir,128. 595-619 (1979) n B. coli RB191 (H. Bo / er and D. Rouland-Dussoir,

A Complemaatatlon Anal/sis Of Restrlction And Modification Of DNA In Escherichia ooll J. mol. Biol.. 41, 459-471 (1969) iii KUdeltaHlO»pPLa2311 kao kontrolnih ližeta, podaci demonstriraj« ovaj relativni efekat kao što je pokazano u Bledečo j tablici, pri Seme je antivirnsna aktivnost »arena kao logjedinica/ml.A Complemaatatlon Anal / sis Of DNA Restriction And Modification In Escherichia ooll J. mol. Biol .. 41, 459-471 (1969) iii KUdeltaHlO "pPLa2311 as control licks, data demonstrate" this relative effect as shown in the Bledeco J table, at Seeds is antiviral activity "arena as logunit / ml.

BB101-pMS2-7 (raskidanja A) BB101-pMS2-7 (Breaking A) 0.7 0.7 HB101—pM82-7 (raskidanja B», ali HB101 — pM82-7 (Breaks B »but bas beta-markaptoetanola of beta-marcaptoethanol bass i baz ssrama teleta) and calf ssrama base) <9.2 <9.2 1.2 1.2 HB101—pMS2—7 (raskidanja B) HB101 — pMS2—7 (Breaks B) nije vršsno not perfect 9.7 9.7 BB101-PMS2-7 (raskidanja B) BB101-PMS2-7 (Breaking B) 9.2 9.2 1.9 1.9 HBl01-pMB2-7 (raskidanja B) HBl01-pMB2-7 (Breaking B) 9.7 9.7 2.6 2.6 K12deltaHI-G-pPLa2311 (raskidanja B) K12deltaHI-G-pPLa2311 (Breaking B) 0.2 0.2 4.9 4.9 K12daltaHI-G-pPLa2311 (42°Cj osmotski K12daltaHI-G-pPLa2311 (42 ° Cj Osmotic šok) 9.5 shock) 9.5 >1.7 > 1.7

Dalje, prisustvo autentičaog Huim-heta ss reflektuje različitim odnosom vrednosti na tEjSM i visoko» vrednošču na Tj, u poredjenju sa onim koji izaziva prisustvo faktora. Ovo je pokazano u sledečo jFurthermore, the presence of authentic Huim-hat ss is reflected by the different ratio of values to tEjSM and high value to Tj, compared to that which causes the presence of factors. This is shown in the following j

TabliciiTablicii

T21 T 21 B|SM B | SM supernatant posla the supernatant of the job Klicni—O-pPIa2Jll (42°C) Dial-O-pPIa2Jll (42 ° C) 9.5 9.5 2.5 2.5 osmotskog šoka of osmotic shock K12*BX-O-pPLa2311 (42°C) K12 * BX-O-pPLa2311 (42 ° C) 1.5 1.5 2.5 2.5 4 Bnm-beta (auten tični) 4 Bnm-beta (Authentic) raskidanja B pos- breakup B pos- HB101-pMS2-7 HB101-pMS2-7 9.2 9.2 2.5 2.5 ls (NHp2SO4 balo-ls (NHp2 SO 4 bal- HB101—pM3-2—7 + HuIFNbeta (autentlSni) HB101 — pM3-2—7 + HuIFNbeta (authentic) 2.7 2.7 2.5 2.5 Senja Senja (dodan pre raskidanja) (added before breaking up)

Zbog tofa, uporedjivanje aktivnosti T21»BjSM 1 morenjs apsolutne aktivnosti na T čelijama oraogučuje koriščenje antivirusnlh tastova.Because of tofu, the comparison of T 21 »BjSM 1 activity of absolute activity on T cells facilitates the use of antiviral tastes.

‘O. ¢8 “ opisanih gore, sa neeuanjivu detekciju HuIFN-beta u balterijekom ekstraktu. Dalje, treba da se naglasi da je za ekstrakte kultura B, goli (lli KlldeltaHI 111 M5219) transformisanih sa nekim plazmidima iz ovog pronalaska, n.pr·, G-pPLa-UPIF-67-12, G-pPLa-HFlP-67-12deltal9, G-pPLc-HFIF-67-8, G-pPLa-HPIP-67-12delta279T, G-pPLa-HFIF-67-12delta2l8MI, G-pPLa-HFIF—67-I2deltaMI iii G-pPLa-HFIP-6?-12deltal9 ΒΧ-2, takvo ometanje pomoču nepoznatog faktora n antivirusnim tastovima bilo je manje jako. U ovim tastovima, ηβ-visoko koncentrovani ekstrakti (na primer, čelije iz kultura od 150-ml pri 6 χ 108 čellja/ml se raskidaju i ekstrahuju u 4 al) pokarivali eu niški iii hedetektujuči nivo antiviruene aktivnosti koja se može pripisati nepoznatcaa fak toru.'O. ¢ 8 opis described above, with non-invasive detection of HuIFN-beta in Baltery extract. Furthermore, it should be emphasized that for extracts of cultures B, the naked (or KlldeltaHI 111 M5219) transformed with some of the plasmids of the present invention are, e.g., G-pPLa-UPIF-67-12, G-pPLa-HFlP-67 -12deltal9, G-pPLc-HFIF-67-8, G-pPLa-HPIP-67-12delta279T, G-pPLa-HFIF-67-12delta2l8MI, G-pPLa-HFIF-67-I2deltaMI or G-pPLa-HFIP-6 ? -12deltal9 ΒΧ-2, such interference with the help of an unknown factor n antivirus father-in-law was less severe. In these tastes, ηβ-highly concentrated extracts (for example, 150-ml cell cultures at 6 × 10 8 cells / ml are cleaved and extracted into 4 al) will erode low or hedetecting levels of antiviral activity that can be attributed to unknown factor. toru.

Pokazano je takodje da prisustvo ovog nepoznatog faktora mole da se detektuje u testu aktivnosti 2,5-A siatataze. Ovde se, medjutim, faktor može kompletno eliminisati taloSenjem sa (NHj^SO*. Zbog toga se stvarno prisuatv- HuIFN-beta u bakterijskem ekstraktu, jasno ratlikovano od prisustva kontaminira jučeg faktora, može takdodje detektovati nedvosmlsleao u ovom testu.It has also been shown that the presence of this unknown factor begs to be detected in the 2,5-A siatatase activity assay. Here, however, the factor can be completely eliminated by precipitation with (NH3 ^ SO *. Therefore, the actual presence of HuIFN-beta in the bacterial extract, clearly ratified by the presence of the contaminating factor yesterday, can also be detected unequivocally in this assay.

Medjutim, ekstrakti S. coli HB101/G-pBR322 (Pst)/HFIF-6, koji imaju nekorapletnu kolineamu sekvencu za kodiranje (pri čemu nedostaje poslednjih nekoliko parova baza) koja je tako nesposobna da izrazi zreli polipeptid, davali su ponovljeno pozitivna 2,5-A slntetaznu aktivnost, ali barem do sada, ne i antivirusnu aktivnost. Ovo demonstrira da se 2,5-A test ne mole smatrati kao jedini kri tari jum za prisustvo interferona koji je kompletno napravljen bakterijama. To takodje demonstrira da i interferon manje kompletne prirode mole imati korisna aktivnost.However, S. coli HB101 / G-pBR322 (Pst) / HFIF-6 extracts, which have a non-intricate collineam coding sequence (lacking the last few base pairs) that is so incapable of expressing a mature polypeptide, yielded a repeat positive 2. 5-A slntetase activity, but at least so far, not antiviral activity. This demonstrates that the 2,5-A test should not be considered as the only criterion for the presence of interferon completely made by bacteria. This also demonstrates that interferons of a less complete nature may also have useful activity.

2,5-A sintetasna aktivnost je »arena pomoču inkorporiranje u 2,5-A trlaor kao Sto je pokazano autoradiografijom· Rezultati (ponor** ljeni 3 puta( su prikazani u sledečo j tablici, pri čemu povečevanje2,5-A synthase activity is »assisted by incorporation into 2,5-A trlaor as indicated by autoradiography · Results (reshaped 3 times (shown in the following table, zooming in)

-‘SS32 pozitivnih vrednosti odražava povedano inkorporiranje p.-'SS32 positive values reflect the increased incorporation of p.

ekstrakt a/pHFIP-6 7+++J posle (NH.),30. taloženje 7++ ekstrakt b/pMS2-7 7+*+» v ekstrakt b/pJSS2-7 >+++» posle (NHJ,So. taloženja 7 ++ plus HuIPN-betaa / pHFIP-6 7 +++ J extract after (NH.), 30. deposition of 7 ++ extract b / pMS2-7 7 + * + »to extract b / pJSS2-7> +++» after (NHJ, So. precipitation of 7 ++ plus HuIPN-beta

Dragi važen problem u ovim testovima je niško regenerisanje HuHV-beta izlučenog ljudskim fibroblastima sa vreme 1 posle rasnih eskparinen talnih faza· Dpored j Ivanje regenerisanje leukoeltnog interferoaa i fibroblaetnog interferona dodanih na 8-100 ekstrakt demonstrira da je HttZPV-feeta lselevan samo sa 10« efikasnoeti nasuprot HuIPH-alfa koji se Izola je sa 100% vrednoždu (antivirusne vrednosti su dato kao logie jedinice/ml» mereno na čelije·*)·Another important problem in these assays is the low regeneration of HuHV-beta secreted by human fibroblasts at time 1 after racial exparininal phases. · Sequence j The regeneration of leukoel interfero and fibroblae interferon added to 8-100 extracts demonstrates that HttZPV-feeta is only excl. efficacy versus HuIPH-alpha which Isola has 100% value (antiviral values are given as log ie units / ml »measured on cells · *) ·

XFW-č. razbl. « 8-100-esktraktu HB101-pMS2-7 (raskidaajo A) 2.5 IFH-alfa razbl. u B-BBM plus 39 seruma teleta 2.7XFW-h. smashed. «8-100-extract HB101-pMS2-7 (break A) 2.5 IFH-alpha decomposed. in B-BBM plus 39 calf serums 2.7

IFB-k razbl. u S-I00-ekstraktu HB101-pHB-2-7 (raakldanje A) 0.7 ITB-C* razbl. u E-MKM plus 3* seruma teleta 1·7IFB-k in S-I00-extract HB101-pHB-2-7 (crack A) 0.7 ITB-C * dec. in E-MKM plus 3 * calf serum 1 · 7

Drugi eksperimenti u kojima je ZTO-beta dodan u deli jaku granulu pre raskidanja i ekstrakcije (Sek je i serum teleta dodan do 3« kao stabilizator) pokazali su da je izolovane samo 10-30« IFB-beta.Other experiments in which ZTO-beta was added to a deli strong granule prior to dissolution and extraction (Sec and calf serum were added up to 3 "as a stabilizer) showed that only 10-30" IFB-beta was isolated.

logX0 jedinloe/mllog X 0 unit / ml

HB101—pHS2—7 (raskidanja B, ali bez beta-merkapteetanola lli seruma teleta)HB101 — pHS2—7 (B rupture but no beta-mercapteethanol or calf serum)

ΙΓΗ-betaΙΓΗ-beta

BSPES BSPES T2l T 2l 2χ2 χ pH 8 pH 8 0.7(10«) 0.7 (10 «) 1.7 1.7 pB 7 pB 7 1.0(20«) 1.0 (20 «) 1.7 1.7 pH 6 pH 6 0.7(10«) 0.7 (10 «) 1.7 1.7 $R 6 $ R 6 1.7(50«) 1.7 (50 «) 1.5 1.5

(nema bakterija)(no bacteria)

Izvrženi su dalji eksperimenti se atestiranje stabilnosti i regenerisanja ZFB-beta aktivnosti. Taloženje sa pra^)2BD^, kao Sto je opisane gore, iii u prisustvu lli otsustvu bakterljskog ekstrakta, daste je izazivalo smanjlvanje titra antivirusneg testa:Further experiments were performed to evaluate the stability and regeneration of ZFB-beta activity. Deposition with pra ^) 2 BD ^, as described above, or in the presence or absence of bacterial extract, caused the titre of the antiviral test to decrease:

log|Q jedinlee/mllog | Q unique / ml

Taloženje aa Deposition aa o·«’»·0«o · «'' · 0 « pre pre posle after ZTO-beta ZTO-beta 1.0 1.0 0.5 0.5 IFN-beta IFN-beta 2.7 2.7 2.5 2.5 HB101—pMS2—7 + OTI-beta HB101 — pMS2—7 + OTI-beta (raskidanja B) (breakup B) 1.5 1.5 1.2 1.2

Kl2aelt<tHl-«-pPLa2311 (2|°C) + IFH-bota (raskidanje B) 1.7 1.5Kl2aelt <tHl - «- pPLa2311 (2 | ° C) + IFH Bot (Breaking B) 1.7 1.5

K12deltaBX—<3—pL&2311 (28°C) ♦ IFN-beta (raskidanje B) 2.2 3.0K12deltaBX— <3 — pL & 2311 (28 ° C) ♦ IFN-beta (Breaking B) 2.2 3.0

Dljaliza IFN-beta (preko aodl n« 4°C naspram PBS) ill e prisustvu lli u otsustvu bakterijskih ekstrakata, takodje je obično dovodila do smanjenog isolovanja IFN-beta aktivnosti» log^g jedinice/mlIFN-beta dialysis (via aodl n «4 ° C vs. PBS) or the presence of lli in the absence of bacterial extracts also usually led to reduced isolation of IFN-beta activity» log ^ g unit / ml.

Dijaliza Dialysis pre pre posle after IFN-beta u PBS IFN-beta in PBS 1.0 1.0 0.5 0.5 IFN-beta u PBS IFN-beta in PBS 2.7 2.7 2.5 2.5 K12deltaHI-G-pPLa8 K12deltaHI-G-pPLa8 (28C) 4 IFN-beta (rask. B) (28C) 4 IFN-beta (cleft B) 1.2 1.2 <0.2 <0.2 « « 4 IFN-beta 4 IFN-beta (raskidanje B) (breakup B) 3.0 3.0 1.7 1.7 4 ZFB-beta 4 ZFB-beta (raskidanje B, (breakup B, 2.S 2.S 1.0 1.0 «I «I 4 IFN-beta 4 IFN-beta (raškidan je (broken) 1.5 1.5 0.5 0.5

Foito je IFN-beta interferon Tipa I njegova aktivnost treba da je stabilna n kiselini. Ovc je testirano dljallzom IFN-beta azorska u prisustvu ill otsustvu bakterijskih oetataka (ekstrakata), preko sodi u 5 sM gliclae-BCl (pB 2.2) na 4°C. Ovo tretiranje lzazvalo je formiranje taloga, koji je granulovan u Bppendorf centrifugi na 12,000 χ g tokom 2 minuta. Supernatant je tada testiran na antlvlruanu aktivnost. Mada je neito antivirusne aktivnosti preostalo pošlo ovog tretiranja, poetojalo je suitlnako gubljenje u koll-lnl izolovanog interferona.Foito is Type I IFN-beta interferon and its activity should be stable in acid. The sheep were tested by IFN-beta azoric acid in the presence or absence of bacterial oats (extracts), over 5 sM glyclae-BCl (pB 2.2) at 4 ° C. This treatment resulted in the formation of a precipitate, which was granulated in a Bppendorf centrifuge at 12,000 χ g for 2 minutes. The supernatant was then tested for antiviral activity. Although there was some antiviral activity left behind by this treatment, there was a costly loss in the coll-lnl of isolated interferon.

logjQ jedinioe/mllogjQ units / ml

DljalizaDaljaliza

HB101-pM82-7 (raskidanje A) 4 IFN-beta X12doltaHI-G-pPTa2311 (28°C) osmotski Sok 4 ♦ IFN-betaHB101-pM82-7 (Breaking A) 4 IFN-beta X12doltaHI-G-pPTa2311 (28 ° C) Osmotic Juice 4 ♦ IFN-beta

M52l9-G-pFLaS (42®C) (raskidanje B, 4 IBT-beta M5219«Oppba8 (28°C) (raskidanje H) 4 IFN-betaM52l9-G-pFLaS (42®C) (cleavage B, 4 IBT-beta M5219 «Oppba8 (28 ° C) (cleavage H) 4 IFN-beta

Sman j Ivanja HuIFN-beta aktivnosti napaSenaThe mismanagement of HuIFN-beta activity is impaired

pre pre posle after 0.7 0.7 0.5 0.5 1.2 1.2 1.2 1.2 1.2 1.2 0.7 0.7 3.0 3.0 2.8 2.8 sa ovim rasnim treti« with these racial treats «

ranjima u odnosu na gore opisane kontrolne eksperimente moraju se Interpretirati oprezno. NISI antlvirusai titri ne znače obaves&o da je laterferon degradiran. Mili tlrtl noga biti posledica nespeelflčnog lepljenja HuIFN-beta sa »nabrane za dljalltu 111 za komponente bakterijskih ekstrakata, n.pr«, sa komponenta membrane. Na primer, dobro je dokazano da je IFN-beta hidrofobni protein (njegova hidrofobnost je takodje devona triraaa njegovem aminoklseliaskom sekvenco») ko ji de nože nespeeifllno lepiti aa zidove «prevete 111 drega povrline.In comparison with the control experiments described above, they must be interpreted with caution. NOT antlvirus titers do not indicate that laterferon is degraded. The fine ground may be due to the non-adhesive gluing of HuIFN-beta from "folded for djalltu 111 for bacterial extract components, e.g." to the membrane component. For example, it has been well proven that IFN-beta is a hydrophobic protein (its hydrophobicity is also devon triaaa by its amino acid sequence ") when it is non-peggly glued to its walls" to 111 111 surface.

Dalje, bakterijski IFN-beta, bez glikozelovanja, moie biti Oak 1 hidro* fobnijl. Zbog toga, saki jedel o lsolovanje glikozllovanog IFN-beta izledenog ljudskim dalijama ne moraju neophodno da se efcstrapoliSe na IFN-beta bakterijskog porekla.Further, bacterial IFN-beta, without glycosylation, may be Oak 1 hydro * fobnijl. Therefore, the sake of eating the glycosylated IFN-beta derived from human dales does not necessarily have to be effervescent to IFN-beta of bacterial origin.

2. Penonstriranje IFN-beta aktivnosti2. Penonstriction of IFN-beta activity

a. Natjvlrusaa aktivnosta. Natjvlrusaa activity

Bakterijski pdnttt ekstrakti B, soli M5219 lil NUdsltaHI, koji sadrie planile ©-pPIe-NFIF-57-12, a-pPLa-Hrn^C7-12deltal9, G-pFLo-BFIF-G7-8, G-pPLa-HFIF-67-12delta279T, G-pLa-HFIF-57-12delta218ΗΣ, Ople*BFIF*d7*12deltaMZ HiG-pPLa-HFIF-47-12d«ltal9 ΒΧ-2 analizirani se aa IFN-beta antiviresae aktivnost. Fostupol sa indzfcolje 1 pravljenje 8-100 ekstrakata 1 sepenatanata posle osmotskog Boka se seitinski ved bili ovde opisani. ISO ni bakterijske kulture (3-5 x 10® delija/ml) keriSdeno je po eksperimentu. Nvi MoloBkl titri dati se e log^ jediaios/ml.Bacterial pdnttt extracts B, salts M5219 lil NUdsltaHI, which contains planiles © -pPIe-NFIF-57-12, a-pPLa-Hrn ^ C7-12deltal9, G-pFLo-BFIF-G7-8, G-pPLa-HFIF-67 -12delta279T, G-pLa-HFIF-57-12delta218ΗΣ, Ople * BFIF * d7 * 12deltaMZ HiG-pPLa-HFIF-47-12d «ltal9 ΒΧ-2 were analyzed for IFN-beta antiviresae activity. Fostupol with indzolcol 1 making 8-100 extracts of 1 sepenate after osmotic BoC were seitinally described herein. ISO No Bacterial Culture (3-5 x 10® Delia / ml) Carried out by experiment. Nvi MoloBkl titers be given e log ^ jediaios / ml.

G-pPLa-HFIF-67-12 je korUden sa transfosmisanje R. poli 113219 i N. ooli NUdeltaBl i 8*100 ekstrakti napravljeni se raskldanjem B. Svi uzorci staloleni se sa (184)3804 pre testiranja anti virusne akti* vnostl.G-pPLa-HFIF-67-12 was co-transfused with R. poly 113219 transfusion and N. ooli NUdeltaBl and 8 * 100 extracts were made by digestion B. All samples were crushed with (184) 3804 before anti-viral activity testing.

*21* 21

X12deltaBZ-«-pLa*aFXF*€7*12 (2I°C) • (42% 90 min.) Μ$219*€*ρΡ£η·ΒΝΣΝ*(7*12 (20¾) • «Λ, 90 Bin.) <0.2 0.2/0 .3 <0.2X12deltaBZ - «- pLa * aFXF * € 7 * 12 (2I ° C) • (42% 90 min.) Μ $ 219 * € * ρΡ £ η · ΒΝΣΝ * (7 * 12 (20¾) •« Λ, 90 Bin. ) <0.2 0.2 / 0 .3 <0.2

0.7/0.7 <x.· (1.0/ <1.0 <1.0 <1.0/ <1.20.7 / 0.7 <x. · (1.0 / <1.0 <1.0 <1.0 / <1.2

Brega cifra e gornjoj tablici je titar koji je odredjen ponovnim testiranjem istog esoska» Noatrolni eksperiment e koje» ja autentiBniThe Brega digit e of the table above is a titer determined by retesting the same esos »Noatrol experiment e» which I authenticate

- 72 <·- 72 <·

IFN-beta dodan n 8. ooH HB101-pK82-7 pre raskidanja Čelija naanaSi* je IFN-beta rageznerlaaaje od 30t u testu. Zbog toga, jasno je da ae posle indukcije IFN-beta detektuje antivirusna aktivnost a bakterijskem 11 »tu. Ti tri, dati niže za detekcijo na E^SM čelijama, pokazuju jasno da IFN-beta aktivnost nije posledica kontaminirajoče bakterijske aktivnosti. Takva kontaminirajoča bakterijska aktivnost dala bi vrednosti najmanje 2.0 aa BjSM rako da odgovara vrednostima 0.5 lli 0.7 na Tj j dalijama (vidi kontrolni eksperiment gore).IFN-beta added n 8. ooH HB101-pK82-7 before termination The naanaSi * cell is an IFN-beta of 30t in the assay. Therefore, it is clear that after induction, IFN-beta detects antiviral activity and bacterial 11 tu. These three, given below for detection on E ^ SM cells, clearly indicate that IFN-beta activity is not due to contaminating bacterial activity. Such contaminating bacterial activity would give a value of at least 2.0 aa BjSM, which would correspond to the values of 0.5 l or 0.7 at TJ j (see control experiment above).

Plasmid G-pP£a«HFZF-č7-12dex»19 kerilčen je za transformisanje B, coli ttSSli a d-ekstrakti sa napravljeni raskidanjem B. Svi uzoreriL ataloleni ea ea kao Što je opisano gore, i testirani eo aa antivirusna aktivnost« Ponovo je jasno prisustvi HuIFN-beta anti« virusne aktivnosti a eks trak tima. Vrednost izmedju »grada pokazuje aivo detekcije, zbog Isvesne toksičnosti odredjcnih uzoraka za ljudske čelije a kulturi tkiva.Plasmid G-pP £ a «HFZF-č7-12dex» 19 was kerilized to transform B, coli ttSSli a d-extracts with cleavage made B. All sampled atalolen ea ea as described above, and tested eo aa antiviral activity «Again is clear about the presence of HuIFN-beta anti-viral activity and the ex-band team. The value between cities indicates the aivo of detection, due to the certain toxicity of specific samples for human cells and tissue culture.

1) M5219—β-ρΡΙΛ—NFIF-67—12deltal9 (29°C) ii) M$219-O>^L»-BrXP-<7-12deltal9 (42°C, »0 min.finalna gustina čelija « 3 x 108/ml) aa T« j na B^SM1) M5219 — β-ρΡΙΛ — NFIF-67—12deltal9 (29 ° C) ii) M $ 219-O> ^ L »-BrXP- <7-12deltal9 (42 ° C,» 0 min.final cell density «3 x 10 8 / ml) aa T «j at B ^ SM

i) <9.3 2.2 ( <2.0) ii) 2.2 (<0.5) 2.2 ( <2.0)i) <9.3 2.2 (<2.0) ii) 2.2 (<0.5) 2.2 (<2.0)

Kontrolni eksperiment a kojem je nutenti&ni TFP-betn dodan na HB101pKB2-7 pre raskidanja čelija pokazao je 30% regenerisanje. Ovde, visoko vrednosti na TjX Čelijama 1 odnos aktivnosti na T21 nad onom na B|SK pokasaju da asm značajno kontaminiraj uče bakterijske aktlvnoeti (kao Ste je diekatovano gore) a temperaturno indakoaanim intervalima·A control experiment, to which nutrient TFP-betn was added to HB101pKB2-7 before cell dissection showed 30% regeneration. Here, high values in TJ X Cells 1 ratio of activity at T 21 over that at B | SK try to significantly contaminate the learning bacterial activity (as stated above) at temperature-indicated intervals ·

Plazmid d-pPic-eFIF-<7-8 keriBČen je sa traznzformisanje B.jopII MS219 a d-ldd ekstrakti aa napravljeni raskidanjem B*The plasmid d-pPic-eFIF- <7-8 was digested with the transformation of B.jopII MS219 and the d-ldd extracts aa made by breaking B *

- 73 Svi uzorci cu staloSaal e* aBonijun-aulfatc« i testirani ne anti— virusna aktivnost.- 73 All samples will be cared for Saal e * aBonium-aulphate and tested for anti-viral activity.

i) Μ52Ι9-β-ρΡ1ο-3Ζ1Γ-«7-8 (26°C)i) Μ52Ι9-β-ρΡ1ο-3Ζ1Γ- «7-8 (26 ° C)

11} * (42°C, 180 min.,.finalna gustina delija * 6 x 10*jtol) na T, d11} * (42 ° C, 180 min., Final particle density * 6 x 10 * jtol) at T, d

n) <0.5n) <0.5

2.2 ( «5.5) na Εχ5!12.2 («5.5) on Ε χ 5! 1

2.2 (¢2.0)2.2 (¢ 2.0)

2.2 ( <2.0)2.2 (<2.0)

Vrednosti α zagradaaa nasnaduju nivo detekcije, zbog tokaičnoati. Kontrolni eksperlaeat u koje* je dodan autentiSni IFR-beta ne ΒΒ1Θ1pKB-2-7 pre raskidanja dalija ispol j io je 308 regenerieenje* Opet, jasno je da je bakterijski ekstrakt ispoljio HuIF!M>eta antivlruenu aktivnost.The values of α brackets increase the level of detection due to the tokaichata. A control experiment to which * authentic IFR-beta was added not ΒΒ1Θ1pKB-2-7 before discontinuation of dahlia exhibited 308 regeneration * Again, it is clear that the bacterial extract exhibited HuIF! M> eta antiviral activity.

JS drugo* eksperimentu supematant ovih deli ja posle osnotskog Beka testiran je na ΧΓΗ-beta anti virusna aktivnostiJS second * to the experiment the supervisor of these parts after Osnotski Beck was tested for ΧΓΗ-beta anti viral activity

1) kontrola: K521>-G-pPIa-HFIF-«7«12daltal> (28°C) ii) M5219-G-pPbe-BFZr<-67-0 (28°C) lil) (42°C, 180 nin, gustina dalija « € x 109Ab1).1) control: K521> -G-pPIa-HFIF- «7« 12daltal> (28 ° C) ii) M5219-G-pPbe-BFZr <-67-0 (28 ° C) lil) (42 ° C, 180 nin, density of dahli «€ x 10 9 Ab1).

Tastovi su vrisal na »n dalijasa, i pre i posle taloSenja ea sulfata». Vrednosti isoedju ragrada narnaSuju nivo detekcije.The toasts were screamed at "n dalyas, both before and after deposition of ea sulfate". The values in the frame are the level of detection.

jaauSfiisSsala <0.2 <0.2jaauSfiisSsala <0.2 <0.2

0.7 ( <0.2}0.7 (<0.2}

i) <0.2 11) <0*2 iii) l.S ( < 0*2)i) <0.2 11) <0 * 2 iii) l.S (<0 * 2)

Isolovanje OH-beta bilo je ako 108 u kontrolni* ekeperiz»atiiaa· Kontrolni lisati nisu pokesali detektujudu aktivnost aa E^SM. vrednosti koje su dobivene m superuatantiz* posle eeaotekog loka objalajavaju da teuperatarno lndukovuni l6219~Q-pPbe-BRP-<?-8 ekstrakt ima anti* virusa« aktivnost koja nije prisutna u neiadakevania uzoreiaa. Vsonfe (iii) posle taleleaja aa aeceijm-zulfatoe, koji iaa tl tar 0.7 loffjg jedinica na el», dijalisevan je na pH 2.2, kao ito je opisane gore.OH-beta isolation was if 108 in control * ekeperis »atiiaa · Control lyses did not repress detectable activity aa E ^ SM. the values obtained by m superuatantis * after eaeotec arc indicate that teuperatar lndukovuni l6219 ~ Q-pPbe-BRP - <? - 8 extract has anti * virus «activity which is not present in the nonadherence of the specimens. Vsonfe (iii) after thaelei aa aeceijm-zulfatoe, which iaa tl tar 0.7 loffjg units on el », was dialysed to pH 2.2, as described above.

- 74 :1 nije pokasao sužtinsko smaajlvanje aktivnosti. Ova stabilnost u kiselini je odred jena osoblna interferona tipa I. n.pr., UW-beta·- 74: 1 did not overdue the essential smearing of activity. This stability in acid is determined by type I personal interferons, e.g., UW-beta ·

G-<?pra-gny-47-12delta27»TG - <? Pra-gny-47-12delta27 »T

Plazmld 9-pKm-»MV-«7-12delta279T koriMen je za transformiranje g, eoli M5219 1 S-100 ekstrakti sa napravljeni raskidanjem B. Uzoroi s« st&leženi sa enoai jum-sulf atom pre testiranja pomodu CPS na T21 dalijama. Ekstrakti delija indukevani na 42°C pokazali su anti virusni titar 1.5-1.7 lov1Q a/ml ekstrakta.Plazmld 9-pKm- "MV-" 7-12delta279T koriMen for transforming g eolia M5219 1 S-100 extracts are rendered with breaking off B. Uzoro with "st & leženi with enoai .mu.m-sulf atom pre testing pomodu CPS T 21 dahlias. Delia extracts induced at 42 ° C showed an anti viral titer of 1.5-1.7 hunting 1Q a / ml extract.

G-ppjz^xy-47-HdeimimG-ppjz ^ xy-47-Hdeimim

Plazmld G-pPLe-«FIF-67-12delta21?MI koriSden j· za transformizaaje g. coli '£5219 i 3-100 ekstrakti sa napravljeni zaskldaajero B. Uzord su sfcaloženl zn osonljuarsalfatea pre testiranja pomedu CFB »atn dalijama. Ekstrakti delija indukevani aa 42°C pokazali su antivirusni titar 1.5 lO9j£ «/ml ekstrakta*Plazmld G-pPLe- «FIF-67-12delta21? MI koriSden j · for transformations g. coli '£ 5219 and 3-100 extracts were made using B. B. The samples were sfcaloženl zn osonljuarsalfatea before testing with CFB »at n dalia. Aa 42 ° C induced deli extracts showed an antiviral titre of 1.5 lO9j £ «/ ml extract *

G-pPI^t-gFIF—07-12deltaMIG-pPI ^ t-gFIF — 07-12deltaMI

Plazmld G-^’La-HFTF-47-12deltaMX koriSden je za traaefermlsanje E. eoli K5219 i 8-100 ekstrakti napravljeni su raskidaajsm B« Ozord su stalokeni sa amoaljun-eulfatcet pre testiranja posoda CPS na deli jama« Esktrakti dalija imdakovaai ma <2°C pokazali su antivirusai titar 2.0 109)4 jediaima/ml ekstrakt.Plasmld G - ^ 'La-HFTF-47-12deltaMX was used to traeferermel E. eoli K5219 and 8-100 extracts were dissolved B «The ozone was rinsed with amoaljun-eulfatcet before testing the CPS vessels on parts of the wells 2 ° C showed an antiviral titer of 2.0 109) 4 units / ml extract.

.*W. * W

Plazmld G-pPLa-3FIF-07-12doltal9 ΒΧ-2 koriftden je za trasnfermisanj« g« ooll S12delta8Z 1 8-100 ekstrakti aa napravljeni raskidaajem B. Bzorci au staloženi oa amoaljma-euifatom pre testiranja poseda en aa i FS-4 dekijama« Ekstrakti delija indukevani aa <0°C pokazali au antivirusai titar 1.7-2.0 levlc u/ml ekstrakta.Plasmld G-pPLa-3FIF-07-12doltal9 ΒΧ-2 koriftden is for transferring «g« ooll S12delta8Z 1 8-100 extracts aa made by breaking up B. Samples held in place oa amoalma-euifate before the test of possession of aa and FS-4 Delia extracts induced aa <0 ° C showed au antivirusai titer of 1.7-2.0 lev lc u / ml extract.

Dalji dekan mufttiamke bakterijsko ekspresije ΧΡβ-beta dat je aka* perimentlma oa noutraliaaoijom antitola. Anti—intorfercn anti-serum aapravljen je aa komama« imnaisirmaim ma 107 jedinica autentl&aog UE- 75 beta (lzluSen ljudski» fibr ob lastnim čeli jacaa), i pračigčea je na »The further dean of mufttiam bacterial expression of ΧΡβ-beta is given by the * * perimentlma oa noutraliaaoia of antibodies. The anti-interfering anti-serum was aa coma «imnaisirmaim ma 10 7 units autentl & aog UE- 75 beta (human hearing» fibr at its own forehead), and was primed to »

• v *Λ kontrolisaaija staklenim perlaaa ea porasm (λ. Billiau et el., gore). Pošto su bakterijski e ke trakti tas tirani kac gore na anti virusna akti— vnest, sroijak« razblažene antiseruma doda au na a lične uzerke, sme&O ee inkubiraju 1 Sne na 37°C, primene ee na ljudske diploidne fibroblaate T2i i proeene ee aa anti virusne aktivnost kao Sto je opisano ranije« Stepen neutrallzaolje pomoču IFN-beta antisoruna varira od ++♦ (kompletne neutralisneijn do - (nema neutrallzaolje) · Vrednosti lsmedju sagrada nasaačuju približno razblaSonje antiseruma sa 50i neutralizaciju.• v * Λ control by glass beads ea porasm (λ. Billiau et el., Above). As the bacterial tracts were titrated up to anti-viral activity, the diluted antiserum was added to our samples, brown &lt; RTI ID = 0.0 &gt; e &lt; / RTI &gt; incubated at 37 [deg.] C., applied to human diploid T 2i fibroblasts and screened anti-viral activity as described previously «The degree of neutralization using IFN-beta antisera varies from ++ ♦ (complete neutralization to - (no neutrality)) · The values between the constructs are approximately approximated by the lower antiserum with 50i neutralization.

1) M5219-G-pPLc-mT-Č7-8 (42°C, 180 min; koji daje 2.2 loglfl antivirusne jodinice/al sa T21 čelijama)1) M5219-G-pPLc-MT-C7-8 (42 ° C, 180 min; koji gives 2.2 log LFL antiviral jodinice / al sa T 21 CELIJA)

2) K52l9-G-p?La-a (42°C, 180 min) na koji ae doda IFli-beta (is ljudskih fibroblaate) pre raskidanja (koje daje 1.7 1o?jq anti vimenih jedinioa na Τ2χ čelijama) · razblaživanje antiseruma (1) (2)2) K52l9-Gp? La (42 ° C, 180 min) to which IFli-beta (and from human fibroblasts) is added before dissolution (which gives 1.7 µg anti-udder units on Τ 2 χ cells) · Antisera dilution (1) (3)

10’ +10 '+

+(10+ (10

4.5)4.5)

Slični resultsti dobiveni au aa ekstraktims is M5219-pFIm-eFXF-<7-X2delt 19 (42°C) · Razlike u titru neutralisaeije lsmedju bakterijsko? HV-beta is ovo? prosa 1 seks i autsntičaog ZFtf-beta mogu biti posledica razliko u antigunesti lli u speelfiftnoj XFM aktivnosti ovih bakterijskih proteina u odnosu na autentiSni ZFN-beta Sto je isasvuno nedostatkom glikozilacije u bakterijski» pcoteimima.Similar results from au aa extracts are M5219-pFIm-eFXF- <7-X2delt 19 (42 ° C) · Differences in neutralization titer but bacterial? HV-beta is this? millet sex and authentic ZFtf-beta may be due to the difference in antigunesta lli in the speelfift XFM activity of these bacterial proteins relative to the authentic ZFN-beta, which is due to a lack of glycosylation in bacterial pcoteim.

=· 3<a»bm»Pst «aIg»-b8t» «BtlvltB»» «ktlvno.U.= · 3 <a »bm» Pst «aIg» -b8t »« BtlvltB »» «ktlvno.U.

(1) Toplotno te.MjM.je irn-tat* la·« aMapMfc Χ,Β-alfa« «slo «MskliUJe» oaoblm .-f' s« njegova antivirusaa aktivnost regenerlSe posle raskidauja u ključalom It 8DS, lt beta-tterkaptoetaaolu, S M karbamidu (Stevart, < W.E. ΣΤ et al.t Distinct Noleoular Spsdes Of Kuzma laterferem, Kegti** nts For Stabiliratlon kad Feaotivation Of Human lencooyte And Fibroblast Interferon, J. Gen, VIrol., 26, 327-331 (1975), mada 1009 regenerisanje etično nije dobiveno. Za ovaj test bakterijske dalije 150 ml kulture resusnenduju ee u puferu aa raskidanje B i jednaka zapremina 29 SDS, 29 beta-merkaptoetanola i 10 H karbamida ae doda, smela ca kuva 2 min. i naprave se frakcije S-100.(1) Thermal te.MjM. is irn-tat * la · «aMapMfc Χ, Β-alfa« «slo« MskliUJe »oaoblm.-F 's« its antivirus activity regenerated after breaking it in boiling It 8DS, lt beta-tterkaptoetaaolu , SM Carbamide (Stevart, <WE ΣΤ et al. T Distinct Noleoular Spsdes Of Kuzma laterferem, Kegti ** nts For Stabiliratlon When Feaotivation Of Human Lencooyte And Fibroblast Interferon, J. Gen, VIrol., 26, 327-331 (1975) , although 1009 regeneration was not ethically obtained. For this test, bacterial further 150 ml of culture were resuspended in buffer aa cleavage B and an equal volume of 29 SDS, 29 beta-mercaptoethanol and 10 H carbamide were added, bold ca 2 min and fractions were made. S-100.

i) kontrola: K5219-G-pPLa-HFIF-57-12deltal9 (28°C) ii) kontrola s 3 log.n jediniča HuIFN-beta razbl. u puferu za S raskidanje iii) K5215-OpPLc-aFIF-67*8 (42VC, 180 min. gustine dalija “i) control: K5219-G-pPLa-HFIF-57-12deltal9 (28 ° C) ii) 3 log control. n HuIFN-beta unit shattered. in S rupture buffer iii) K5215-OpPLc-aFIF-67 * 8 (42 V C, 180 min daly density "

S Z 10*/ml).S Z 10 * / ml).

Teatovi su vrleui na T^-dcli jarca. Vrednost u ze—adarca pokazuje graaicu detekcije, zfcof uautralnje toksičnosti.The teats were returned to the T ^ -dcli of the goat. The ze-adarca value indicates the detection site, zfcof of internal toxicity.

Pre kuvania Posle kuvanjaBefore cooking After cooking

i) <1.5 <1.5 ii) 2.2 ( <1.5) 2.0 ( <0.5) iii) 3.0 ( <2.0) 2.2 ( <1.5)i) <1.5 <1.5 ii) 2.2 (<1.5) 2.0 (<0.5) iii) 3.0 (<2.0) 2.2 (<1.5)

Kontrolni eksperiment pbkazao je regemerisanje od oko 105 IFS-beta aktivnosti· Nema detektujude vrednosti n Z^SM u paralelnim kontrolnim lizatina. Ovi podavi pokazuju da iako je samo oko 109 dodanog IFN-beta regemeriaane u koatrolaom eksperimenta, ta IFH-beta antivirusna aktivnost bila je prisotna u ekstraktu iz temperaturno lndukovaae K5219-G-pP2>o-HFIF-67*8 Ček i posle ovog ofitrog tretiranje. Ustvari, nadjena je vila antivirusna aktivnost posle ovog tretiranje u poredjenju set postopkom raskidanje B, *to aasnaftuje moguče lepljenje XF»*beta za dali jake komponent» u poslednje» postopku.The control experiment showed a regression of about 105 IFS-beta activity. · No detectable value of n Z ^ SM in parallel lysatin controls. These data indicate that although only about 109 IFN-beta regemeriaane was added to the coatrol experiment, this IFH-beta antiviral activity was present in the extract from the temperature K5219-G-pP2> o-HFIF-67 * 8 check even after this ofitrog treatment. In fact, a fairy antiviral activity was found after this treatment in comparison with the set procedure by breaking the B, * this augments the possible bonding of XF »* beta to give strong components» in the last «procedure.

<2) m>»»<2) m> »»

HuIFN-beta antivirusna aktivnost se takodje se mole dijallzevati. Sz primer, poale dijelize naspram PBS tokom 16 časova na neutralaeet pB i na 4°c antivirusna aktivnost (log^ u/ml) bakterijskih ekstrakuta je očrtana, meda ea smanjenim titremcHuIFN-beta antiviral activity is also being sought for dialysis. Sz example, the pools versus PBS for 16 h at neutral pB and at 4 ° c antiviral activity (log ^ u / ml) of bacterial extracts were delineated, albeit with reduced titremc.

i) i) Il5213-prtc-HFXF-67-3 Il5213-prtc-HFXF-67-3 (42*0 (42 * 0 ii) ii) KS 219-pILa-nPIF-67-12delte19 KS 219-pILa-nPIF-67-12delte19 <42*0 <42 * 0 iii) iii) IFN-beta u M3219-f£La-8 IFN-beta in M3219-f £ La-8 «2*0 «2 * 0

Pre «UlaUze Posle .«gJallseBefore «UlaUze After.« GJallse

i) i) 2.3 2.3 2.3 2.3 1) 1) 3 3 2.3 2.3 i) i) 1.5 1.5 1.3 1.3 U) U) 2.3 2.3 1.3 1.3 U) U) 2.3 2.3 2 2 li) li) 2.3 2.3 1 1

Bapaženo smanj Ivanje aktivnosti posle dijalize mole biti posledice nespecifično^» lepljenja ITN-beta ee membrane «a dl jeli su, itd.The observed decrease in the activity after dialysis may be due to the non-specific adhesion of the ITN-beta ee membrane and they were eaten, etc.

(3) Telotenje ee (NB*)3804(3) Telecommunication ee (NB *) 3804

Antivirasna aktivnoet (log1Q «/!) bakterijskih eketrakata is ovog pronaiaska odrlavaaa je poele talolenja sa 674 zasičeni» amonij«·» sulfatom (2 zapr (NHpjSO* rastvor do 1 zapr. ekstrakta), a to je koncentracija za kkje se srna da taloži HuIFN-beta. Posle 30 min. na ledu, granule se eentrifuglra na 12000 x g tokom 10 minuta i ponovo se rastvori u BBS radi testiranja«The anti-viral activity (log 1Q «/!) Of bacterial extracts has, from this finding, begun to melt with 674 saturated" ammonium "sulfate (2 const (NHpjSO * solution up to 1 const. Extract), which is the concentration for dew After 30 min on ice, the granules were eentrifuged at 12,000 xg for 10 min and redissolved in BBS for testing. "

i) ii) iii) i) ii) iii) KS219~pPLc-HFTP-67-8 X5219-p?La-HFIF-67-l2deltal9 IFM-bcta a MS219—pPLa—6 KS219 ~ pPLc-HFTP-67-8 X5219-p? La-HFIF-67-l2deltal9 IFM-bcta a MS219 — pPLa — 6 (42*C) (42*0 (42*C) (42 * C) (42 * 0 (42 * C) pre taloženja before deposition posle balo after the balo i) i) 2 2 2 2 i) i) 2 2 2.3 2.3 li) li) 2 2 2 2 iii) iii) 1.3 1.3 1.3 1.3 lil) lil) 1.5 1.5 1.3 1.3

<»> a» P«?<"> A" P "?

Antivirusna aktivnost (log10 u/ml) bakterijskih eketrakata iz ovog pronaiaska bila je takodje stabilna prema kiselini. Esktrakti su 111 dljallzovanl toke» 15 Časov« naspram 50 ml glicin-NCl (pB 2.2), posle čega je vržena dl Ja lisa naspram MHS tokom 3 Časa lli su zakilolj«ni sa BCl pa je onda vržena neutralisaelja «a VaOR. Posle odvajanja taloga izvršen je test:The antiviral activity (log 10 µg / ml) of bacterial extracts from this finding was also stable to acid. The extracts were 111 times for 15 hrs against 50 ml of glycine-NCl (pB 2.2), after which the slurry was returned to MHS for 3 h and was subsequently sacrificed with BCl and then neutralized with VaOR. After separation of the precipitate, a test was performed:

i) M5219-pPTx=-HFIF-67-8 ii) M5219-pPlA-HFIT-57-12fielta 12 iii) IFN-beta u M52i9-p?La-S i) M5219-pPTx = -HFIF-67-8 ii) M5219-pPlA-HFIT-57-12filt 12 iii) IFN-beta in M52i9-p? la-S (42°C) (42*0 (42 ° C) (42 * 0 (42°C) (42 ° C) poale -Ussllae poale -Ussllae pre kiseline before acid i) i) 2 2 1.3 1.3 i) i) 0.7 0.7 0.7 0.7 ii) ii) 2 2 1 1 iii) iii) 3 3 2 2

d. 2,5-A Slntetazna aktivnostd. 2,5-A Slntetase activity

Supernatant posle osmotskog Soka M52l9-G-pPLc-HFIF-67-8 (opisan gore) testira se aa prlsostvb 2,5-A sintetaze kao Sto je opisano gore, aa nlkrotitarskin pločlcaoa, izuzev Sto eu kori&čene Bela dalij« umesto Ej&M čelija« Dobiveni s« sledeči rezultati aThe supernatant after osmotic Juice M52l9-G-pPLc-HFIF-67-8 (described above) was tested for aa prlsostvb 2,5-A synthetase as described above, and for a noncritical plaque, except for Sto ei &lt; / RTI &gt; Obtained with «the following results a

1) M5219—G—pPLo—HFIF-67-8 (28°C) (vidi gore) ii) M5219-G-pPLc-KFII’-67-8 (42°C) (vidi gore)1) M5219-G-pPLo-HFIF-67-8 (28 ° C) (see above) ii) M5219-G-pPLc-KFII'-67-8 (42 ° C) (see above)

Vrddnoeti koje odražavaju aktivnost 2,5-A sintetaze, pokazuju 32Pr-diokativnost lnkorporiranu u oblik triaera 2,5-kValues reflecting the activity of 2,5-A synthetase exhibit 32 Pr-dioctivity incorporated into the 2,5-k triac form

1) netretirane delije1) untreated cells

2) bakterijski ekstrakt (i): rasblaienje 1/62) bacterial extract (s): 1/6 dilution

3) bakterijski ekstrakt (11)x rasblaienje 1/63) bacterial extract (11) x 1/6 dilution

4) bakterijski ekstrakt (1) t IFK-beta do 1*5 log10 jedinica/ml4) bacterial extract (1) t IFK-beta to 1 * 5 log 10 units / ml

5) vidi 3 ali inkubirano sa antl-IFN-beta antiserunon5) see 3 but incubated with ant1-IFN-beta antiserunone

6) vidi 4 ali inkubirano «a aa ti-IFN-be ta-an tiaezuao®6) see 4 but incubated «a aa ti-IFN-be ta-an tiaezuao®

7) kontrolni IFH-beta 0.5 log^ jedinica/ml7) control IFH-beta 0.5 log ^ units / ml

8) kontrolni IFN-beta leg^ jediniee/nl8) control IFN-beta leg ^ units / nl

9) kontrolni IFK-beta9) control IFK-beta

1.5 1«9|£ jediniee/nl1.5 1 «9 | £ Unit / nl

10) Kontrolni IFH-beta log^ jedinica/ml10) Control IFH-beta log ^ unit / ml

(iznerena odbrojavanja) (confused countdown) (posle odbzinanja endogene osnove) (after rejection of endogenous base) 3342 cpm 3342 cpm 0 βρΛ 0 βρΛ 1972 1972 -4370 -4370 6960 6960 363 8 363 8 7037 7037 3693 3693 3950 3950 608 608 2960 2960 -382 -382 4463 4463 1120 1120 7680 7680 4338 4338 13615 13615 10273 10273 25040 25040 21G98 21G98

! * 79..Kezultati testirana aktivnosti 2r5-K sla te teze deaoastriraju da οηρ·»» natant posle osmetskeg Aoka temperaturno indukovanog M5219-O-pPLe* HPIP-67—8j koji Ima antivirusau aktivnost (vidi gore), takodje indukuje aktivnost 2,5-A sintetaze dok nainčufcovani bakterijski iso j to ae Sini· Ovo Je paralelno ea rožnitatima testiranja anti virusne aktivnosti.! * 79..Experts tested activity 2 r 5-K sla these theses deaastriate that οηρ · »» natant after osmetic Aok temperature-induced M5219-O-pPLe * HPIP-67-8j which has antiviral activity (see above) also induces activity 2,5-A synthetase while uninfected bacterial iso j to ae Sini · This is parallel to the corneas of anti-viral activity testing.

Stepen stimulacije 2,5-A sintetaze je jednak sa aktivnoSča IF8*b«t< dodanog na kontrolni lizat (uporedi primere (3) i(4))· Koriščenje krivo koncentracije razred jene iz uzoraka (7) do (10) pokazuje da se, uzlma&jem a obzir razblašenja, mole preceniti aktivnost od 1°9jqThe degree of stimulation of 2,5-A synthetase is equal to the activity of IF8 * b «t <added to the control lysate (compare examples (3) and (4)) · Using the wrong concentration of the class from samples (7) to (10) shows that I take note of the distractions, please overestimate the activity of 1 ° 9jq

1.7 jedinica/el n oba uzorka (3) i (4), Bto je kompatibilno ea vred» nostima n direktno» anti virusno» testu, t.j., 1.5 log-- jedieiea za oba uzorka. Ova serija ekaper imena ta takodje dsmoeztrira da se indukcija 2,5-K sintetaza mole nsutralisati ea anti-IFR-beta antioeru» non, kao u slučaju antivirusnog testa.1.7 units / el n of both samples (3) and (4), which is compatible with the values of n directly to the “anti-viral” test, i.e., 1.5 log-- units for both samples. This series of eccentric names also indicates that the induction of 2,5-K synthetases is required to neutralize ea anti-IFR-beta antioera »non, as in the case of the antiviral test.

e. AatlTtr-J»»» ahttvnoafr j» fau.i» ^ll-jnfcin H,nt1wwe. AatlTtr-J »» »ahttvnoafr j» fau.i »^ ll-jnfcin H, nt1ww

BkatcakU (1) i (11) <ηϊ31»-0-ρΡΐΛ-Ηηρ-«Τ-β, f»’! »« testirani aa antivirusn« aktivnost na različitim čelijskim linijama alSjeg, majaunskog lli glodarskog porekla. Oni nisu pokazali nikakvu de tak tuj udu aativlruanu aktivnost na ovim čelijanai a t» nije ni anten» tičal IFM-beta napravljen ljudski» dalijama. Takodje nije nad jena aktivnost na aaSjoj čelijskoj liniji pluča koja ja bila oaetljiva na ljudski leukoeitni interferon. ovi rezultati obezbedjuju dalji dokaz da ira-beta proizveden poeodu bakterija lepoljava suštinski Identične osobine sa eseblnas« TFS-beta izludenog ljudskim fibroblastaJ čelijama.BkatcakU (1) and (11) <ηϊ31 »-0-ρΡΐΛ-Ηηρ-« Τ-β, f »'! "" Tested aa antiviral "activity on various cell lines of all of Mayan or rodent origin. They did not show any such foreign interference with the active activity on these cells, and neither the IFM-beta antenna touch was made with human dalium. There was also no activity on the lung cell line that was sensitive to human leukoeitic interferon. these results provide further evidence that the ira-beta produced by the bacterial strain attaches substantially identical features to the human fibroblast cells exfoliated TFS-beta.

£. Oseti jivost na proteaze£. Feel the sensitivity to proteases

Osetljivost ISTT-beta iz bakterijskih domačina iz vod pronalaska testirana jo tretiranje« raZblaSenih bakterijskih ekotrakata sa povedeva judo» količin osa tripsina tokom 1 časa na 37*c. An ti virusna aktivno IFN-beta se ukida trips in oo*. pri sllCnlm koncentracijama sa onima koje akičaja aktlvaoet anteatično« IFB-beLa čodaao« »a iaaktivni kontrol»!The susceptibility of ISTT-beta from the bacterial hosts of the invention was tested by treating "diluted bacterial ecotracks with judo" amounts of trypsin axis for 1 hour at 37 * c. The so-called viral active IFN-beta abolishes tryps and oo *. at sllCnlm concentrations with those which the acutea activates anteatically «IFB-beLa affe« «and iaactive control»!

llsat.llsat.

X5219-pPLe-&Xr»€7-12čeitel9 MS 2 lO-pPLe-gFIt-67-3 UV-beta « MS21>-pPLa-t M52l>-pPL®-ira-67« MS210-pFI»(42*C)(1000 tt/bl) <42*C) ’ (42*0 (42*C> C 30 tt/al) (42*0 krajnje tačka JteML—X5219-pPLe- & Xr »€ 7-12cheitor9 MS 2 lO-pPLe-gFIt-67-3 UV-beta« MS21> -pPLa-t M52l> -pPL®-ira-67 «MS210-pFI» (42 * C) (1000 tt / bl) <42 * C) '(42 * 0 (42 * C> C 30 tt / al) (42 * 0 endpoint JteML—

0.030.03

0.030.03

0.030.03

0.030.03

0.030.03

3. tčuUilkaol laaktivaegirM^eta prolsvoča van i da ga bakterijske Čelije m praračjaj« poč nelevlaa teatiruja « aktiva* prolsvoč. Xbeg tega« IVP-beta aktivnost koja je Čstsktovaaa a rasel» bakterijski» ekstrakti»*« kao Sto je opieaao gore, je verovatao peolečiea prerade očekivaaik keačusovaalh proteina (n.pr·« HalFM-beta koačeasevaae« sa beta-laktaaasa, K32 lli bekterleke eigaelae sekvenee) peneča bakterija lli peč nelevlaa testiranja a aktivni prolsvoč.3. tUUilkaol laaktivaegirM ^ eta leak it out and have the bacterial Cells m «t to it« begin unobtrusive theatry «of the actives * prolsvoch. Xbeg of this "IVP-beta activity which is Chstskt's augmented" bacterial "extracts" * "as described above, was believed to be a more efficient processing of the expectant cacheus protein (e.g.," HalFM-beta coacasease "with beta-lactaaase, K32 lli bekterleke eigaelae sekvenee) sparkling bacterium or furnace non-testable a active prolsvok.

M je Isvesao ča 11 je aktivu prolsvoč a takvi» esktraktiaa «reli BaZnHbeta (sreli HalO-beta je aeravae prolsvoč S-pPXa-HFIP-<712čeltaMl 1 G-pPLa-fiFZP«<<7-12čeltal8 ΒΧ-2). mčjoti»« frakeloaaelja bakterijskih ekstrakata slsktrefereso» aa pollakrtlaalčaea «ala poč aalovlaa čeastarlsaaja otkrlla je prisaetve čva aktivam prolsvoča.M is Isvesao cha 11 is an asset of pro-leakage, and such is the "extraction" of the BaZnHbeta rally (met HalO-beta is the aeravae pro-lever of S-pPXa-HFIP- <712 celtaMl 1 G-pPLa-fiFZP «<< 7-12celtal8 ΒΧ-2). mcjoti »« frakeloaaela bacterial extracts slsktrefereso »aa pollakrtlaalčaea« ala pocha aalovlaa чеastarlsaaja has discovered the planting of the activum prolsvo.

>rvi oč tik prolsvoča laso je prlblilaa vailčlaa oč 15000-10000 čaltoae i aogao je očfovsrati srele» Baznhfeeta· Bra«l prolsvoč, koji je lase veča aolekelak« teilaa, »oče biti keodusaeleai prolsvoč ill aakoapletao preračjeal prolsvoč koji la» ZVMeta aktlvaoet ill aaSe biti pcooavoč koji je preračjea a sreli snHbeta poč «sleviaa koriSČeajea čebre posaatlk iskalka« onofačlče očreč jivuje koji proteini proisveči« ako ib laa« pereč srele« EFM-beta« Ispoljava ja aktivnost BaZnhfeeta.> rvi's eye just shed his hair lengthened his eyelids 15000-10000 chaltoae and aogao to see the happy "Baznhfeeta · Bra" l sash, who is a hair bigger aolekelak "teilaa," his father to be keodusaele and shed ill aakoapletao to let out a short hair aaShe will be a pcooavoc who is a metaphor and met a snHbeta begin «sleviaa use of a bower posaatlk finder« onofaclce a canine jiv which protein proves «if ib laa« a pere met «EFM-beta« It manifests the activity of BaZnhfeet.

PoboSanj· prinosa 1 aktivnosti polipeptida koji iepoljavaj« aktivnostImprovement · of yield of 1 activity of polypeptide that enhances «activity

BCWt«te«t<>lt nw»tmtal m»«wwiWMl«ti ........... .. ,. /BCWt «te« t <> lt nw »tmtal m» «wwiWMl« ti ........... ..,. /

Sivo proizvoda j« proteina j· komaadovan aa tri glavna faktora« broj«* k-pija njegovih gena unutar delija, efikasaoSdu na kojem se koplje gm transkrihuju 1 efikasaoSdu sa kojom ee ene translatiraju.The gray product of the j protein is comaaded aa three main factors of the number of k-pop of its genes within the deli, the efflux on which the gm spear is transcribed 1 the efflux with which the ene is translated.

Efikasnost transkripcije 1 translacije (koje sajedalčkl Sine ekspresija) je opet zavisna od nukleotidnih sekvenci koje e« normalno situirane lepred Soljene sekvence sa kodiranje. Ove nukleotidna sekvence lli sekvence sa kontrolu ekspresije definiSa, izmedju ostalog, lokacija aa kojoj SBk poliasrasa lnteraguje take da lalelra transkripcij (premoterska sekvenca) 1 aa kejej ee vezaju rlbosoml i interagu ju ee mksk (proizvod transkripcije) tako da se lalelra tr-anslacija.The efficiency of transcription 1 translation (which is expressed by Sine expression) is again dependent on the nucleotide sequences that are normally positioned by an annealed Salt coding sequence. These nucleotide sequences or expression control sequences define, inter alia, the site aa to which the SBk polyasrase interacts such that lalelra transcription (premotor sequence) 1 aa kaye binds rlbosoml and interacts with mksk (transcription product) so that it laller.

e funkelealie ave takve sekvence za ek kontrola ekspresije na podjednaken efikaenoSdu. Tako je kariese da se edvoje specifične sekvence sn kodiranje se Kaljeni protein ed sjihovih sosednih nukleotidnih sekund i de se «cesto tega kondenzuju sa druge poznate sekvence se kontrola ekspresije teko de ee flevorisaju vili nlvei depresije.e functionals such sequences for the expression control of uniform efficacy. Thus, caries are that the only specific sequences are encoded. The tempered protein ed by their adjacent nucleotide seconds and is often condensed from other known sequences, control of expression is more often than not perfected by the villi of depression.

u plaze&d sa vedi* krojen kaplja lli derivat bakterlofnga u cilju povedanja breja kopija gena unutar delijo pa tako 1 daljeg peboljSe* vanje prinosa Keljeneg proteina.The plaza is also known to tailor a droplet or bacteriophage derivative for the purpose of breeding copies of genes within the gene, thereby further enhancing the yield of the Celiac protein.

MoSe ee koristiti nekoliko sekvenci sa kontrolu ekspresije kao Ste je spisane gore. Ove uključuju operator, prumctcr, sekvenca sn vauivaaje tikove*· 1 lntnrakelaee sekvence (uklječujudl sekvence kao Ste eu thine-Balgarae sekvence) laktosaog eperona E. coli (lac sistem), edgovarajude sekvence sistema eintetase trlptofana (trp sistem), glavne eperatocde 1 preeetemks ragione fega lamda kao Sto jo opišemo gora 1 β^Τχ) t kontrolni region Pilerantous DU faga ca jodacn niti« lli drage eekveaoe koje koatEoUSa ekspresiju gena prokariotaklh lli eukariotsklh delija 1 njihovih virusa. Sbog togaYou may use several expression control sequences as described above. These include operator, prumctcr, sn sequencing tic * * 1 lntnrakelaee sequences (including sequences such as Ste eu thine-Balgarae sequences) of E. coli lactose eperon (lac system), corresponding sequences of epthetase trlptophan eintetase (trpocode), major eperetoxet eperonet (trp system), ragione fega lamda as we describe worse 1 β ^ Τ χ ) t control region Pilerantous DU phage ca iodacn threads «lli dear eekveaoe that coatEoUSa expression of prokaryotic genes or eukaryotic cells 1 of their viruses. Because of that

- 82 ** za pefceljBavaaje proizvodnja odredjenog poHpeptlda « odgovarajuče« domačin«, mola — napraviti pan koji kodira oa taj polipeptid kao real Je i odvojiti ia rekombimantnog DMA molekula hlila njegevoj prve* bitooj sekvenci aa kontrol« ekspresije IH pod koatrolem jedne ili vile gornik aekvenei sa kontrol« ekspresije. Takvi postupci s« posneti u nauči.- 82 ** for pefceljIt is the production of a particular Hepptld "appropriate" host "mole - make a pan that encodes that polypeptide as real Is and to separate the recombinant DMA molecule for its first * bit sequence and to control the expression of IH under the control of one or the villa burner" aekvenei from controls «expression. Such procedures are «recorded in science.

Drugi postopal sa poboljčavanje efikassosti translacija uključuju «metaaje kemijski IH enziamtski napravljenih oligonukleotida ispred iniolrajučeg kodoma. Ovim postopkom so mole dobiti eptimalnlja strele» tora, primarna i sekundarna, msaindSer ISA. Speolfičnije, nekvsmea so takodje aeSe tako konstruisati da se iaiciraJudi AOG kodom javlja « lako (n.pr., koji mi jo maskiran sekundarnem strukturam) IH aa vrh« nsvojka IH o dragim repičnima sa jednom niti. Takodje srn poloBaj 1 sekvenca ranija sposNautog 8biao*Balpasno segmenta moča aa sličan način optiaisirati. inačaj generalne struktur« iomotavsnja) ansladfiar BMA j« bio dokumentov«» (D. Zenreataat sad 9 Ptmrs •čooondazp Struoturm Of sBSA And Effieieao? Of Translatlen Inltiation·, Osma, 9, 1*12 (1980).Other steps to improve translation efficiency include targeting chemically IH enzyme-made oligonucleotides in front of an iniolating codome. This procedure is intended to obtain the optimal lightning bolts, primary and secondary, msaindSer ISA. More speculatively, some are also constructed so that the AOG code appears easily (eg, masked by secondary structures) IH aa the tip of their IH about precious single-strand tails. Also deer position 1 sequence of the earlier 8biao * * Balpas power segment aa similar way to optiais. otherwise the general structures of «loom) ansladfiar BMA j« bio documents «» (D. Zenreataat sad 9 Ptmrs • chooondazp Struoturm Of sBSA And Effieieao? Of Translatlen Inltiation ·, Eighth, 9, 1 * 12 (1980).

Dalja povečevanja ČaHjakog prinosa Beljenih proizvoda savisa od povečanja breja pmna koji sa mogu koristiti u ČsHJl. Ovo so močo postičl «metanjem Huipp-beta pena (sa IH bas kontrolnih elemenata transkripcije i translaeije) u plasmid Čak sa večin brojem kopija IH u plasmid sa temperaturno koatroliaanin brojem kopija (t. j·, plasmid koji tako mutira da oo broj kopija plasmida povečava posla menjanja temperaturo, B« Oblin ot al«, Flasmlds Kitk Teaperature-depnmdu»t Cepy Steber Por Ampilfleat-en Qt domsd gamse And Tbeir Predmete·, čeme,Further increase in the yield of bleached bleach products than the increase in brena pmn that can be used in CsHJl. This power is achieved by throwing Huipp-beta foam (with IH bass transcription and translaeia controls) into the plasmid Even with most copies of IH into the plasmid with a temperature coatroliaanin copy number (i.e., a plasmid that mutates to oo the copy number of plasmids increase in the job of changing the temperature, B «Oblin ot al«, Flasmlds Kitk Teaperature-depnmdu »t Cepy Steber Por Ampilfleat-en Qt domsd gamse And Tbeir Subjects ·,

6, 91-106 (1979)) · Alternativno so povečanje done pome noBo pestiči*6, 91-106 (1979)) · Alternatively, the increase is done with no fists *

M primer, «metanjem rsfcomblnaBtaih OSA malokmlm hemsnru**»»*» ma način koji jo opisan ranijo u baktsriefagu laafeda, najproett js dlperovanjsm olamoite sa restzikaioiLim da aa dsbiva linearen molekul koji sa opat nafta aa nosačem sa kloniranje ograničenog faga lsabte (n.pr·* tipa koji ja opisan a l.E. Murray at al·, lafedald Pbagaa That Blnpllfp The Baaovaz? Of Za Vitro Reoonblaaats*, Mol· Caa, Canet. ISO, 53-61 (1977) i ».S. Marray at al·, Meleeular Clealng Of Λο DNA Ugaša Osne From Basterlepbage T4·, J· Hol.Blol« , 132, 493-505 (1979) pa aa rekombinantni OSA molekul proisvadi inkubaeijom sa OSA ligasom. taljeni rekomblasatnl fag as tada bira kao ranijo 1 kartati aa te Usogunlsuje saj domačina E, aali»M example, «by throwing rsfcomblnaBtaih OSA a small mlm hemsnru **» »*» in the manner described earlier in the bafsriefage of laafed, the most prolet js dlperovanjsm olamoite with restzikaioiLim that aa dsbiva a linear molecule which with the abbot of oil aa carrier with cloning. pr · * the type I described a lE Murray at al ·, lafedald Pbagaa That Blnpllfp The Baaovaz? of For Vitro Reoonblaaats *, Mol · Caa, Canet. ISO, 53-61 (1977) and ».S. Marray at al · , Meleeular Clealng Of DNAο DNA Quenches Osne From Basterlepbage T4 ·, J · Hol.Blol «, 132, 493-505 (1979) so aa recombinant OSA molecule incubates with OSA ligase. provided by Host E, aali »

Naročit» podesni nosači sa kloniranja lanbda sadri» temperaturne ooetljlva mataelju u represleaem genu oZ i impresivne mataelje u «emu pri temu ja ovaj proisvad neopkoten sa raskidanje telijo domačina, kae i gaa B, keji ja glavni sa psaisvadnja kapsidaag preteiaa virusa, te avlm sistemom lisogoae teli ja ae kaltivifta aa relativno alakej temperaturi (n.pr·, 28-32¾) i tada ae segrevajo aa viftaj toaparaturi (n«px 48—45°C) take te se ladukuje eečenje protega. FrodaSeai rast aa viftaj temperaturi vadi da visokih alvoa pralsveteje proteina, keji aa sadrftavi unutar telijo, poftto ova joft nisu raaklsete pomete ganskih prelivate tega na normalni način, a poftto iasert gena tega nije kapsaliran an ostaja prlstapačan sa dalja traaskripeiju. vefttačko raskidanje telijo tada oslobadja Soljeni preisvod a visokem prinaša. Bolto sna a ovoj prijavi mi takodje koristili lanbda raprasarski sistem sa kontrolu ekspresije, mofts biti nsepbadaa te ss kontralifte sečanje profaga pa taka 1 breja kopija gams pomote bstorainmssMkog komtrolneg ragieaa, n.pr·, isvedeaog is lambdaidnag tega 21.Particularly "suitable carriers from the cloning of the lanbda contain" temperature oetljlva parent in the repre- sented gene oZ and impressive mothers in this, though this one is untouched by breaking the calf of the host, says gaa B, who is the chief of the psychedelic capsid virus system, lisogoae calvate the caltivift aa relatively low temperature (eg, 28-32¾) and then heat it and lift the apparatus (n «px 48-45 ° C) so that the leakage of the stretch occurs. FrodaSea growth and a high temperature make the high alvoys flush with proteins, which are contained within the calf, since this joft is not a slight sweep of the Ghanaian spillovers, and the poftto iasert gene is not encapsulated and remains trapped by further traaskripe. then breaking up the calf then frees Salt production and brings high. Bolto dream and this report also used me lanbda raprasar system with expression control, mofts be nsepbadaa and ss contralifte cutting of the prophagus, so 1 brea copy of gams help bstorainmssMkog komtrolnogo ragieaa, n.pr ·, derived from the lambdaidnag of 21.

Treba te ja jasno te sa polipeptidi keji iapaljavaju ZFB-bata aktivnost (napravijeni prema ovom pronalaska) naga napraviti a oblika kondsnsavansg proteina (n«pr·, epejenog sa prokarlotskl M-tarsčanlni segment keji namerava islačibanje) iii a oblika prointerteraaa (n.pr..You should clearly and with the polypeptide moieties ignite the ZFB-bat activity (made according to the present invention) to make a form of a condensing protein (n «pr · epeed with a procarlot M-tarschannel segment intends to leach out) or a form of a prointerteraa (e.g. ..

polasečl od signalne sekvence Interferona koja oa aoSo ruklautl posl« lzluSivuja) 1X1 kao srell Interferon (poslednji jo eatvurljlv zato Sto zreli fibroblastni interferon poleži aa netlulnem, aadnoklmllnom koja a« koristi sa nlnlolruje translacije). Prinos ovih različitih oblika polipeptida mola sa poboljiati mako jam od kombinacija postupaka koji su diskutovani goro. Takodje se koriste rasličlti kodonl sa lato ill sve kodone koji se korist« u sadainjim DNA sekvencama koji se mogu i samuiti, Ovi supstituisanl kodonl mogu kodirati sa udnakiseHne Identične sa onima koje su kodirane zamenjanim kodoalma ali je rezultat vlil prinos polipeptida. Alternativno« šamana jednog 111 kombinacije kodona koja vodi do šamana amlnoklsellne ill do HulTR-betasrodnog polipeptida duieg 111 kradeg nlsa mol· promsnltl njegovo osobine na koristna način (n.pr·, povečanje stabilnosti, povodu je rastvorljlvostl, povečuje utlvlrusno aktivnosti, povečuje 2,5-A slatatasne aktivnosti 111 povečuje Intervala speelfienostl za padjenta}departed from the interferon signal sequence which oa aoooo handled the sentinel) 1X1 as the happy Interferon (the latter being eaten as a mature fibroblast interferon lays aa non-null, aadoclonal that a «uses with nlnlolrul translation). The yield of these various forms of the mole polypeptide with improved mako yam from the combinations of methods discussed in detail. Various codonl with lato or all codons are also used which are used in self-contained DNA sequences. These substituted codonl can be encoded with a gene identical to those encoded by the substituted codoalma but result in a polypeptide yield. Alternatively «a shaman of one 111 combination of codons leading to a shaman of amlnoklsellne ill to a HulTR-betaase-like polypeptide of duieg 111 stealing nlsa mol · promsnltl its properties in a useful way (e.g., increase in stability, cause solubility, increase 2 activity, increase in activity, increase 5-A Sweet Activity 111 Increases Interval Speelfienostl for Fallen}

Kona&ao, aktivnost polipeptida proizvedenih tekerablnantnia DNA molekullma ls ovog pronalaska mola se poboljiati fragmutlrujen, nodifi) oljem 111 detlvatlzaeijom SNA sekvenci polipeptida Is ovog pronalaska u dobro poznate načine, bet otstupuja od oblam pronaluka«Finally, the activity of the polypeptides of the tekerablantine DNA molecule produced by the present invention is supposed to be enhanced by fragmented, nodifiable 111 SNA sequences of the polypeptides of the present invention, in well-known ways, departing from the scope of the invention "

Solekd ju hibridnog faga Isvedenog ls fragmenata ljudske ae DMA koja jo bila generlsana paroljalnlm rasklduje» sa gasili i Alul« 1 spojena sa gcoRIvetlvne elemente i za Lambda Charoa krake napravio je R. M. Lava ot al.. Celi, 15, pp. 1157-74 (1975). Ova banka gena je testirana pomoču *ln situ* postupka (W«D. Butu and R.W. Beda, gcienoe, 196, pp. 189-82 (1977); T. Mulati* et al·, Celi, 15, pp. <17701 (1978)); kerlldujem kao sonde ^^P-marfcirane ZTN-beta eDBA «motka ~ 85 iseČsnsg pemoča Tao-BgHI restrikcije la pHPIP-21.· dodan klen fega pecltlvan na hibridisaeljB oo tselaje 1« 000,908 ploSlea ponovljenim prečiščevanje pločioe (T. Manietie at al», fara)· Ova pločica ja označena laabda£H4A-gH2TP-l. Beetrikcicna aaallaa ove ploSioa dezvonetrimla ja da «na aadrli oko 16.3 Xb ljudska DHA.The solecd of the hybrid phage Derived from the fragments of human ae DMA that had yet been generated parojalnlm breaks "with fireflies and Alul" 1 fused with gcoRIvetlvne elements and for the Lambda Charoa arms was made by R. M. Lava ot al .. Celi, 15, pp. 1157-74 (1975). This gene bank was tested using the * ln situ * procedure (W «D. Butu and RW Beda, gcienoe, 196, pp. 189-82 (1977); T. Mulati * et al ·, Celi, 15, pp. <17701 (1978)); kerlld as probes ^^ P-marfcated ZTN-beta eDBA «pole ~ 85 iseSsgg of tao-BgHI restriction la pHPIP-21. · added maple fega pecltlvan to hybridiselB oo tselae 1« 000,908 ploSlea by repeated purification of plate at (al. Maniet , fara) · This tile is labeled laabda £ H4A-gH2TP-l. The beetriccic aaallaa of this plot devolved I «on aadrla about 16.3 Xb human DHA.

BooBI digestije laAdaCl4A-g8FIF**l ge&erisala ja, pored dva Cbaren <A kraka faga, osa» insertaih fragmenata — 4.6, 3.5, 2.4, 1.9, 1.3, 1.2, 0,1 l 0.6 Kb po dat tal · Posla Southern bletting, aamo je 1.9 Kb fragment hibrldisevao u TwBglIX fragment pBFIP-21.BooBI digestion laAdaCl4A-g8FIF ** l ge & erised, in addition to two Cbaren <A phage arms, axis »inserta fragments - 4.6, 3.5, 2.4, 1.9, 1.3, 1.2, 0,1 l 0.6 Kb per dat tal · Jobs Southern bletting. aamo 1.9 Kb fragment was hybridized to TwBglIX fragment pBFIP-21.

1.9 Xb fragment jo rekloniran direktno n BCOWI mesto pBR322 (derivat pBH322 koji takodje nosi rezistentaoet na hleramfeaikol koji aadrli jedno BcoRI mesto). Posle ligeelje 0.6 ^ug BooM-digerovane lambdaCB4A-gHFIP-l DHA na 100 ng pHK32$ 1 tmaeformnelje n B, celil BB101, isabrane jo nekoliko klona. Sano oni kloni koji sadrše 1.9 Kb fragment hlbrldlzuju a ZPHHbotn oDHA eendu. Ovaj klon jo osnafien p(32S)~gHFXPM.The 1.9 Xb fragment is still directly promoted to the BCOWI site of pBR322 (a pBH322 derivative that also carries a chloramfeaicol resistance that adheres to one BcoRI site). After Ligella 0.6 ^ ug BooM-digested lambdaCB4A-gHFIP-l DHA at 100 ng pHK32 $ 1 tmaeformnelje n B, healed BB101, and several clones were selected. Sano those clones containing a 1.9 Kb fragment hlbrldlz a ZPHHbotn oDHA eendu. This clone is still strong p (32S) ~ gHFXPM.

Oporedjlvanje reetrikdoneg fragmenta ISbedsnog is pBPIP-21 i p(325)-gHFZF-4 demonstriralo je da nama ometajučlh sekvenci a bremosenr nom klona i da jo informacija koja aosi DBA tog klona identična aa enem is pBPXF~21.Determination of the reetricdone fragment of ISbeds with pBPIP-21 and p (325) -gHFZF-4 demonstrated that the interfering sequences of a clone were burdened, and that the information contained in the DBA of that clone was identical with that of pBPXF ~ 21.

Identifikacija 1 izolovanje hrcoosomao CHA koja kodira sa BuIFH-beta omogučuje trasnfozmaelju odgovarajučih domačina sa ton DHA i ekspresija HuIFB-beta is njo. Takva ekspresija jo počasna zato Sto d« rasni signali koji praks hrane romne DHA sekvence biti prisutni a takvis klenima. Ovi signali če biti pristupaSni da aktiviraju vile princes posle ekspresi jo i moida prerode postekopresljom polipeptida koji jo kodira regicnom sa kodiranja hzamoseme DHA.Identification 1 Isolation of the hrcoosomao CHA encoding with BuIFH-beta enables the transpositor of the respective hosts with the tone of DHA and the expression of HuIFB-beta and with it. Such expression is still honorable because there are racial signals that feed the practices of the DHA sequences to be present and to the clans. These signals will be accessible to activate the princess fairies after expressing and reborn moids by postexpressing a polypeptide that encodes it by regis- ting from the DHA chromosome encoding.

• Plasaid pHVZP-21 jo ldeatiflkevan jo poetskem testira ja is ovog preaalaeka.Tasl-BglZI fragment tog plassdda sadrši skoro tfcupan Botram* alatirsni FtagtaS i «SP» rogien kodiranja sa nt nat * 8€• Plasaid pHVZP-21 is further tested poetically by me from this compilation.Tasl-BglZI fragment of this plassdd contains almost tfcupent Botram * tooling FtagtaS and «SP» rogien encodings with nt nat * 8 €

Mikroorganizmi i rekeabiaamtnl DMA molekuli w^rwl jeni postopkom koji jo ovde opisan represeatuju kultur« koja su dsponomao u kolekciji kultura Deutsche Saamlung ven Mikroorganisn u Gatingenu, Sapadna Nemafika 2 aprila, 1980, i identlflkovani su sa HHF-A de C»Microorganisms and rekeabiaamtnl DMA molecules w ^ rwl by a process described here still represent the cultures "that were disseminated in the Deutsche Saamlung ven Microorganism Collection in Gatingen, Western Germany, April 2, 1980, and identified with HHF-A de C"

At Σ, COll »101 (G-pBR322{Pet)/HITP3)At Σ, COll »101 (G-pBR322 {Five) / HITP3)

At E, coli »181 (O-pBR322(Pet)/HnF6)At E, coli »181 (O-pBR322 (Five) / HnF6)

C« °°U 33101 (β-pB A322 (>S t)/HFIT7)C «°° U 33101 (β-pB A322 (> S t) / HFIT7)

Ove kultura su dobila pristopne brojeva BSM 1791—1793. Takodje su ilustrovaai kulturama koja au depoaovnae u koleslji kultura DeutscheThese cultures were given accession numbers BSM 1791-1793. They are also illustrations of cultures that are depopulated by the Deutsche culture wheel

1988, 1 idontifikovani kao HFIF-D da β1988, 1 identified as HFIF-D that β

Dt *« ββ** «5219 (<hpPAa*aPXP-<7*12)Dt * «ββ **« 5219 (<hpPAa * aPXP- <7 * 12)

B» B» OOli Xl2deltaSX (8«φΚ4ΗΤΣΜ7-12)B »B» OOli Xl2deltaSX (8 «φΚ4ΗΤΣΜ7-12)

Tt S&JSM 115219 <G^1*-fflW-«7-12deltal9)Tt S & JSM 115219 <G ^ 1 * -fflW- «7- 1 2deltal9)

C. B, OOll Χ5219 (ΟρΡΙο-ΗΚΡ-67-8)C. B, OOll Χ5219 (ΟρΡΙο-ΗΚΡ-67-8)

Ovo kulturo au dobilo pristopna brojeve DSN 1851-1854· X kultura koja au depenovaae u America T^pe Culture Collection, Bokvil, Merllead 28 februar«, 1981, identlflkovane au kaotThis au culture received accession numbers DSN 1851-1854 · X culture that was deposited in America T ^ pe Culture Collection, Bokville, Merllead February 28, 1981, identified as chaot

B> B, 0011X5219 <pK*-HriF-€7-12delfcaXI)B> B, 0011X5219 <pK * -HriF- € 7-12delfcaXI)

x. g> ooli »181 (p<325)-bayiF-4)x. g> ooli »181 (p <325) -bayiF-4)

Ovo kulturo debila su pristopno brojeva ATCC 3/824 1 3/825.This trunk culture is accession numbers ATCC 3/824 1 3/825.

Kada jo ovde prikazan vadi broj realizacija ia pronalaska, jamo jo da m sala osnovna konstrukcija ude prameni tl tako da se ebezbede druga realizacij« koja koriste postopke i preparate la ovog pronalaaka. Cbog toga, bide jasno da obim ovog pronalaska jesta definiaan pridodanim ftahtevima a aa spoelflSalm raulizaui jama koje cu ovde date radi primera.When the number of embodiments and inventions disclosed herein is taken into account, the small basic structure will further erode the strands of the invention so as to provide other embodiments using the methods and preparations of the invention. For that matter, it will be clear that the scope of the present invention is defined by the attached requirements and aa spoelflSalm raulizaui pits which I will give here by way of example.

Claims (15)

PATENTNI ZAHTEVIPATENT REQUIREMENTS 1. Postupak za dobijanje rekombinantnog molekula DNK sposobnog da u jednočelijskom domačinu indukuje ekspresiju polipeptida koji ispoljava imunološko iii biološko dejstvo humanog β-interferona, naznačen time, što se u nosač za kloniranje uvodi sekvenca DNK odabrana od inserata DNK G-pPLa-HFIF-67-12 [HincII-Sau3AIj, G-pPLa-HFIF-67-12A19 [HincII-Sau3AIj i G-pPLc-HFIF-67-8 [HincII-Sau3AIj, nošenih u mikroorganizmima koji imaju pristupne brojeve od DSM 1851 do DSM 1854, od sekvenci DNK koje hibridizuju sa bilo kojirn od navedenih inserata DNK i od sekvenci DNK koje su degenerisane kao rezultat genetskog koda, ali koje kodiraju za polipeptid sa istom aminokiselinskom sekvencom kao i navedeni inserti i sekvence DNK; pri čemu je sekvenca DNK u navedenom rekombinantnom molekulu DNK operativno vezana za sekvencu za kontrolu ekspresije.1. A method for producing a recombinant DNA molecule capable of inducing in a single-cell host the expression of a polypeptide exhibiting the immunological or biological effect of human β-interferon, characterized in that a DNA sequence selected from the DNA insert G-pPLa-HFIF-67 is introduced into the cloning carrier -12 [HincII-Sau3AIj, G-pPLa-HFIF-67-12A19 [HincII-Sau3AIj and G-pPLc-HFIF-67-8 [HincII-Sau3AIj, carried in microorganisms having access numbers DSM 1851 to DSM 1854, from DNA sequences that hybridize to any of said DNA inserts and DNA sequences that have degenerated as a result of a genetic code but encode for a polypeptide with the same amino acid sequence as said DNA inserts and sequences; wherein the DNA sequence in said recombinant DNA molecule is operatively linked to the expression control sequence. 2. Postupak prema zahtevu 1, naznačen tine, što sekvenca DNK koja hibridizuje sa navedenim insertima DNK predstavlja insert DNK G-pPLa-HFIF67-12ΔΜ1 [BamHI-Sau3AIj, nošen u mikroorganizmu sa pristupnim brojem ATCC 31824.The method of claim 1, characterized in that the DNA sequence that hybridizes with said DNA inserts is a DNA insert of G-pPLa-HFIF67-12ΔΜ1 [BamHI-Sau3AIj, carried in a microorganism with ATCC accession number 31824. 3. Postupak prema zahtevu 1, naznačen tine, što sekvenca DNK koja hibridizuje sa navedenim insertima DNK predstavlja insert DNK p[325l-gHFIF-4 [EcoRlj nošen u mikroorganizmu sa pristupnim brojem ATCC 31825.The method of claim 1, characterized in that the DNA sequence that hybridizes to said DNA inserts is a DNA insert of p [325l-gHFIF-4 [EcoRl carried in a microorganism with ATCC accession number 31825. 4. Postupak prema bilo kojem od zahteva 1 do 3, naznačen tine, što je sekvenca DNK odabrana medu sekvencama formula:A method according to any one of claims 1 to 3, characterized in that the DNA sequence is selected from the sequences of the formulas: atgaccaacaagtgtctcctccaaattgctctcctgttgtgcttctccactacagatgaccaacaagtgtctcctccaaattgctctcctgttgtgcttctccactacag CTCTTTCCATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGCAATTTTCACTCTTTCCATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGCAATTTTCA GTGTGAGAAGČTCCTGTGGCAATTGAATGGGAGGCTTGAATACTGCCTCAAGCACGTGTGAGAAGČTCCTGTGGCAATTGAATGGGAGGCTTGAATACTGCCTCAAGCAC AGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGTTCCAGAAGGAGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGTTCCAGAAGG AGGAOGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGCTATTTTCAGAGGAOGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGCTATTTTCAG ACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAACCTCCTGGCTACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAACCTCCTGGCT AATGTCTATCATCAGATAAACCATCTGAAGACAGTCCTGGAAGAAAAACTGGAGAAATGTCTATCATCAGATAAACCATCTGAAGACAGTCCTGGAAGAAAAACTGGAGA AAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAAAAGATATTA tgggaggattctgcattacctgaaggccaaggagtacagtcactgtgcctggaccAAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAAAAGATATTA tgggaggattctgcattacctgaaggccaaggagtacagtcactgtgcctggacc ATAGTCAGAGTGGAAATCCTAAGGAACTTTTACTTCATTAACAGACTTACAGGTTATAGTCAGAGTGGAAATCCTAAGGAACTTTTACTTCATTAACAGACTTACAGGTT ACCTCČGAAACACCTCЧGAAAC - ZAHTEVI/2 i ATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAG caattttcagtgtcagaagctcctgtggcaattgaatgggaggcttgaatactgc ctcaagcacaggatgaactttgacatccctgaggagattaagcagctgcagcagt tccagaaggaggacgccgcattgaccatctatgagatgctccagaacatctttgc tattttcagacaagattcatctagcactggctggaatgagactattgttgagaac ctcctggctaatgtctatcatcagataaaccatctgaagacagtcctggaagaaa aactggagaaagaagatttcaccaggggaaaactcatgagcagtctgcacctgaa aagatattatgggaggattctgcattacctgaaggccaaggagtacagtcactgt gcctggaccatagtcagagtggaaatcctaaggaacttttacttcattaacagac ttacaggttacctccgaaac.- Request / 2 i ATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAG caattttcagtgtcagaagctcctgtggcaattgaatgggaggcttgaatactgc ctcaagcacaggatgaactttgacatccctgaggagattaagcagctgcagcagt tccagaaggaggacgccgcattgaccatctatgagatgctccagaacatctttgc tattttcagacaagattcatctagcactggctggaatgagactattgttgagaac ctcctggctaatgtctatcatcagataaaccatctgaagacagtcctggaagaaa aactggagaaagaagatttcaccaggggaaaactcatgagcagtctgcacctgaa aagatattatgggaggattctgcattacctgaaggccaaggagtacagtcactgt gcctggaccatagtcagagtggaaatcctaaggaacttttacttcattaacagac ttacaggttacctccgaaac. 5. Postupak prema bilo kojem od zahteva 1 do 4, naznačen tiae, što je navedena sekvenca za kontrolu ekspresije odabrana od sistema lac, sistema5. The method of any one of claims 1 to 4, characterized by tiae, which is said expression control sequence selected from lac system, system 8-lac, sistema trp, glavnog operatorskog i promotorskog regiona faga λ, kontrolnog regiona ovojnog proteina fd i drugih sekvenci koje kontrolišu ekspresiju gena prokariotskih i li eukariotskih čelija i njihovih virusa, pri čemu se sekvenca za kontrolu ekspresije uvodi u nosač za kloniranje kako bi kontrolisala i regulisala ekspresiju sekvence DNK.8-lac, the trp system, the major operator and promoter region of phage λ, the control region of the fd envelope protein and other sequences that control the expression of genes of prokaryotic and eukaryotic cells and their viruses, wherein the expression control sequence is introduced into a cloning carrier to controlled and regulated expression of the DNA sequence. 6. Postupak prema zahtevu 5, naznačen time, Što se proizvedeni rekombinantni molekul DNK hira od G-pPLa-HFIF-67-12, G-pPLa-HFIF-67-12A19 i G-pPLaHFIF-67-8, pri čemu su navedeni rekombinantni molekuli DNK nošeni u mikroorganizmima sa pristupnim brojevima DSM 1851 do DSM 1854.6. The method of claim 5, wherein the recombinant chiral DNA molecule produced is G-pPLa-HFIF-67-12, G-pPLa-HFIF-67-12A19 and G-pPLaHFIF-67-8, wherein recombinant DNA molecules carried in microorganisms with accession numbers DSM 1851 to DSM 1854. 7. Postupak prema zahtevu 5, naznačen time, što je proizvedeni rekombinantni molekul DNK G-pPLa-HFIF-67-12AMl, nošen u mikrorganizmu sa pristupnim brojem ATCC 31824.The method of claim 5, wherein the recombinant DNA molecule produced is G-pPLa-HFIF-67-12AMl, carried in a microorganism with ATCC accession number 31824. 8. Postupak za transformisanje jednočelijskog domačina, naznačen time, što se u njega uvodi rekombinantni molekul DNK proizveden postupkom iz bilo kojeg od zahteva 1 do 7.A method for transforming a single-celled host by introducing into it a recombinant DNA molecule produced by the method of any one of claims 1 to 7. 9. Postupak za dobijanje polipeptida koji ispoljava imunološko iii biološko dejstvo humanog β-interferona, naznačen time, što se gaji transformisani domačin proizveden postupkom prema zahtevu 8.A method for producing a polypeptide that exhibits the immunological or biological action of human β-interferon, characterized in that it is grown by a transformed host produced by the method of claim 8. - ZAHTEVI/3- REQUIREMENTS / 3 10. Postupak prema zahtevu 9, naznačen time, što je transformisani domačin odabran od E.coli HB101 iii E.coli Κ12ΔΗΙ (G-pPLa-HFIF-67-12) [DSM 1851, DSM 1852] , E.coli M5219 (G-pPLa-HFIF-67-1219) [DSM 1853] i E.coli M5219 (G-pPLa-HFIF-67-8) [DSM 1854].10. The method of claim 9, wherein the transformed host is selected from E. coli HB101 or E. coli Κ12ΔΗΙ (G-pPLa-HFIF-67-12) [DSM 1851, DSM 1852], E. coli M5219 (G -pPLa-HFIF-67-1219) [DSM 1853] and E. coli M5219 (G-pPLa-HFIF-67-8) [DSM 1854]. 11. Postupak prema zahtevu 9, naznačen time, što je transformisani domačin11. The method of claim 9, wherein the transformed host is E.coli M5219 (G-pPLa-HFIF-67-12AMl) [ATCC 31824].E. coli M5219 (G-pPLa-HFIF-67-12AMl) [ATCC 31824]. 12. Postupak prema bilo kojem od zahteva 9 do 11, naznačen time, što je polipeptid odabran od polipeptida formula:A method according to any one of claims 9 to 11, wherein the polypeptide is selected from the polypeptide of the formula: Met-Thr-Aen-LyB-Cys-Leu-Leu-Gln-Ile-Ala-LeU’Iieu-LeuCys-Phe-Ser-Thr-Thr-Ala-Leu-Ser-Met-Ser-Tyr-Asn-LeuLeu-Gly-Phe-Leu-Gln-Arg-Ser-ser-ABn’-Phe“Gln“Cya-GlnLys-Leu-Leu-Trp-Gln-Leu-Asn-Gly-Arg-Leu-GlU“Tyr-CysLeu-Lye‘-Aep-Arg-Met-Asn-Phe-Asp-lle-Pro-GlU“Glu-IleLys-Gln-teu*-Gln-Gln-Phe-Gln-Lys-Glu-Asp-Ala~Ala-LeuThr-Ile-Tyr“Glu-Mat-Leu-Gln-ABn-Ile-Phe-Ala-Ile-PheArg-Gln-Asp-Ser-Ser-Ser-Thr-Gly“Trp-Asn-Glu-Thr-Ile~Met-Thr-Aen-LyB-Cys-Leu-Leu-Gln-Ile-Ala-LeU'Iieu-LeuCys-Phe-Ser-Thr-Thr-Ala-Leu-Ser-Met-Ser-Tyr-Asn-LeuLeu- Gly-Phe-Leu-Gln-Arg-Ser-ser-ABn'-Phe “Gln” Cya-GlnLys-Leu-Leu-Trp-Gln-Leu-Asn-Gly-Arg-Leu-GlU Tyr-CysLeu-Lye '-Aep-Arg-Met-Asn-Phe-Asp-lle-Pro-GlU' Glu-IleLys-Gln-teu * -Gln-Gln-Phe-Gln-Lys-Glu-Asp-Ala ~ Ala-LeuThr-Ile -Tyr "Glu-Mat-Leu-Gln-ABn-Ile-Phe-Ala-Ile-PheArg-Gln-Asp-Ser-Ser-Ser-Thr-Gly" Trp-Asn-Glu-Thr-Ile ~ Val-Glu-Aen-Leu-Leu-Ala-Asn-Val-I^r-His-Gln-Ile-AsnHis-Leu-Lys-Thr-Val-LeU“Glu-Glu-Lys-Leu-Glu-Lys-GlU“Val-Glu-Aen-Leu-Leu-Ala-Asn-Val-I ^ r-His-Gln-Ile-AsnHis-Leu-Lys-Thr-Val-LeU “Glu-Glu-Lys-Leu-Glu-Lys- GlU " Asp-Phe-Thr-Arg-Gly-Lys-Leu-Met-Ser-Ser-Leu-His-Leu~Asp-Phe-Thr-Arg-Gly-Lys-Leu-Met-Ser-Ser-Leu-His-Leu ~ Lys-Arg-Tyr-Tyr-Gly-Arg-ile-Leu-His-Tyr-Leu-Ly9-AlaLys-Glu-Tyr-Ser-His-Cys*-Ala“Trp-Thr-Ile-Val-Arg-ValGlu-Ile-Leu-Arg-Asn-Phe-Tyr-Phe*-Ile-Asn-Arg-LeU“ThrGly-Tyr-Leu-Arg-Asn i Met-Ser-Tyr-Aan*-Leu-Leu-GlyPhe-Leu-Gln-Arg“Ser-Ser-Asn-Phe-Gln-Cys-Gln-Lys-LeuLeu-Trp-Gln-Leu-Asn-Gly-Arg-Leu~Glu-Tyr-Cys-lieu-LysAsp-Arg-Met-Asn“Phe~AsO-lle-Pro-Gli:-Glu-Ils-Lys-GlnLeU“Gln-Gln-Phe-Gln*-Lys-Glu-Asp-Ala-Ala-Leu-Tnr-IleTyr-Glu-Met-Leu-Gln-Asn-Ile-Phe-Ala-Ile-Phe-Arg-GlnAsp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr-Ile-Val-GluAsn-Leu-Lleu-Ala-Asn-Val-Tyr“His-Gln-Ile-Aen-His-LeuLys-Thr-Vhl'-Leu-Glu-Glu-LyS“Leu-Glu-Lys-Glu-Asp-PheThr-Arg-GXy-Lys-Leu-Met-Ser-Ser-Leu-His-Leu-Lye-ArgTyr-Tyr-Gly-Arg-Ile-Leu-His-Tyr-Leu-Lys-’Ala“Lys-GluTyr-Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arg-Val-Glu-IleLeu-Arg-Aen-:Phe-Tyr-Phe-lle-Asn-Arg-Leu-'Thr“Gly-TyrLeu-Arg-Aen.Lys-Arg-Tyr-Tyr-Gly-Arg-ile-Leu-His-Tyr-Leu-Ly9-AlaLys-Glu-Tyr-Ser-His-Cys * -Ala Trp-Thr-Ile-Val-Arg-ValGlu -Ile-Leu-Arg-Asn-Phe-Tyr-Phe * -Ile-Asn-Arg-LeU “ThrGly-Tyr-Leu-Arg-Asn and Met-Ser-Tyr-Aan * -Leu-Leu-GlyPhe-Leu -Gln-Arg “Ser-Ser-Asn-Phe-Gln-Cys-Gln-Lys-LeuLeu-Trp-Gln-Leu-Asn-Gly-Arg-Leu ~ Glu-Tyr-Cys-lieu-LysAsp-Arg-Met -Asn “Phe ~ AsO-lle-Pro-Gli: -Glu-Ils-Lys-GlnLeU“ Gln-Gln-Phe-Gln * -Lys-Glu-Asp-Ala-Ala-Leu-Tnr-IleTyr-Glu-Met -Leu-Gln-Asn-Ile-Phe-Ala-Ile-Phe-Arg-GlnAsp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr-Ile-Val-GluAsn-Leu-Lleu-Ala -Asn-Val-Tyr "His-Gln-Ile-Aen-His-LeuLys-Thr-Vhl'-Leu-Glu-Glu-LyS" Leu-Glu-Lys-Glu-Asp-PheThr-Arg-GXy-Lys- Leu-Met-Ser-Ser-Leu-His-Leu-Lye-ArgTyr-Tyr-Gly-Arg-Ile-Leu-His-Tyr-Leu-Lys-'Ala Lys-GluTyr-Ser-His-Cys-Ala -Trp-Thr-Ile-Val-Arg-Val-Glu-IleLeu-Arg-Aen-: Phe-Tyr-Phe-lle-Asn-Arg-Leu-'Thr “Gly-TyrLeu-Arg-Aen. - ZAHTEVI/4- REQUIREMENTS / 4 13. Postupak za dobijanje polipeptida koji ispoljava imunološko iii biološko dejstvo humanog β-interferona, naznačen tine, što se gaji jednočelijski domačin transformisan sekvencom DNK odabranom od sekvenci formula:13. A process for producing a polypeptide that exhibits the immunological or biological action of human β-interferon, characterized in that it is grown by a single-cell host transformed with a DNA sequence selected from the sequences of the formulas: ATGACCAACAAGTGTCTCCTCCAAATTGCTCTCCTGTTGTGCTTCTCCACTACAGATGACCAACAAGTGTCTCCTCCAAATTGCTCTCCTGTTGTGCTTCTCCACTACAG CTCTTTCCATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGCAATTTTCA gtgtcagaagctcctgtggcaattgaatgggaggcttgaatactgcctcaagcacCTCTTTCCATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGCAATTTTCA gtgtcagaagctcctgtggcaattgaatgggaggcttgaatactgcctcaagcac AGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGTTCCAGAAGGAGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGTTCCAGAAGG AGGACGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGCTATTTTCAGAGGACGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGCTATTTTCAG ACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAACCTCCTGGCT aatgtctatcatcagataaaccatctgaagacagtcctggaagaaaaactggagaACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAACCTCCTGGCT aatgtctatcatcagataaaccatctgaagacagtcctggaagaaaaactggaga AAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAAAAGATATTAAAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAAAAGATATTA TGGGAGGATTCTGCATTACCTGAAGGCCAAGGAGTACAGTCACTGTGCCTGGACCTGGGAGGATTCTGCATTACCTGAAGGCCAAGGAGTACAGTCACTGTGCCTGGACC ATAGTCAGAGTGGAAATCCTAAGGAACTTTTACTTCATTAACAGACTTACAGGTTATAGTCAGAGTGGAAATCCTAAGGAACTTTTACTTCATTAACAGACTTACAGGTT ACCTCCGAAAC i ATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAGACCTCCGAAAC and ATGAGCTACAACTTGCTTGGATTCCTACAAAGAAGCAG CAATTTTCAGTGTCAGAAGCTCCTGTGGCAATTGAATGGGAGGCTTGAATACTGC CTCAAGCACAGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGT TCCAGAAGGAGGACGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGC TATTTTCAGACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAAC CTCCTGGCTAATGTCTATCATCAGATAAACCATCTGAAGACAGTCCTGGAAGAAA AACTGGAGAAAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAA aagatattatgggaggattctgcattacctgaaggcoaaggagtacagtcactgt gcctggaccatagtcagagtggaaatcctaac-gaacttttacttcattaacagac ttacaggttacctccgaaac, pri čemu je sekvenca DNK operativno vezana za sekvencu za kontrolu ekspresije u navedenom jednočelijskom domačinu.CAATTTTCAGTGTCAGAAGCTCCTGTGGCAATTGAATGGGAGGCTTGAATACTGC CTCAAGCACAGGATGAACTTTGACATCCCTGAGGAGATTAAGCAGCTGCAGCAGT TCCAGAAGGAGGACGCCGCATTGACCATCTATGAGATGCTCCAGAACATCTTTGC TATTTTCAGACAAGATTCATCTAGCACTGGCTGGAATGAGACTATTGTTGAGAAC CTCCTGGCTAATGTCTATCATCAGATAAACCATCTGAAGACAGTCCTGGAAGAAA AACTGGAGAAAGAAGATTTCACCAGGGGAAAACTCATGAGCAGTCTGCACCTGAA aagatattatgggaggattctgcattacctgaaggcoaaggagtacagtcactgt gcctggaccatagtcagagtggaaatcctaac-gaacttttacttcattaacagac ttacaggttacctccgaaac, in what is a DNA sequence operably linked to sekvencu for kontrolu expression in navedenom jednočelijskom local man. 14. Postupak prema zahtevu 13, naznačen time, što je navedeni polipeptid, koji ispoljava imunološko iii biološko dejstvo humanog β-interferona, odabran od polipeptida formula:14. The method of claim 13, wherein said polypeptide exhibiting the immune or biological action of human β-interferon is selected from the polypeptide of the formula: Mat-Thr-Asn-Lye'Cys-Leu-Leu-Gln-Ile-Ala*-Leii-Leu-LeuCys-Phe-Ser-Thr-Thr-Ala-Leu-Ser-Met-Ser-Tyr-Asn-LeuLeu-Glv-CPhe-Leu-Gln-Arg-Ser-Ser-Asn-Phe-Gln-Cva-GlnLys-Leu“keu-Trp-Gln-LeU“Asn-Gl.y-Arg-Leu“Glu-Tyr“CysLeu-Lys-Asp-Arg*-Met-Asn-Phe-Asp-Ile-Pro-Glu-Glu-IleLyB-Gln-Leu-Gln-Gln-Phe-Gln-Lys-Glu-Aap-Ala‘-Ala-Leu’Thr-Ile-!Tyr-Glu-Met-Leu-Gln-Asn-Ile-Phe-Ala-lle-Phe- ZAHTEVI/5 Arg-Gln-Asp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr-IleVal-Glu-Asn-Leu-Leu-Ala-Asn-Val-l^r-Hia-Gln-lle-AsnHis-Leu-t/ye-Thr-Val-Leu-Glu-GlU“Lys-Leu-Glu-Lys“GluAsp-Phe-Thr-Arg~Gly-Lys-Leu-Met-Ser-Ser-Leu-His-LeuLys-Arg-Tyr-Tyr-Gly-Arg-Ile-Leu-His-Tyr-L&u-Lys-AlaLy6-Glu-Tyr-Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arcj-Val“ Glu-Ile-Leu-Arg-Asn-Phe-Tyr-Phe-'Ile-Asn-Arg-Leu-ThrGly-Tyr-teu-Arg-Asn i Met-Ser-Tyr-Asn-Leu-Leu-GlyPhe-Leu-Gln-Arg-Ser-Ser-Asn~Phe-Gln-Cys-Gln-Lys-LeuLeu-Trp-Gln-Leu“Asn-Gly-Arg-Leu-Glu-Tyr-Cys-Leu-LyeAsp-Arg-Met-Asn-Phe-Asp-Ile-Pro-Glu-Glu-Ile-Lys-GlnLeu-Gln-Gln-Phe-Gln-Lys-Glu-Asp-Ala-Ala-Leu--Thr-IleTyr-Glu-Met-Leu-Gln“Asn“Xle-Phe-Ala-Ile-Phe-Arg-GlhAsp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr-Ile-Val“GluAsn-Leu-Iieu~Ala-Asn-Val-Tyr-His-Gln“lle-Asn“His-LeuLys-Thr“Val-Leu-Glu-Glu-Lys-Leu-Glu-Lye-Glu-Asp-Phe·*Mat-Thr-Asn-Lye'Cys-Leu-Leu-Gln-Ile-Ala * -Leii-Leu-LeuCys-Phe-Ser-Thr-Thr-Ala-Leu-Ser-Met-Ser-Tyr-Asn-LeuLeu -Glv-CPhe-Leu-Gln-Arg-Ser-Ser-Asn-Phe-Gln-Cva-GlnLys-Leu "keu-Trp-Gln-LeU" Asn-Gl.y-Arg-Leu "Glu-Tyr" CysLeu -Lys-Asp-Arg * -Met-Asn-Phe-Asp-Ile-Pro-Glu-Glu-IleLyB-Gln-Leu-Gln-Gln-Phe-Gln-Lys-Glu-Aap-Ala'-Ala-Leu 'Thr-Ile-! Tyr-Glu-Met-Leu-Gln-Asn-Ile-Phe-Ala-lle-Phe-REQUIREMENTS / 5 Arg-Gln-Asp-Ser-Ser-Ser-Thr-Gly-Trp-Asn Glu-Thr-IleVal-Glu-Asn-Leu-Leu-Ala-Asn-Val-l ^ r-Hia-Gln-lle-AsnHis-Leu-t / ye-Thr-Val-Leu-Glu-GlU “Lys -Leu-Glu-Lys “GluAsp-Phe-Thr-Arg ~ Gly-Lys-Leu-Met-Ser-Ser-Leu-His-LeuLys-Arg-Tyr-Tyr-Gly-Arg-Ile-Leu-His-Tyr -L & u-Lys-AlaLy6-Glu-Tyr-Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arcj-Val “Glu-Ile-Leu-Arg-Asn-Phe-Tyr-Phe-'Ile- Asn-Arg-Leu-ThrGly-Tyr-teu-Arg-Asn and Met-Ser-Tyr-Asn-Leu-Leu-GlyPhe-Leu-Gln-Arg-Ser-Ser-Asn ~ Phe-Gln-Cys-Gln- Lys-LeuLeu-Trp-Gln-Leu “Asn-Gly-Arg-Leu-Glu-Tyr-Cys-Leu-LyeAsp-Arg-Met-Asn-Phe-Asp-Ile-Pro-Glu-Glu-Ile-Lys- GlnLeu-Gln-Gln-Phe-Gln-Lys-Glu-Asp-Ala-Ala -Leu - Thr-IleTyr-Glu-Met-Leu-Gln "Asn" Xle-Phe-Ala-Ile-Phe-Arg-GlhAsp-Ser-Ser-Ser-Thr-Gly-Trp-Asn-Glu-Thr- Ile-Val "GluAsn-Leu-Iieu ~ Ala-Asn-Val-Tyr-His-Gln" lle-Asn "His-LeuLys-Thr" Val-Leu-Glu-Glu-Lys-Leu-Glu-Lye-Glu- Asp-Phe Thr-Arg-Gly-Lys-Leu-Met-Ser-Ser-Leu-His-Leu-Lye-ArgTyr-Tyr-Gly-Arg-Ile-LeU“His-Tyr-Leu-Lys-Ala-Lys-GluTyr-Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arg“Val-Glu-IleLeu-Arg-A'sn-Phe-Tyr“Phe-Ile-Aen-Arg-LeU“Thr-Gly-TyrLeu-Arg-Asn.Thr-Arg-Gly-Lys-Leu-Met-Ser-Ser-Leu-His-Leu-Lye-ArgTyr-Tyr-Gly-Arg-Ile-LeU His-Tyr-Leu-Lys-Ala-Lys-GluTyr- Ser-His-Cys-Ala-Trp-Thr-Ile-Val-Arg "Val-Glu-IleLeu-Arg-A'sn-Phe-Tyr" Phe-Ile-Aen-Arg-LeU "Thr-Gly-TyrLeu- Arg-Asn. 15. Postupak za proizvodnju preparata za tretiranje humanih virusa iii za tretiranje raka iii tumora kod čoveka, iii za imunomodulaciju, naznačen tiae, što se kao jedini IFN-β koristi polipeptid proizveden postupkom prema bilo kojem od zahteva 9 do 14.A process for the manufacture of a human virus preparation preparation iii for the treatment of human cancer or tumor III, or for immunomodulation, designated thiae, which is used as the sole IFN-β by a polypeptide produced by the method of any one of claims 9 to 14.
SI8110859A 1980-04-03 1981-04-01 Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host SI8110859A8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8011306 1980-04-03
GB8018701 1980-06-06
YU859/81A YU45104B (en) 1980-04-03 1981-04-01 Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host

Publications (1)

Publication Number Publication Date
SI8110859A8 true SI8110859A8 (en) 1997-06-30

Family

ID=27260902

Family Applications (1)

Application Number Title Priority Date Filing Date
SI8110859A SI8110859A8 (en) 1980-04-03 1981-04-01 Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host

Country Status (3)

Country Link
BA (1) BA96097B1 (en)
HR (1) HRP921091B1 (en)
SI (1) SI8110859A8 (en)

Also Published As

Publication number Publication date
BA96097B1 (en) 1998-12-28
HRP921091B1 (en) 1996-04-30

Similar Documents

Publication Publication Date Title
KR102072013B1 (en) Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
DK170476B1 (en) Recombinant DNA molecule, uni-cellular host transformed with at least one recombinant DNA molecule, method for transforming a unicellular host, and methods for producing a polypeptide exhibiting the immunological or biological activity of human beta-interferon
Roditi et al. Unravelling the procyclin coat of Trypanosoma brucei
JP2740417B2 (en) Preparation method of human nerve growth factor by genetic recombination
AU604634B2 (en) Dog and horse interferons
DE68915282T2 (en) EXPRESSION CASSETTE FOR PLANTS.
Van Eldik et al. Synthesis and expression of a gene coding for the calcium-modulated protein S100 beta and designed for cassette-based, site-directed mutagenesis.
JPS62501470A (en) Purification, production and use of tumor necrosis factor
JPH01502985A (en) Leukemia inhibitory factor
JPS63500800A (en) Insertion of a gene encoding an interferon-induced protein into an animal
SI8110859A8 (en) Process for producing recombinant dnk molecule, capable of inducting polypeptide expression in an one-cell host
EP0240224A2 (en) An alpha interferon analogue
TW480272B (en) Mpl ligand analogs
JP6871547B2 (en) ADP ribosylation domain gene of piericin 1A and sericin cocoon
HUT52154A (en) Recombinant interleukin-2 hybrid proteins.
JPH02500641A (en) Manufacture of new protein sweeteners
EP1233024A3 (en) 25466, a human transporter family member and uses therefor
JP2003325188A (en) Cytokine gene recombinant silkworm and method for producing the protein
WO2024143785A1 (en) Manufacture of elastin-like polypeptide-based recombinant protein and animal cell expression platform thereof
Samara et al. Molecular biology and therapy of disease
HUT56881A (en) Process for expressing human nerve growth factor in arthropoda frugiperda cells infected with recombinant baculovirus
KR20240105210A (en) Platform for recombinant proteins using elastin like/based polypeptide and it&#39;s expression in animal cells
KR20170084653A (en) Plant cell having a resistance to gastric proteinase
JP2982177B2 (en) Expression plasmid, transformed yeast and method for producing feline interferon using the yeast
JP2843048B2 (en) Novel recombinant lymphotoxin derivatives